[
  {
    "id": 8489,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5706,
      "drug_code": 37569,
      "updated_date": "2025-05-15T03:48:00-04:00",
      "company": {
        "id": 604,
        "created_date": "2017-03-09T13:22:58-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 6996,
        "mfr_code": "BEW08",
        "name": "BRACCO IMAGING CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11065 BOUL. L-H LAFONTAINE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "VILLE D'ANJOU",
        "postal_code": "H1J 2Z4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8310379,
          "ingredient": {
            "id": 2042,
            "ingredient_code": 9697,
            "en_name": "MEGLUMINE IODIPAMIDE",
            "fr_name": "Iodipamide de méglumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "52",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02228556",
      "brand_name": "CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H5111",
      "number_of_ais": "1",
      "ai_group_no": "0103118001"
    },
    "created_date": "2017-05-01T20:34:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02228556",
    "company_name": "BRACCO IMAGING CANADA",
    "atc_number": "V08AC",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-20T06:00:02-05:00",
    "status": "active_confirmed",
    "en_comments": "This product is under review by the company's Marketing team as the demand has been very low over the last 7 years",
    "en_drug_brand_name": "CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV",
    "en_drug_common_name": "Cholografin",
    "fr_drug_brand_name": "CHOLOGRAFIN",
    "fr_drug_common_name": "CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV",
    "en_ingredients": "MEGLUMINE IODIPAMIDE",
    "fr_ingredients": "Iodipamide de méglumine",
    "drug_strength": "52%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10X20ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8495,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5710,
      "drug_code": 37573,
      "updated_date": "2025-05-15T03:48:00-04:00",
      "company": {
        "id": 604,
        "created_date": "2017-03-09T13:22:58-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 6996,
        "mfr_code": "BEW08",
        "name": "BRACCO IMAGING CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11065 BOUL. L-H LAFONTAINE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "VILLE D'ANJOU",
        "postal_code": "H1J 2Z4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8310384,
          "ingredient": {
            "id": 2044,
            "ingredient_code": 10131,
            "en_name": "DIATRIZOATE MEGLUMINE",
            "fr_name": "Diatrizoate de méglumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "52.7",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "%",
          "base": false
        },
        {
          "id": 8310383,
          "ingredient": {
            "id": 2042,
            "ingredient_code": 9697,
            "en_name": "MEGLUMINE IODIPAMIDE",
            "fr_name": "Iodipamide de méglumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "26.9",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "%",
          "base": false
        }
      ],
      "din": "02228599",
      "brand_name": "SINOGRAFIN - LIQ IU",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H5115",
      "number_of_ais": "2",
      "ai_group_no": "0201810001"
    },
    "created_date": "2017-05-01T20:44:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02228599",
    "company_name": "BRACCO IMAGING CANADA",
    "atc_number": "V08",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-21T06:00:03-05:00",
    "status": "active_confirmed",
    "en_comments": "This product is under review by the company's Marketing team as the demand has been very low over the last 7 years",
    "fr_comments": "Ce produit est en evaluation car la demande du marche au cours des 7 dernieres annees fut tres faible",
    "en_drug_brand_name": "SINOGRAFIN - LIQ IU",
    "en_drug_common_name": "SINOGRAFIN",
    "fr_drug_brand_name": "SINOGRAFIN",
    "fr_drug_common_name": "SINOGRAFIN",
    "en_ingredients": "DIATRIZOATE MEGLUMINE\r\nMEGLUMINE IODIPAMIDE",
    "fr_ingredients": "Diatrizoate de méglumine\r\nIodipamide de méglumine",
    "drug_strength": "52.7%\r\n26.9%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAUTERINE",
    "drug_route_fr": "Intra-utérine",
    "drug_package_quantity": "10 X 10ml",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8500,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10062,
      "drug_code": 6463,
      "updated_date": "2025-05-15T03:29:57-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8280325,
          "ingredient": {
            "id": 1600,
            "ingredient_code": 4182,
            "en_name": "CARBAMAZEPINE",
            "fr_name": "Carbamazépine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00665088",
      "brand_name": "TEGRETOL CHEWTABS 200 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63145",
      "number_of_ais": "1",
      "ai_group_no": "0108674001"
    },
    "created_date": "2017-05-01T21:01:02-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00665088",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "N03AF",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-06-05T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Remaining supply now depleted",
    "fr_supply_disruption_mitigation": "Stock restant maintenant épuisé",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-06-06T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEGRETOL CHEWTABS 200MG",
    "en_drug_common_name": "TEGRETOL 200MG CHEWTABS 100'S",
    "fr_drug_brand_name": "TEGRETOL 200MG CHEWTABS",
    "fr_drug_common_name": "TEGRETOL 200MG CHEWTABS 100'S",
    "en_ingredients": "CARBAMAZEPINE",
    "fr_ingredients": "Carbamazépine",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8504,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10060,
      "drug_code": 6462,
      "updated_date": "2025-05-15T03:29:57-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8280324,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00632732",
      "brand_name": "VOLTAREN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63144",
      "number_of_ais": "1",
      "ai_group_no": "0114417001"
    },
    "created_date": "2017-05-01T21:14:06-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00632732",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2017-07-25T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-11-02T20:27:54-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "VOLTAREN SUP 100MG",
    "en_drug_common_name": "VOLTAREN 100MG SUPPOSITORY (5X6)",
    "fr_drug_brand_name": "VOLTAREN SUPPOSITORY",
    "fr_drug_common_name": "VOLTAREN 100MG SUPPOSITORY (5X6)",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL",
    "drug_route_fr": "Rectale",
    "drug_package_quantity": "5 X 6",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 8528,
    "drug": {
      "current_status": "MARKETED",
      "id": 9150,
      "drug_code": 61971,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253594,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238545",
      "brand_name": "ASAPHEN E.C. 80 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101169013"
    },
    "created_date": "2017-05-02T13:00:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238545",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02BA",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "anticipated_start_date": "2017-07-07T00:00:00-04:00",
    "estimated_end_date": "2017-08-21T00:00:00-04:00",
    "actual_start_date": "2017-07-07T00:00:00-04:00",
    "actual_end_date": "2017-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-12T16:09:16-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "ASAPHEN E.C.",
    "en_drug_common_name": "ASAPHEN",
    "fr_drug_brand_name": "ASAPHEN ENROBÉ LOW DOSE",
    "fr_drug_common_name": "ASAPHEN",
    "en_ingredients": "ACETYLSALICYLIC ACID",
    "fr_ingredients": "Acide acétylsalicylique",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8533,
    "drug": {
      "current_status": "MARKETED",
      "id": 24048,
      "drug_code": 86679,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258651,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381052",
      "brand_name": "PMS-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434004"
    },
    "created_date": "2017-05-02T13:12:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381052",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2017-06-26T00:00:00-04:00",
    "estimated_end_date": "2018-01-30T00:00:00-05:00",
    "actual_start_date": "2017-06-26T00:00:00-04:00",
    "actual_end_date": "2018-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-12T19:42:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "PMS-ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8543,
    "drug": {
      "current_status": "MARKETED",
      "id": 24048,
      "drug_code": 86679,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258651,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381052",
      "brand_name": "PMS-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434004"
    },
    "created_date": "2017-05-02T13:16:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381052",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2017-07-11T00:00:00-04:00",
    "estimated_end_date": "2018-02-20T00:00:00-05:00",
    "actual_start_date": "2017-07-11T00:00:00-04:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-20T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATOMOXETINE",
    "en_drug_common_name": "ATOMEXETINE",
    "fr_drug_brand_name": "PMS-ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8550,
    "drug": {
      "current_status": "MARKETED",
      "id": 3728,
      "drug_code": 19221,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252462,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02179660",
      "brand_name": "PMS-CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81512",
      "number_of_ais": "1",
      "ai_group_no": "0111558003"
    },
    "created_date": "2017-05-02T13:19:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02179660",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AE",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-06-19T00:00:00-04:00",
    "estimated_end_date": "2017-08-21T00:00:00-04:00",
    "actual_start_date": "2017-06-19T00:00:00-04:00",
    "actual_end_date": "2017-05-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-12T16:14:33-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "PMS-CLONAZEPAM- TAB 0.25MG",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "PMS-CLONAZEPAM- TAB 0.25MG",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "0.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8555,
    "drug": {
      "current_status": "MARKETED",
      "id": 2172,
      "drug_code": 14587,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251987,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02048728",
      "brand_name": "PMS-CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76238",
      "number_of_ais": "1",
      "ai_group_no": "0111558004"
    },
    "created_date": "2017-05-02T13:20:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02048728",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AE",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-07-29T00:00:00-04:00",
    "estimated_end_date": "2017-10-25T00:00:00-04:00",
    "actual_start_date": "2017-07-29T00:00:00-04:00",
    "actual_end_date": "2017-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T19:54:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-CLONAZEPAM TAB 1.0MG",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "PMS-CLONAZEPAM TAB 1.0MG",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8564,
    "drug": {
      "current_status": "MARKETED",
      "id": 2172,
      "drug_code": 14587,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251987,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02048728",
      "brand_name": "PMS-CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76238",
      "number_of_ais": "1",
      "ai_group_no": "0111558004"
    },
    "created_date": "2017-05-02T13:21:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02048728",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AE",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-07-13T00:00:00-04:00",
    "actual_start_date": "2017-07-13T00:00:00-04:00",
    "actual_end_date": "2017-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-12T16:14:09-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "PMS-CLONAZEPAM TAB 1.0MG",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "PMS-CLONAZEPAM TAB 1.0MG",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8573,
    "drug": {
      "current_status": "MARKETED",
      "id": 26356,
      "drug_code": 88705,
      "updated_date": "2025-05-15T02:33:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259521,
          "ingredient": {
            "id": 1546,
            "ingredient_code": 6760,
            "en_name": "COLCHICINE",
            "fr_name": "Colchicine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402181",
      "brand_name": "PMS-COLCHICINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107264001"
    },
    "created_date": "2017-05-02T13:25:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402181",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M04AC",
    "atc_description": "ANTIGOUT PREPARATIONS",
    "anticipated_start_date": "2017-05-05T00:00:00-04:00",
    "estimated_end_date": "2019-11-18T00:00:00-05:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2019-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2019-12-24T13:58:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-COLCHICINE",
    "en_drug_common_name": "COLCHICINE",
    "fr_drug_brand_name": "PMS-COLCHICINE",
    "fr_drug_common_name": "COLCHICINE",
    "en_ingredients": "COLCHICINE",
    "fr_ingredients": "Colchicine",
    "drug_strength": "0.6MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8576,
    "drug": {
      "current_status": "MARKETED",
      "id": 4606,
      "drug_code": 23261,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252746,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01964976",
      "brand_name": "PMS-DEXAMETHASONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "E4122",
      "number_of_ais": "1",
      "ai_group_no": "0106303001"
    },
    "created_date": "2017-05-02T13:27:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01964976",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2017-05-16T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-01T14:13:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS DEXAMETHASONE TAB 0.5MG USP",
    "en_drug_common_name": "DEXAMETHASONE",
    "fr_drug_brand_name": "PMS DEXAMETHASONE TAB 0.5MG USP",
    "fr_drug_common_name": "DEXAMETHASONE",
    "en_ingredients": "DEXAMETHASONE",
    "fr_ingredients": "Dexaméthasone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8581,
    "drug": {
      "current_status": "MARKETED",
      "id": 1366,
      "drug_code": 12967,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251712,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01946897",
      "brand_name": "PMS-DEXAMETHASONE ELIXIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74210",
      "number_of_ais": "1",
      "ai_group_no": "0106303010"
    },
    "created_date": "2017-05-02T13:28:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01946897",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2017-06-30T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-07T16:44:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS DEXAMETHASONE ELIXIR 0.5MG/5ML",
    "en_drug_common_name": "DEXAMETHASONE",
    "fr_drug_brand_name": "PMS DEXAMETHASONE ELIXIR 0.5MG/5ML",
    "fr_drug_common_name": "DEXAMETHASONE",
    "en_ingredients": "DEXAMETHASONE",
    "fr_ingredients": "Dexaméthasone",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8584,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 352,
      "drug_code": 10878,
      "updated_date": "2025-12-03T01:05:00-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8287186,
          "ingredient": {
            "id": 186,
            "ingredient_code": 9152,
            "en_name": "DOCUSATE SODIUM",
            "fr_name": "Docusate sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00880140",
      "brand_name": "PMS-DOCUSATE SODIUM DROPS 10MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71002",
      "number_of_ais": "1",
      "ai_group_no": "0104351004"
    },
    "created_date": "2017-05-02T13:29:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00880140",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AA",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T11:16:28-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-DOCUSATE SODIUM DROPS 10MG/ML",
    "en_drug_common_name": "DOCUSATE",
    "fr_drug_brand_name": "PMS-DOCUSATE SODIUM DROPS 10MG/ML",
    "fr_drug_common_name": "DOCUSATE SODIUM",
    "en_ingredients": "DOCUSATE SODIUM",
    "fr_ingredients": "Docusate sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BOTTLE 500mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8587,
    "drug": {
      "current_status": "MARKETED",
      "id": 4826,
      "drug_code": 2657,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250432,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00362158",
      "brand_name": "DIAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50813",
      "number_of_ais": "1",
      "ai_group_no": "0103614001"
    },
    "created_date": "2017-05-02T13:29:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00362158",
    "company_name": "APOTEX INC",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "estimated_end_date": "2017-06-26T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-13T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "APO-DIAZEPAM  5 MG TAB 1000 BTL is available",
    "fr_comments": "APO-DIAZEPAM  5 MG TAB 1000 BTL est disponible",
    "en_drug_brand_name": "APO DIAZEPAM TAB 5MG",
    "en_drug_common_name": "DIAZEPAM",
    "fr_drug_brand_name": "APO DIAZEPAM TAB 5MG",
    "fr_drug_common_name": "DIAZEPAM",
    "en_ingredients": "DIAZEPAM",
    "fr_ingredients": "Diazépam",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8590,
    "drug": {
      "current_status": "DORMANT",
      "id": 29826,
      "drug_code": 91867,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369233,
          "ingredient": {
            "id": 3156,
            "ingredient_code": 13346,
            "en_name": "ELETRIPTAN",
            "fr_name": "Élétriptan (Bromhydrate d'élétriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434342",
      "brand_name": "PMS-ELETRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150241001"
    },
    "created_date": "2017-05-02T13:31:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434342",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2017-07-13T00:00:00-04:00",
    "actual_start_date": "2017-07-13T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T11:20:15-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-ELETRIPTAN",
    "en_drug_common_name": "ELETRIPTAN",
    "fr_drug_brand_name": "PMS-ELETRIPTAN",
    "fr_drug_common_name": "ELETRIPTAN",
    "en_ingredients": "ELETRIPTAN",
    "fr_ingredients": "ELETRIPTAN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8593,
    "drug": {
      "current_status": "MARKETED",
      "id": 12454,
      "drug_code": 71083,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254585,
          "ingredient": {
            "id": 2190,
            "ingredient_code": 1381,
            "en_name": "FENOFIBRATE",
            "fr_name": "Fénofibrate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246860",
      "brand_name": "AA-FENO-SUPER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118895004"
    },
    "created_date": "2017-05-02T13:32:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246860",
    "company_name": "APOTEX INC",
    "atc_number": "C10AB",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-09-15T00:00:00-04:00",
    "actual_start_date": "2017-08-08T00:00:00-04:00",
    "actual_end_date": "2017-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-29T14:24:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-FENO-SUPER",
    "en_drug_common_name": "FENOFIBRATE",
    "fr_drug_brand_name": "APO-FENO-SUPER",
    "fr_drug_common_name": "FENOFIBRATE",
    "en_ingredients": "FENOFIBRATE",
    "fr_ingredients": "Fénofibrate",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8595,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8534,
      "drug_code": 60020,
      "updated_date": "2025-12-03T01:16:45-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8324121,
          "ingredient": {
            "id": 240,
            "ingredient_code": 4007,
            "en_name": "GLYBURIDE",
            "fr_name": "Glyburide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236734",
      "brand_name": "PMS-GLYBURIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108708001"
    },
    "created_date": "2017-05-02T13:32:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02236734",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2017-05-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-02T13:57:53-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-GLYBURIDE",
    "en_drug_common_name": "GLYBURIDE",
    "fr_drug_brand_name": "PMS-GLYBURIDE",
    "fr_drug_common_name": "GLYBURIDE",
    "en_ingredients": "GLYBURIDE",
    "fr_ingredients": "Glyburide",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 8599,
    "drug": {
      "current_status": "DORMANT",
      "id": 5784,
      "drug_code": 38260,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367182,
          "ingredient": {
            "id": 674,
            "ingredient_code": 2395,
            "en_name": "LACTULOSE",
            "fr_name": "Lactulose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "667",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00703486",
      "brand_name": "PMS-LACTULOSE SYR 667MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "K0863",
      "number_of_ais": "1",
      "ai_group_no": "0113020001"
    },
    "created_date": "2017-05-02T13:34:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00703486",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AD",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "anticipated_start_date": "2017-05-03T00:00:00-04:00",
    "estimated_end_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-05-18T21:40:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "en_drug_common_name": "LACTULOSE",
    "fr_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "fr_drug_common_name": "LACTULOSE",
    "en_ingredients": "LACTULOSE",
    "fr_ingredients": "Lactulose",
    "drug_strength": "667MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "BOTTLE",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 8602,
    "drug": {
      "current_status": "MARKETED",
      "id": 15290,
      "drug_code": 75834,
      "updated_date": "2025-05-15T02:31:42-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255461,
          "ingredient": {
            "id": 1284,
            "ingredient_code": 1298,
            "en_name": "ISOSORBIDE-5-MONONITRATE",
            "fr_name": "5-mononitrate d'isosorbide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02272830",
      "brand_name": "APO-ISMN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120456002"
    },
    "created_date": "2017-05-02T13:35:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02272830",
    "company_name": "APOTEX INC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "estimated_end_date": "2017-07-14T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-27T11:39:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ISMN",
    "en_drug_common_name": "ISMN",
    "fr_drug_brand_name": "APO-ISMN",
    "fr_drug_common_name": "ISMN",
    "en_ingredients": "ISOSORBIDE-5-MONONITRATE",
    "fr_ingredients": "5-mononitrate d'isosorbide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8605,
    "drug": {
      "current_status": "MARKETED",
      "id": 18204,
      "drug_code": 79471,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256388,
          "ingredient": {
            "id": 2412,
            "ingredient_code": 11446,
            "en_name": "LETROZOLE",
            "fr_name": "Létrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309114",
      "brand_name": "PMS-LETROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132937001"
    },
    "created_date": "2017-05-02T13:35:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309114",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "anticipated_start_date": "2017-10-26T00:00:00-04:00",
    "estimated_end_date": "2017-11-11T00:00:00-05:00",
    "actual_end_date": "2017-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-07T21:18:35-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "PMS-LETROZOLE",
    "en_drug_common_name": "LETROZOLE",
    "fr_drug_brand_name": "PMS-LETROZOLE",
    "fr_drug_common_name": "LETROZOLE",
    "en_ingredients": "LETROZOLE",
    "fr_ingredients": "Létrozole",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 8608,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 452,
      "drug_code": 10977,
      "updated_date": "2025-12-03T01:05:02-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8287312,
          "ingredient": {
            "id": 164,
            "ingredient_code": 10225,
            "en_name": "LIDOCAINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de lidocaïne"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00811874",
      "brand_name": "PMS-LIDOCAINE VISCOUS 2%",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71143",
      "number_of_ais": "1",
      "ai_group_no": "0101280001"
    },
    "created_date": "2017-05-02T13:37:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00811874",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N01BB",
    "atc_description": "ANESTHETICS, LOCAL",
    "anticipated_start_date": "2017-05-01T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T12:09:33-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-LIDOCAINE VISCOUS 2%",
    "en_drug_common_name": "LIDOCAINE",
    "fr_drug_brand_name": "PMS-LIDOCAINE VISCOUS 2%",
    "fr_drug_common_name": "LIDOCAINE",
    "en_ingredients": "LIDOCAINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de lidocaïne",
    "drug_strength": "2%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "DENTAL",
    "drug_route_fr": "Dentaire",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8612,
    "drug": {
      "current_status": "MARKETED",
      "id": 2490,
      "drug_code": 15925,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252072,
          "ingredient": {
            "id": 1184,
            "ingredient_code": 11182,
            "en_name": "MINOCYCLINE",
            "fr_name": "Minocycline (Chlorhydrate de minocycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02084104",
      "brand_name": "MINOCYCLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77688",
      "number_of_ais": "1",
      "ai_group_no": "0131309002"
    },
    "created_date": "2017-05-02T13:40:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02084104",
    "company_name": "APOTEX INC",
    "atc_number": "J01AA",
    "atc_description": "TETRACYCLINES",
    "estimated_end_date": "2017-06-02T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-06T01:08:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MINOCYCLINE CAP 100MG",
    "en_drug_common_name": "MINOCYCLINE",
    "fr_drug_brand_name": "APO-MINOCYCLINE CAP 100MG",
    "fr_drug_common_name": "MINOCYCLINE",
    "en_ingredients": "MINOCYCLINE",
    "fr_ingredients": "MINOCYCLINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8615,
    "drug": {
      "current_status": "MARKETED",
      "id": 18044,
      "drug_code": 79224,
      "updated_date": "2025-12-03T00:31:17-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256347,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02306530",
      "brand_name": "APO-OXYCODONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552005"
    },
    "created_date": "2017-05-02T13:42:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02306530",
    "company_name": "APOTEX INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2017-05-31T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-06T01:43:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OXYCODONE CR",
    "en_drug_common_name": "OXYCODONE",
    "fr_drug_brand_name": "APO-OXYCODONE CR",
    "fr_drug_common_name": "OXYCODONE",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8620,
    "drug": {
      "current_status": "MARKETED",
      "id": 32190,
      "drug_code": 9910,
      "updated_date": "2025-12-03T00:30:29-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251244,
          "ingredient": {
            "id": 116,
            "ingredient_code": 9880,
            "en_name": "METRONIDAZOLE",
            "fr_name": "Métronidazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00783137",
      "brand_name": "PMS-METRONIDAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69272",
      "number_of_ais": "1",
      "ai_group_no": "0102572003"
    },
    "created_date": "2017-05-02T13:43:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00783137",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J01XD",
    "atc_description": "OTHER ANTIBACTERIALS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-06-10T12:21:23-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-METRONIDAZOLE",
    "en_drug_common_name": "METRONIDAZOLE",
    "fr_drug_brand_name": "PMS-METRONIDAZOLE",
    "fr_drug_common_name": "METRONIDAZOLE",
    "en_ingredients": "METRONIDAZOLE",
    "fr_ingredients": "Métronidazole",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8624,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19352,
      "drug_code": 80626,
      "updated_date": "2025-12-03T01:26:25-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8346606,
          "ingredient": {
            "id": 1598,
            "ingredient_code": 1250,
            "en_name": "OMEPRAZOLE",
            "fr_name": "Oméprazole (Oméprazole magnésium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02320851",
      "brand_name": "PMS-OMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121643001"
    },
    "created_date": "2017-05-02T13:46:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02320851",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-23T16:56:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-OMEPRAZOLE",
    "en_drug_common_name": "OMEPRAZOLE",
    "fr_drug_brand_name": "PMS-OMEPRAZOLE",
    "fr_drug_common_name": "OMEPRAZOLE",
    "en_ingredients": "OMEPRAZOLE",
    "fr_ingredients": "Oméprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8627,
    "drug": {
      "current_status": "MARKETED",
      "id": 6434,
      "drug_code": 43358,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253071,
          "ingredient": {
            "id": 1396,
            "ingredient_code": 10040,
            "en_name": "OXYBUTYNIN CHLORIDE",
            "fr_name": "Chlorure d'oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02223376",
      "brand_name": "PMS-OXYBUTYNIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9689",
      "number_of_ais": "1",
      "ai_group_no": "0114692002"
    },
    "created_date": "2017-05-02T13:47:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02223376",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-10-23T00:00:00-04:00",
    "actual_start_date": "2017-12-17T00:00:00-05:00",
    "actual_end_date": "2018-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-29T14:02:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-OXYBUTYNIN",
    "en_drug_common_name": "OXYBUTYNIN",
    "fr_drug_brand_name": "PMS-OXYBUTYNIN",
    "fr_drug_common_name": "OXYBUTYNIN",
    "en_ingredients": "OXYBUTYNIN CHLORIDE",
    "fr_ingredients": "Chlorure d'oxybutynine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 mg/mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8630,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10592,
      "drug_code": 66172,
      "updated_date": "2025-12-03T01:19:25-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8332470,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02242453",
      "brand_name": "PMS-RANITIDINE 150 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2017-05-02T13:48:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242453",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-05-19T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-09T18:38:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "PMS-RANITIDINE 150 MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8633,
    "drug": {
      "current_status": "MARKETED",
      "id": 15750,
      "drug_code": 76481,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255638,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02279266",
      "brand_name": "PMS-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332003"
    },
    "created_date": "2017-05-02T13:51:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279266",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-05-15T00:00:00-04:00",
    "estimated_end_date": "2017-05-29T00:00:00-04:00",
    "actual_end_date": "2017-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-09T18:39:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "PMS-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 mg/mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 8636,
    "drug": {
      "current_status": "MARKETED",
      "id": 9072,
      "drug_code": 61730,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253569,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238327",
      "brand_name": "PMS-SOTALOL - 160 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778001"
    },
    "created_date": "2017-05-02T13:53:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238327",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-07-04T00:00:00-04:00",
    "estimated_end_date": "2017-12-14T00:00:00-05:00",
    "actual_start_date": "2017-07-04T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T17:26:33-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SOTALOL - 160 MG",
    "en_drug_common_name": "SOTALOL",
    "fr_drug_brand_name": "PMS-SOTALOL - 160 MG",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "CAPL 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8639,
    "drug": {
      "current_status": "MARKETED",
      "id": 9070,
      "drug_code": 61729,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253568,
          "ingredient": {
            "id": 1478,
            "ingredient_code": 2048,
            "en_name": "SOTALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de sotalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238326",
      "brand_name": "PMS-SOTALOL - 80 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113778002"
    },
    "created_date": "2017-05-02T13:53:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238326",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-06-12T00:00:00-04:00",
    "actual_end_date": "2017-11-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-22T22:10:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SOTALOL - 80 MG",
    "en_drug_common_name": "SOTALOL",
    "fr_drug_brand_name": "PMS-SOTALOL - 80 MG",
    "fr_drug_common_name": "SOTALOL",
    "en_ingredients": "SOTALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de sotalol",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "CAPL 500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8642,
    "drug": {
      "current_status": "MARKETED",
      "id": 14560,
      "drug_code": 74841,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255234,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02263009",
      "brand_name": "PMS-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938002"
    },
    "created_date": "2017-05-02T13:54:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02263009",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-11-21T00:00:00-05:00",
    "actual_start_date": "2017-06-19T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2017-11-17T17:26:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "PMS-TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8702,
    "drug": {
      "current_status": "DORMANT",
      "id": 18668,
      "drug_code": 79944,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368175,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313928",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858002"
    },
    "created_date": "2017-05-02T15:02:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313928",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2017-07-10T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-27T11:43:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8705,
    "drug": {
      "current_status": "MARKETED",
      "id": 13768,
      "drug_code": 73644,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254956,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02251515",
      "brand_name": "APO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858001"
    },
    "created_date": "2017-05-02T15:04:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02251515",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2017-05-31T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-09T12:26:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "APO-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8707,
    "drug": {
      "current_status": "MARKETED",
      "id": 13768,
      "drug_code": 73644,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254956,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02251515",
      "brand_name": "APO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858001"
    },
    "created_date": "2017-05-02T15:06:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02251515",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2017-06-15T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-09T01:28:26-04:00",
    "status": "resolved",
    "en_comments": "APO-RAMIPRIL CAP 1.25MG 30 BLS",
    "fr_comments": "APO-RAMIPRIL CAP 1.25MG 30 BLS est disponible",
    "en_drug_brand_name": "APO-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "APO-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8710,
    "drug": {
      "current_status": "MARKETED",
      "id": 20620,
      "drug_code": 82363,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257288,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02337983",
      "brand_name": "APO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2017-05-02T15:10:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02337983",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-08-31T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-16T17:32:45-04:00",
    "status": "resolved",
    "en_comments": "APO-ROSUVASTATIN FCT 10MG 100 BTL is available",
    "fr_comments": "APO-ROSUVASTATIN FCT 10MG 100 BTL est disponible",
    "en_drug_brand_name": "APO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "APO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8713,
    "drug": {
      "current_status": "MARKETED",
      "id": 20624,
      "drug_code": 82365,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257290,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338009",
      "brand_name": "APO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2017-05-02T15:12:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338009",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-08-31T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-08-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-17T12:33:13-04:00",
    "status": "resolved",
    "en_comments": "APO-ROSUVASTATIN FCT 40MG 100 BTL  is available",
    "fr_comments": "APO-ROSUVASTATIN FCT 40MG 100 BTL",
    "en_drug_brand_name": "APO-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "APO-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8716,
    "drug": {
      "current_status": "MARKETED",
      "id": 13300,
      "drug_code": 72895,
      "updated_date": "2025-05-15T02:31:30-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254824,
          "ingredient": {
            "id": 380,
            "ingredient_code": 10238,
            "en_name": "TRYPTOPHAN",
            "fr_name": "Tryptophane"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248540",
      "brand_name": "APO-TRYPTOPHAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111038003"
    },
    "created_date": "2017-05-02T15:29:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248540",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-07-24T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-01T02:11:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TRYPTOPHAN",
    "en_drug_common_name": "TRYPTOPHAN",
    "fr_drug_brand_name": "APO-TRYPTOPHAN",
    "fr_drug_common_name": "TRYPTOPHAN",
    "en_ingredients": "TRYPTOPHAN",
    "fr_ingredients": "Tryptophane",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8719,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27586,
      "drug_code": 89818,
      "updated_date": "2025-05-15T04:21:39-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8353713,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413523",
      "brand_name": "MYLAN-RISPERIDONE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332005"
    },
    "created_date": "2017-05-02T16:12:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413523",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "hc_updated_date": "2021-11-23T19:03:30-05:00",
    "actual_start_date": "2017-05-02T00:00:00-04:00",
    "actual_end_date": "2021-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-11-23T19:03:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-RISPERIDONE ODT",
    "en_drug_common_name": "RISPERIDONE ODT",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE ODT",
    "fr_drug_common_name": "RISPERIDONE ODT",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8723,
    "drug": {
      "current_status": "MARKETED",
      "id": 10028,
      "drug_code": 64499,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253820,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240908",
      "brand_name": "APO-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131002"
    },
    "created_date": "2017-05-02T16:27:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240908",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-07-14T00:00:00-04:00",
    "actual_start_date": "2017-05-02T00:00:00-04:00",
    "actual_end_date": "2017-06-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-28T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "APO-PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8733,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15422,
      "drug_code": 76001,
      "updated_date": "2025-05-15T04:10:47-04:00",
      "company": {
        "id": 1216,
        "created_date": "2017-03-09T13:23:57-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 12463,
        "mfr_code": "",
        "name": "GENMED A DIVISION OF PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-800-387-4974\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8341991,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02274574",
      "brand_name": "GD-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072003"
    },
    "created_date": "2017-05-02T19:27:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274574",
    "company_name": "GENMED A DIVISION OF PFIZER CANADA INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2017-05-16T00:00:00-04:00",
    "actual_start_date": "2017-04-21T00:00:00-04:00",
    "actual_end_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-05-06T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Resolved May 5, 2017",
    "fr_comments": "Résolu le 5 mai 2017",
    "en_drug_brand_name": "GD-AZITHROMYCIN",
    "en_drug_common_name": "GD-AZITHROMYCIN",
    "fr_drug_brand_name": "GD-AZITHROMYCIN",
    "fr_drug_common_name": "GD-AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "600mg/15mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 8754,
    "drug": {
      "current_status": "DORMANT",
      "id": 9844,
      "drug_code": 6394,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366407,
          "ingredient": {
            "id": 2504,
            "ingredient_code": 6030,
            "en_name": "PROCYCLIDINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de procyclidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00649392",
      "brand_name": "PDP-PROCYCLIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62935",
      "number_of_ais": "1",
      "ai_group_no": "0107590003"
    },
    "created_date": "2017-05-03T12:17:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00649392",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "N04AA",
    "atc_description": "ANTICHOLINERGIC AGENTS",
    "anticipated_start_date": "2017-06-06T00:00:00-04:00",
    "actual_start_date": "2017-06-06T00:00:00-04:00",
    "actual_end_date": "2017-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-09-13T16:09:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-PROCYCLIDINE",
    "en_drug_common_name": "pdp-PROCYCLIDINE 2.5mg TABS 100",
    "fr_drug_brand_name": "pdp-PROCYCLIDINE",
    "fr_drug_common_name": "pdp-PROCYCLIDINE 2.5mg TABS 100",
    "en_ingredients": "PROCYCLIDINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de procyclidine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8757,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6436,
      "drug_code": 43361,
      "updated_date": "2025-05-15T03:49:52-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8312938,
          "ingredient": {
            "id": 2174,
            "ingredient_code": 1751,
            "en_name": "INTERFERON ALFA-2B",
            "fr_name": "Interféron alfa-2b"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8312937,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "ML",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02223406",
      "brand_name": "INTRON A",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9692",
      "number_of_ais": "2",
      "ai_group_no": "0228673003"
    },
    "created_date": "2017-05-03T12:56:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02223406",
    "company_name": "MERCK CANADA INC",
    "atc_number": "L03AB",
    "atc_description": "IMMUNOSTIMULANTS",
    "anticipated_start_date": "2017-05-03T00:00:00-04:00",
    "estimated_end_date": "2017-07-21T00:00:00-04:00",
    "actual_start_date": "2017-05-03T00:00:00-04:00",
    "actual_end_date": "2017-07-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-07-15T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Limited quantities will be available",
    "fr_comments": "Quantité limitée disponible jusqu'au prochain lot.",
    "en_drug_brand_name": "INTRON A",
    "en_drug_common_name": "interferon alfa-2b  lyophilized powder",
    "fr_drug_brand_name": "INTRON A",
    "fr_drug_common_name": "interféron alfa-2b poudre lyophilisée",
    "en_ingredients": "WATER\r\nINTERFERON ALFA-2B",
    "fr_ingredients": "Eau\r\nInterféron alfa-2b",
    "drug_strength": "1ML\r\n10000000UNIT",
    "drug_dosage_form": "LIQUID\r\nPOWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Liquide\r\nPoudre pour solution",
    "drug_route": "INTRALESIONAL\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intralésionnelle\r\nIntramusculaire\r\nIntraveineuse\r\nSous-cutanée",
    "drug_package_quantity": "1X10 MIU",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8764,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27584,
      "drug_code": 89817,
      "updated_date": "2025-05-15T04:21:39-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8353712,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02413515",
      "brand_name": "MYLAN-RISPERIDONE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332002"
    },
    "created_date": "2017-05-03T13:54:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02413515",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "hc_updated_date": "2021-11-23T19:04:48-05:00",
    "actual_start_date": "2018-05-02T00:00:00-04:00",
    "actual_end_date": "2021-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2021-11-23T19:04:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-RISPERIDONE ODT",
    "en_drug_common_name": "RISPERIDONE ODT",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE ODT",
    "fr_drug_common_name": "RISPERIDONE ODT",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "3MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8767,
    "drug": {
      "current_status": "DORMANT",
      "id": 17624,
      "drug_code": 78674,
      "updated_date": "2025-05-15T06:55:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368107,
          "ingredient": {
            "id": 2808,
            "ingredient_code": 12006,
            "en_name": "CABERGOLINE",
            "fr_name": "Cabergoline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02301407",
      "brand_name": "ACT CABERGOLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141281001"
    },
    "created_date": "2017-05-03T13:58:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02301407",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "G02CB",
    "atc_description": "OTHER GYNECOLOGICALS",
    "actual_start_date": "2015-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-10-05T05:00:02-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACT CABERGOLINE",
    "en_drug_common_name": "CABERGOLINE",
    "fr_drug_brand_name": "ACT CABERGOLINE",
    "fr_drug_common_name": "CABERGOLINE",
    "en_ingredients": "CABERGOLINE",
    "fr_ingredients": "Cabergoline",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "8",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 8810,
    "drug": {
      "current_status": "MARKETED",
      "id": 30176,
      "drug_code": 92223,
      "updated_date": "2025-05-15T02:34:41-04:00",
      "company": {
        "id": 226,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 8892,
        "mfr_code": "RAX08",
        "name": "STERIMAX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2770 PORTLAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 6R4",
        "post_office_box": "",
        "contact_information": "1-800-881-3550"
      },
      "drug_ingredients": [
        {
          "id": 8261023,
          "ingredient": {
            "id": 418,
            "ingredient_code": 8344,
            "en_name": "CEFTAZIDIME",
            "fr_name": "Ceftazidime (Ceftazidime pentahydratée)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02437864",
      "brand_name": "CEFTAZIDIME FOR INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "I.V. INFUSION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116900009"
    },
    "created_date": "2017-05-03T19:55:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437864",
    "company_name": "STERIMAX INC",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2017-05-19T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-05-25T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTAZIDIME FOR INJECTION BP",
    "en_drug_common_name": "CEFTAZIDIME FOR INJECTION BP",
    "fr_drug_brand_name": "CEFTAZIDIME POUR INJECTION BP",
    "fr_drug_common_name": "CEFTAZIDIME POUR INJECTION BP",
    "en_ingredients": "CEFTAZIDIME",
    "fr_ingredients": "Ceftazidime",
    "drug_strength": "6G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8815,
    "drug": {
      "current_status": "MARKETED",
      "id": 30108,
      "drug_code": 92143,
      "updated_date": "2025-05-15T02:34:39-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260968,
          "ingredient": {
            "id": 1568,
            "ingredient_code": 11180,
            "en_name": "CEFAZOLIN",
            "fr_name": "Céfazoline (Céfazoline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02437120",
      "brand_name": "CEFAZOLIN FOR INJECTION",
      "brand_name_fr": "CÉFAZOLINE POUR INJECTION",
      "descriptor": "MULTI-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109442006"
    },
    "created_date": "2017-05-03T19:58:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02437120",
    "company_name": "STERIMAX INC",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-06-07T12:13:24-04:00",
    "status": "resolved",
    "en_comments": "Product is available",
    "fr_comments": "Ce produit est disponible",
    "en_drug_brand_name": "CEFAZOLIN FOR INJECTION",
    "en_drug_common_name": "CEFAZOLIN FOR INJECTION",
    "fr_drug_brand_name": "CÉFAZOLIN POUR INJECTION",
    "fr_drug_common_name": "CÉFAZOLIN POUR INJECTION",
    "en_ingredients": "CEFAZOLIN",
    "fr_ingredients": "CEFAZOLIN (CEFAZOLIN SODIUM)",
    "drug_strength": "10G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "PACK OF 10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8822,
    "drug": {
      "current_status": "MARKETED",
      "id": 30078,
      "drug_code": 92123,
      "updated_date": "2025-05-15T02:34:39-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8260952,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02436914",
      "brand_name": "AURO-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830003"
    },
    "created_date": "2017-05-03T20:17:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436914",
    "company_name": "AURO PHARMA INC",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "anticipated_start_date": "2017-05-04T00:00:00-04:00",
    "estimated_end_date": "2017-08-15T00:00:00-04:00",
    "actual_end_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-09-05T18:46:56-04:00",
    "status": "resolved",
    "en_comments": "Resolved",
    "fr_comments": "Produit attribué à cause d’une demande croissante",
    "en_drug_brand_name": "AURO-CLINDAMYCIN",
    "en_drug_common_name": "Clindamycin",
    "fr_drug_brand_name": "Auro-Clindamycin",
    "fr_drug_common_name": "Clindamycine",
    "en_ingredients": "CLINDAMYCIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de clindamycine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 8842,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10906,
      "drug_code": 66826,
      "updated_date": "2025-05-15T04:02:35-04:00",
      "company": {
        "id": 150,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T03:21:46-04:00",
        "company_code": 16525,
        "mfr_code": "",
        "name": "LIEBEL-FLARSHEIM CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7500 TRANSCANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "POINTE-CLAIRE",
        "postal_code": "H9R 5H8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8333290,
          "ingredient": {
            "id": 2850,
            "ingredient_code": 12039,
            "en_name": "GADOVERSETAMIDE",
            "fr_name": "Gadoversétamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "330.9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242986",
      "brand_name": "OPTIMARK",
      "brand_name_fr": "OPTIMARK",
      "descriptor": "VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142281001"
    },
    "created_date": "2017-05-03T22:59:10-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02242986",
    "company_name": "LIEBEL-FLARSHEIM CANADA INC",
    "atc_number": "V08CA06",
    "atc_description": "MAGNETIC RESONANCE IMAGING CONTRAST MEDIA",
    "discontinuation_date": "2018-03-23T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2018-03-28T16:03:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "OPTIMARK",
    "en_drug_common_name": "GADOVERSETAMIDE INJECTION",
    "fr_drug_brand_name": "OPTIMARK",
    "fr_drug_common_name": "INJECTION Gadoversétamide",
    "en_ingredients": "GADOVERSETAMIDE",
    "fr_ingredients": "Gadoversétamide",
    "drug_strength": "330.9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "5, 10, 15, 20mL vials",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 8859,
    "drug": {
      "current_status": "MARKETED",
      "id": 13872,
      "drug_code": 73770,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254987,
          "ingredient": {
            "id": 2616,
            "ingredient_code": 11795,
            "en_name": "CLOPIDOGREL",
            "fr_name": "Clopidogrel (Bisulfate de clopidogrel)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02252767",
      "brand_name": "APO-CLOPIDOGREL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134440001"
    },
    "created_date": "2017-05-04T12:21:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02252767",
    "company_name": "APOTEX INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2017-05-16T00:00:00-04:00",
    "estimated_end_date": "2017-07-21T00:00:00-04:00",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2017-07-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-22T18:46:44-04:00",
    "status": "resolved",
    "en_comments": "APO-CLOPIDOGREL FCT 75MG 100 BTL available",
    "fr_comments": "APO-CLOPIDOGREL FCT 75MG 100 BTL  est disponible",
    "en_drug_brand_name": "APO-CLOPIDOGREL",
    "en_drug_common_name": "CLOPIDOGREL",
    "fr_drug_brand_name": "APO-CLOPIDOGREL",
    "fr_drug_common_name": "CLOPIDOGREL",
    "en_ingredients": "CLOPIDOGREL",
    "fr_ingredients": "CLOPIDOGREL",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8862,
    "drug": {
      "current_status": "DORMANT",
      "id": 29202,
      "drug_code": 91232,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369149,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02427826",
      "brand_name": "APO-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2017-05-04T12:23:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427826",
    "company_name": "APOTEX INC",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-05-23T00:00:00-04:00",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_start_date": "2017-06-05T00:00:00-04:00",
    "actual_end_date": "2017-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-18T16:59:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-EZETIMIBE",
    "en_drug_common_name": "EZETIMIBE",
    "fr_drug_brand_name": "APO-EZETIMIBE",
    "fr_drug_common_name": "EZETIMIBE",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8865,
    "drug": {
      "current_status": "MARKETED",
      "id": 11790,
      "drug_code": 69270,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254377,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245246",
      "brand_name": "APO-INDAPAMIDE 1.25 MG TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115402002"
    },
    "created_date": "2017-05-04T12:29:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245246",
    "company_name": "APOTEX INC",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "anticipated_start_date": "2017-06-12T00:00:00-04:00",
    "estimated_end_date": "2017-12-20T00:00:00-05:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2017-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-14T18:57:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-INDAPAMIDE 1.25 MG TABLETS",
    "en_drug_common_name": "INDAPAMIDE",
    "fr_drug_brand_name": "APO-INDAPAMIDE 1.25 MG TABLETS",
    "fr_drug_common_name": "INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8868,
    "drug": {
      "current_status": "DORMANT",
      "id": 6332,
      "drug_code": 43222,
      "updated_date": "2025-05-15T06:55:26-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367206,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02217503",
      "brand_name": "APO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9549",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2017-05-04T12:31:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02217503",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-05-15T00:00:00-04:00",
    "estimated_end_date": "2017-06-30T00:00:00-04:00",
    "actual_start_date": "2017-05-08T00:00:00-04:00",
    "actual_end_date": "2017-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-23T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "APO-LISINOPRIL 10 MG TAB 100 BTL available",
    "fr_comments": "APO-LISINOPRIL 10 MG TAB 100 BTL est disponible",
    "en_drug_brand_name": "APO-LISINOPRIL TABLET 10 MG",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "APO-LISINOPRIL TABLET 10 MG",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8871,
    "drug": {
      "current_status": "MARKETED",
      "id": 13566,
      "drug_code": 73355,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254906,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248973",
      "brand_name": "APO-MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676003"
    },
    "created_date": "2017-05-04T12:33:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248973",
    "company_name": "APOTEX INC",
    "atc_number": "M01AC",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2017-09-18T00:00:00-04:00",
    "actual_end_date": "2017-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T12:52:38-04:00",
    "status": "resolved",
    "en_comments": "APO-MELOXICAM TAB 7.5MG 100 BTL available",
    "fr_comments": "APO-MELOXICAM TAB 7.5MG 100 BTL  est disponible",
    "en_drug_brand_name": "APO-MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "APO-MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8874,
    "drug": {
      "current_status": "MARKETED",
      "id": 16410,
      "drug_code": 77206,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255850,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286610",
      "brand_name": "APO-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928001"
    },
    "created_date": "2017-05-04T12:38:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286610",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-05-26T00:00:00-04:00",
    "estimated_end_date": "2017-06-27T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-15T12:57:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "APO-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8877,
    "drug": {
      "current_status": "DORMANT",
      "id": 21384,
      "drug_code": 83782,
      "updated_date": "2025-12-03T02:32:27-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368454,
          "ingredient": {
            "id": 1570,
            "ingredient_code": 118,
            "en_name": "MYCOPHENOLATE MOFETIL",
            "fr_name": "Mofétilmycophénolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02352567",
      "brand_name": "APO-MYCOPHENOLATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128158002"
    },
    "created_date": "2017-05-04T12:42:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352567",
    "company_name": "APOTEX INC",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "anticipated_start_date": "2017-06-08T00:00:00-04:00",
    "estimated_end_date": "2017-06-28T00:00:00-04:00",
    "actual_end_date": "2017-06-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-04T17:51:20-04:00",
    "status": "resolved",
    "en_comments": "APO-MYCOPHENOLATE MOF FCT 500MG 100 BTL  available",
    "fr_comments": "APO-MYCOPHENOLATE MOF FCT 500MG 100 BTL  est disponible",
    "en_drug_brand_name": "APO-MYCOPHENOLATE",
    "en_drug_common_name": "MYCOPHENOLATE",
    "fr_drug_brand_name": "APO-MYCOPHENOLATE",
    "fr_drug_common_name": "MYCOPHENOLATE",
    "en_ingredients": "MYCOPHENOLATE MOFETIL",
    "fr_ingredients": "Mofétilmycophénolate",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "50 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 8880,
    "drug": {
      "current_status": "MARKETED",
      "id": 11072,
      "drug_code": 67227,
      "updated_date": "2025-05-15T02:31:14-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254159,
          "ingredient": {
            "id": 2870,
            "ingredient_code": 1893,
            "en_name": "PROPAFENONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propafénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243324",
      "brand_name": "APO-PROPAFENONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116258001"
    },
    "created_date": "2017-05-04T12:51:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243324",
    "company_name": "APOTEX INC",
    "atc_number": "C01BC",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "anticipated_start_date": "2017-06-23T00:00:00-04:00",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_start_date": "2017-06-05T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-13T14:21:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PROPAFENONE",
    "en_drug_common_name": "PROPAFENONE",
    "fr_drug_brand_name": "APO-PROPAFENONE",
    "fr_drug_common_name": "PROPAFENONE",
    "en_ingredients": "PROPAFENONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propafénone",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8883,
    "drug": {
      "current_status": "DORMANT",
      "id": 18670,
      "drug_code": 79945,
      "updated_date": "2025-05-15T06:55:37-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368176,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313936",
      "brand_name": "APO-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2017-05-04T12:56:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313936",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-05-22T00:00:00-04:00",
    "estimated_end_date": "2017-07-07T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-04T17:50:40-04:00",
    "status": "resolved",
    "en_comments": "APO-QUETIAPINE FCT 200MG 500 BTL  is available",
    "fr_comments": "APO-QUETIAPINE FCT 200MG 500 BTL  est disponible",
    "en_drug_brand_name": "APO-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "APO-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8886,
    "drug": {
      "current_status": "DORMANT",
      "id": 14190,
      "drug_code": 7426,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8366484,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00733059",
      "brand_name": "APO-RANITIDINE TABLET 150MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65394",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2017-05-04T13:04:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00733059",
    "company_name": "APOTEX INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-06-19T00:00:00-04:00",
    "estimated_end_date": "2017-08-08T00:00:00-04:00",
    "actual_start_date": "2017-05-29T00:00:00-04:00",
    "actual_end_date": "2017-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-26T12:37:53-04:00",
    "status": "resolved",
    "en_comments": "APO-RANITIDINE FCT 150MG 60 BLS is available",
    "fr_comments": "APO-RANITIDINE FCT 150MG 60 BLS  est disponible",
    "en_drug_brand_name": "APO-RANITIDINE TABLET 150MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "APO-RANITIDINE TABLET 150MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8889,
    "drug": {
      "current_status": "DORMANT",
      "id": 14194,
      "drug_code": 7427,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8366485,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00733067",
      "brand_name": "APO-RANITIDINE TABLET 300MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65395",
      "number_of_ais": "1",
      "ai_group_no": "0115150001"
    },
    "created_date": "2017-05-04T13:09:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00733067",
    "company_name": "APOTEX INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-06-12T00:00:00-04:00",
    "estimated_end_date": "2017-08-08T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-07-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-22T18:41:49-04:00",
    "status": "resolved",
    "en_comments": "APO-RANITIDINE FCT 300MG 500 BTL available",
    "fr_comments": "APO-RANITIDINE FCT 300MG 500 BTL  est disponible",
    "en_drug_brand_name": "APO-RANITIDINE TABLET 300MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "APO-RANITIDINE TABLET 300MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8892,
    "drug": {
      "current_status": "MARKETED",
      "id": 26654,
      "drug_code": 88949,
      "updated_date": "2025-05-15T02:33:53-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259610,
          "ingredient": {
            "id": 3336,
            "ingredient_code": 19840,
            "en_name": "RASAGILINE",
            "fr_name": "Rasagiline (Mésylate de rasagiline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02404699",
      "brand_name": "APO-RASAGILINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151662002"
    },
    "created_date": "2017-05-04T13:12:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02404699",
    "company_name": "APOTEX INC",
    "atc_number": "N04BD",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-05-26T00:00:00-04:00",
    "estimated_end_date": "2018-04-27T00:00:00-04:00",
    "actual_start_date": "2017-06-15T00:00:00-04:00",
    "actual_end_date": "2018-04-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-05T15:17:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RASAGILINE",
    "en_drug_common_name": "RASAGILINE",
    "fr_drug_brand_name": "APO-RASAGILINE",
    "fr_drug_common_name": "RASAGILINE",
    "en_ingredients": "RASAGILINE",
    "fr_ingredients": "RASAGILINE",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8899,
    "drug": {
      "current_status": "MARKETED",
      "id": 8812,
      "drug_code": 60939,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253530,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237600",
      "brand_name": "PMS-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2017-05-04T13:15:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237600",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-06-18T00:00:00-04:00",
    "estimated_end_date": "2017-11-15T00:00:00-05:00",
    "actual_end_date": "2017-06-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-19T19:59:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "PMS-ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 8903,
    "drug": {
      "current_status": "MARKETED",
      "id": 24046,
      "drug_code": 86678,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258650,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381044",
      "brand_name": "PMS-ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434003"
    },
    "created_date": "2017-05-04T13:16:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381044",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2017-07-06T00:00:00-04:00",
    "estimated_end_date": "2018-01-28T00:00:00-05:00",
    "actual_start_date": "2017-07-06T00:00:00-04:00",
    "actual_end_date": "2018-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2018-02-12T19:28:51-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "PMS-ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8912,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28158,
      "drug_code": 90303,
      "updated_date": "2025-12-03T01:32:01-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354152,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02418460",
      "brand_name": "PMS-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072003"
    },
    "created_date": "2017-05-04T13:17:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418460",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "hc_updated_date": "2020-06-09T14:59:48-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-06-09T14:59:51-04:00",
    "status": "resolved",
    "en_comments": "PRODUCT IN DEACTIVATION PROCESS\r\nProduct to be discontinued",
    "fr_comments": "EN PROCESSUS DE DÉSACTIVATION",
    "en_drug_brand_name": "PMS-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "PMS-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "5 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8919,
    "drug": {
      "current_status": "DORMANT",
      "id": 1302,
      "drug_code": 12877,
      "updated_date": "2025-05-15T06:55:23-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366697,
          "ingredient": {
            "id": 476,
            "ingredient_code": 10193,
            "en_name": "BISACODYL",
            "fr_name": "Bisacodyl"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00582883",
      "brand_name": "PMS-BISACODYL",
      "brand_name_fr": "",
      "descriptor": "SUPPOSITORIES",
      "pediatric_flag": false,
      "accession_number": "74106",
      "number_of_ais": "1",
      "ai_group_no": "0101506002"
    },
    "created_date": "2017-05-04T13:19:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00582883",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AB",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "anticipated_start_date": "2017-07-17T00:00:00-04:00",
    "actual_start_date": "2017-07-17T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-06-10T10:53:55-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-BISACODYL",
    "en_drug_common_name": "BISACODYL",
    "fr_drug_brand_name": "PMS-BISACODYL",
    "fr_drug_common_name": "BISACODYL",
    "en_ingredients": "BISACODYL",
    "fr_ingredients": "Bisacodyl",
    "drug_strength": "10MG",
    "drug_dosage_form": "SUPPOSITORY",
    "drug_dosage_form_fr": "Suppositoire",
    "drug_route": "RECTAL",
    "drug_route_fr": "Rectale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8922,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28312,
      "drug_code": 90464,
      "updated_date": "2025-05-15T04:22:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8354327,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8354326,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420023",
      "brand_name": "APO-TELMISARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783001"
    },
    "created_date": "2017-05-04T13:19:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420023",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2017-07-17T00:00:00-04:00",
    "actual_start_date": "2017-06-26T00:00:00-04:00",
    "actual_end_date": "2018-09-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-09-12T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "no production planned for the foreseeable future",
    "en_drug_brand_name": "APO-TELMISARTAN/HCTZ",
    "en_drug_common_name": "TELMISARTAN/HCTZ",
    "fr_drug_brand_name": "APO-TELMISARTAN/HCTZ",
    "fr_drug_common_name": "TELMISARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nTELMISARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nTelmisartan",
    "drug_strength": "12.5MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8925,
    "drug": {
      "current_status": "MARKETED",
      "id": 7524,
      "drug_code": 50220,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253328,
          "ingredient": {
            "id": 1618,
            "ingredient_code": 1890,
            "en_name": "BUSPIRONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de buspirone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230942",
      "brand_name": "PMS-BUSPIRONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116263001"
    },
    "created_date": "2017-05-04T13:20:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230942",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05BE",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2017-06-12T00:00:00-04:00",
    "estimated_end_date": "2017-07-09T00:00:00-04:00",
    "actual_end_date": "2017-07-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-19T20:12:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-BUSPIRONE",
    "en_drug_common_name": "BUSPIRONE",
    "fr_drug_brand_name": "PMS-BUSPIRONE",
    "fr_drug_common_name": "BUSPIRONE",
    "en_ingredients": "BUSPIRONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de buspirone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 8929,
    "drug": {
      "current_status": "MARKETED",
      "id": 8948,
      "drug_code": 6130,
      "updated_date": "2025-05-15T02:30:36-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250864,
          "ingredient": {
            "id": 1386,
            "ingredient_code": 5937,
            "en_name": "PYRAZINAMIDE",
            "fr_name": "Pyrazinamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00618810",
      "brand_name": "PDP-PYRAZINAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62370",
      "number_of_ais": "1",
      "ai_group_no": "0107627001"
    },
    "created_date": "2017-05-04T13:21:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00618810",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "J04AK",
    "atc_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
    "anticipated_start_date": "2017-10-15T00:00:00-04:00",
    "estimated_end_date": "2017-12-17T00:00:00-05:00",
    "actual_end_date": "2017-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-16T19:12:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-PYRAZINAMIDE",
    "en_drug_common_name": "pdp-PYRAZINAMIDE 500mg TABS 100",
    "fr_drug_brand_name": "pdp-PYRAZINAMIDE",
    "fr_drug_common_name": "pdp-PYRAZINAMIDE 500mg TABS 100",
    "en_ingredients": "PYRAZINAMIDE",
    "fr_ingredients": "Pyrazinamide",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8931,
    "drug": {
      "current_status": "DORMANT",
      "id": 11204,
      "drug_code": 6756,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366428,
          "ingredient": {
            "id": 112,
            "ingredient_code": 9150,
            "en_name": "DOCUSATE CALCIUM",
            "fr_name": "Docusate de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "240",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00664553",
      "brand_name": "PMS DOCUSATE-CALCIUM CAP 240MG USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "63973",
      "number_of_ais": "1",
      "ai_group_no": "0117478001"
    },
    "created_date": "2017-05-04T13:22:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00664553",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AA",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "anticipated_start_date": "2017-05-22T00:00:00-04:00",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-08T20:57:28-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS DOCUSATE-CALCIUM CAP 240MG USP",
    "en_drug_common_name": "DOCUSATE CALCIUM",
    "fr_drug_brand_name": "PMS DOCUSATE-CALCIUM CAP 240MG USP",
    "fr_drug_common_name": "DOCUSATE-CALCIUM",
    "en_ingredients": "DOCUSATE CALCIUM",
    "fr_ingredients": "Docusate de calcium",
    "drug_strength": "240MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8935,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8534,
      "drug_code": 60020,
      "updated_date": "2025-12-03T01:16:45-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8324121,
          "ingredient": {
            "id": 240,
            "ingredient_code": 4007,
            "en_name": "GLYBURIDE",
            "fr_name": "Glyburide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236734",
      "brand_name": "PMS-GLYBURIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108708001"
    },
    "created_date": "2017-05-04T13:23:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236734",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "actual_start_date": "2017-05-03T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-06-10T12:02:15-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "PMS-GLYBURIDE",
    "en_drug_common_name": "GLYBURIDE",
    "fr_drug_brand_name": "PMS-GLYBURIDE",
    "fr_drug_common_name": "GLYBURIDE",
    "en_ingredients": "GLYBURIDE",
    "fr_ingredients": "Glyburide",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 8938,
    "drug": {
      "current_status": "DORMANT",
      "id": 14190,
      "drug_code": 7426,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8366484,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00733059",
      "brand_name": "APO-RANITIDINE TABLET 150MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65394",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2017-05-04T13:24:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00733059",
    "company_name": "APOTEX INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-06-30T00:00:00-04:00",
    "estimated_end_date": "2017-08-08T00:00:00-04:00",
    "actual_start_date": "2017-06-15T00:00:00-04:00",
    "actual_end_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-31T12:58:51-04:00",
    "status": "resolved",
    "en_comments": "APO-RANITIDINE FCT 150MG 60 BLS is available",
    "fr_comments": "APO-RANITIDINE FCT 150MG 60 BLS est disponible",
    "en_drug_brand_name": "APO-RANITIDINE TABLET 150MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "APO-RANITIDINE TABLET 150MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "RANITIDINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 8941,
    "drug": {
      "current_status": "DORMANT",
      "id": 5022,
      "drug_code": 2949,
      "updated_date": "2025-05-15T06:55:19-04:00",
      "company": {
        "id": 17157,
        "created_date": "2022-01-07T05:00:11-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 16672,
        "mfr_code": "",
        "name": "LIEBEL-FLARSHEIM COMPANY LLC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8800 DURANT RD.",
        "province": "NORTH CAROLINA",
        "country": "UNITED STATES",
        "city": "RALEIGH",
        "postal_code": "27616",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8366124,
          "ingredient": {
            "id": 544,
            "ingredient_code": 12859,
            "en_name": "IOTHALAMATE MEGLUMINE",
            "fr_name": "Iothalamate de méglumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "172",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00397466",
      "brand_name": "CYSTO-CONRAY II",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "52148",
      "number_of_ais": "1",
      "ai_group_no": "0102763004"
    },
    "created_date": "2017-05-04T13:24:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00397466",
    "company_name": "LIEBEL-FLARSHEIM CANADA INC",
    "atc_number": "V08AA",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "estimated_end_date": "2018-10-22T00:00:00-04:00",
    "actual_start_date": "2017-05-03T00:00:00-04:00",
    "actual_end_date": "2018-10-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-10-23T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Shipment is in transit. For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com, or by fax at 1-519-751-9149.",
    "fr_comments": "L' expédition en transit. Pour plus d'informations, veuillez contacter Methapharm Inc. au 1-800-287-7686, sales@methapharm.com, ou par fax au 1-519-751-9149.",
    "en_drug_brand_name": "CYSTO-CONRAY II",
    "en_drug_common_name": "Iothalamate Meglumine Injection USP 17.2%",
    "fr_drug_brand_name": "CYSTO-CONRAY II",
    "fr_drug_common_name": "Iothalamate Meglumine Injection USP 17.2%",
    "en_ingredients": "IOTHALAMATE MEGLUMINE",
    "fr_ingredients": "Iothalamate de méglumine",
    "drug_strength": "172MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "URETHRAL",
    "drug_route_fr": "Urétrale",
    "drug_package_quantity": "250 mL, 500 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8944,
    "drug": {
      "current_status": "MARKETED",
      "id": 15390,
      "drug_code": 75953,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255509,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274086",
      "brand_name": "PMS-HYDROCHLOROTHIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101048004"
    },
    "created_date": "2017-05-04T13:25:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274086",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C03AA",
    "atc_description": "LOW-CEILING DIURETICS, THIAZIDES",
    "estimated_end_date": "2017-11-17T00:00:00-05:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T17:27:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-HYDROCHLOROTHIAZIDE",
    "en_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "fr_drug_brand_name": "PMS-HYDROCHLOROTHIAZIDE",
    "fr_drug_common_name": "HYDROCHLOROTHIAZIDE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8948,
    "drug": {
      "current_status": "DORMANT",
      "id": 28180,
      "drug_code": 90319,
      "updated_date": "2025-12-03T02:32:35-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369056,
          "ingredient": {
            "id": 1522,
            "ingredient_code": 1966,
            "en_name": "NIFEDIPINE",
            "fr_name": "Nifédipine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02418630",
      "brand_name": "PMS-NIFEDIPINE ER",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115253004"
    },
    "created_date": "2017-05-04T13:27:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418630",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "anticipated_start_date": "2017-08-31T00:00:00-04:00",
    "actual_start_date": "2017-08-31T00:00:00-04:00",
    "actual_end_date": "2018-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-03T20:09:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-NIFEDIPINE ER",
    "en_drug_common_name": "NIFEDIPINE ER",
    "fr_drug_brand_name": "PMS-NIFEDIPINE ER",
    "fr_drug_common_name": "NIFEDIPINE",
    "en_ingredients": "NIFEDIPINE",
    "fr_ingredients": "Nifédipine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8952,
    "drug": {
      "current_status": "MARKETED",
      "id": 18274,
      "drug_code": 79557,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256408,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02309882",
      "brand_name": "PMS-OXYCODONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552002"
    },
    "created_date": "2017-05-04T13:31:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02309882",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-10-26T00:00:00-04:00",
    "estimated_end_date": "2017-11-15T00:00:00-05:00",
    "actual_end_date": "2017-09-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-07T21:19:58-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "PMS-OXYCODONE CR",
    "en_drug_common_name": "OXYCODONE CR",
    "fr_drug_brand_name": "PMS-OXYCODONE CR",
    "fr_drug_common_name": "OXYCODONE CR",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 8955,
    "drug": {
      "current_status": "MARKETED",
      "id": 23774,
      "drug_code": 86433,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258566,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378531",
      "brand_name": "PMS-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2017-05-04T13:33:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378531",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-07-24T00:00:00-04:00",
    "actual_start_date": "2017-06-01T00:00:00-04:00",
    "actual_end_date": "2017-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-25T14:22:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "PMS-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 8958,
    "drug": {
      "current_status": "MARKETED",
      "id": 23776,
      "drug_code": 86434,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258567,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378558",
      "brand_name": "PMS-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2017-05-04T13:35:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378558",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-06-16T00:00:00-04:00",
    "estimated_end_date": "2017-10-26T00:00:00-04:00",
    "actual_start_date": "2017-06-16T00:00:00-04:00",
    "actual_end_date": "2017-11-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-09T21:32:30-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "PMS-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8961,
    "drug": {
      "current_status": "MARKETED",
      "id": 23772,
      "drug_code": 86432,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258565,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378523",
      "brand_name": "PMS-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2017-05-04T13:36:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378523",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-02-23T00:00:00-05:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2018-02-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-20T06:00:07-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "PMS-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8964,
    "drug": {
      "current_status": "MARKETED",
      "id": 19048,
      "drug_code": 80311,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256669,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317583",
      "brand_name": "SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "DIAMOND-SHAPED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261003"
    },
    "created_date": "2017-05-04T13:39:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317583",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-09-15T00:00:00-04:00",
    "estimated_end_date": "2017-10-10T00:00:00-04:00",
    "actual_start_date": "2017-09-15T00:00:00-04:00",
    "actual_end_date": "2017-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T21:03:10-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 8967,
    "drug": {
      "current_status": "MARKETED",
      "id": 24074,
      "drug_code": 86701,
      "updated_date": "2025-05-15T02:33:14-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258665,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02381230",
      "brand_name": "PMS-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626003"
    },
    "created_date": "2017-05-04T13:40:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381230",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2017-05-18T00:00:00-04:00",
    "estimated_end_date": "2017-06-16T00:00:00-04:00",
    "actual_end_date": "2017-07-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-07T16:50:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-VALACYCLOVIR",
    "en_drug_common_name": "VALACYCLOVIR",
    "fr_drug_brand_name": "PMS-VALACYCLOVIR",
    "fr_drug_common_name": "VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "21",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 8996,
    "drug": {
      "current_status": "MARKETED",
      "id": 3498,
      "drug_code": 18786,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 216,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17065,
        "mfr_code": "",
        "name": "ASPEN PHARMACARE CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2030 BRISTOL CIRCLE, SUITE 201",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "OAKVILLE",
        "postal_code": "L6H 0H2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252386,
          "ingredient": {
            "id": 1482,
            "ingredient_code": 450,
            "en_name": "BUFFER SOLUTION",
            "fr_name": "Solution tampon"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "ML",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8252385,
          "ingredient": {
            "id": 536,
            "ingredient_code": 9872,
            "en_name": "MELPHALAN",
            "fr_name": "Melphalan (Chlorhydrate de melphalan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02087286",
      "brand_name": "ALKERAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81060",
      "number_of_ais": "2",
      "ai_group_no": "0225962001"
    },
    "created_date": "2017-05-04T14:44:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02087286",
    "company_name": "ASPEN PHARMACARE CANADA INC.",
    "atc_number": "L01AA",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2017-06-01T00:00:00-04:00",
    "estimated_end_date": "2017-06-19T00:00:00-04:00",
    "actual_end_date": "2017-06-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-17T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Product released as of June 16, 2017",
    "fr_comments": "Produit disponible à compter du 16 juin 2017",
    "en_drug_brand_name": "ALKERAN",
    "en_drug_common_name": "Alkeran Injection / Melphalan",
    "fr_drug_brand_name": "Alkeran Injection",
    "fr_drug_common_name": "melphalan",
    "en_ingredients": "MELPHALAN\r\nBUFFER SOLUTION",
    "fr_ingredients": "Melphalan\r\nSolution tampon",
    "drug_strength": "50MG\r\n10ML",
    "drug_dosage_form": "KIT\r\nPOWDER FOR SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Trousse\r\nPoudre pour solution\r\nSolution",
    "drug_route": "INTRAVENOUS\r\nINTRA-ARTERIAL",
    "drug_route_fr": "Intraveineuse\r\nIntra-artérielle",
    "drug_package_quantity": "1 vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 9016,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27066,
      "drug_code": 89315,
      "updated_date": "2025-05-15T04:21:19-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8353264,
          "ingredient": {
            "id": 2884,
            "ingredient_code": 12149,
            "en_name": "RABEPRAZOLE SODIUM",
            "fr_name": "Rabéprazole sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408392",
      "brand_name": "MYLAN-RABEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143681001"
    },
    "created_date": "2017-05-04T16:12:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408392",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-12-01T00:00:00-05:00",
    "actual_end_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:07-05:00",
    "status": "resolved",
    "en_comments": "discontinued under ID 16039",
    "fr_comments": "discontinued under ID 16039",
    "en_drug_brand_name": "MYLAN-RABEPRAZOLE",
    "en_drug_common_name": "RABEPRAZOLE",
    "fr_drug_brand_name": "MYLAN-RABEPRAZOLE",
    "fr_drug_common_name": "Rabéprazole",
    "en_ingredients": "RABEPRAZOLE SODIUM",
    "fr_ingredients": "Rabéprazole sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9019,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24336,
      "drug_code": 86928,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351488,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02383527",
      "brand_name": "MYLAN-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885003"
    },
    "created_date": "2017-05-04T16:22:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02383527",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T14:05:40-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 20209",
    "fr_comments": "discontinued in ID 20209",
    "en_drug_brand_name": "MYLAN-VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "MYLAN-VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9036,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14274,
      "drug_code": 74355,
      "updated_date": "2025-05-15T04:09:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340423,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02258331",
      "brand_name": "MYLAN-CLINDAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830002"
    },
    "created_date": "2017-05-04T17:05:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02258331",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01FF",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2018-05-01T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-07-04T05:00:13-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 51308",
    "fr_comments": "Discontinued in ID 51308",
    "en_drug_brand_name": "MYLAN-CLINDAMYCIN",
    "en_drug_common_name": "CLINDAMYCIN",
    "fr_drug_brand_name": "MYLAN-CLINDAMYCIN",
    "fr_drug_common_name": "CLINDAMYCIN",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCIN",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9045,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16010,
      "drug_code": 76794,
      "updated_date": "2025-05-15T04:11:30-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342870,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282283",
      "brand_name": "MYLAN-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332002"
    },
    "created_date": "2017-05-04T17:25:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282283",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-07-11T00:00:00-04:00",
    "actual_end_date": "2017-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-03T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Discontinuation reported under ID 16166.",
    "fr_comments": "Discontinuation reported under ID 16166.",
    "en_drug_brand_name": "MYLAN-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "MYLAN-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "3.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9049,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24342,
      "drug_code": 86931,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351491,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02383551",
      "brand_name": "MYLAN-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885004"
    },
    "created_date": "2017-05-04T17:28:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02383551",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T14:05:18-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 20217",
    "fr_comments": "discontinued in ID 20217",
    "en_drug_brand_name": "MYLAN-VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "MYLAN-VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "320MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9053,
    "drug": {
      "current_status": "MARKETED",
      "id": 14424,
      "drug_code": 74685,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255199,
          "ingredient": {
            "id": 286,
            "ingredient_code": 1204,
            "en_name": "FLUCONAZOLE",
            "fr_name": "Fluconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02261472",
      "brand_name": "FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122529003"
    },
    "created_date": "2017-05-04T18:06:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261472",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "anticipated_start_date": "2017-05-01T00:00:00-04:00",
    "estimated_end_date": "2017-06-30T00:00:00-04:00",
    "actual_end_date": "2017-09-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-15T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "CA2J1445, Fluconazole Injection, USP 400 mg/ 200 mL (2mg/mL) is still available.",
    "fr_comments": "CA2J1445, Fluconazole Injectable, USP 400 mg / 200 mL (2mg / mL) est encore disponible.",
    "en_drug_brand_name": "FLUCONAZOLE  IN SODIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "Fluconazole Injection, USP 200 mg/ 100 mL",
    "fr_drug_brand_name": "FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP",
    "fr_drug_common_name": "Fluconazole Injection, USP 200 mg/ 100 mL",
    "en_ingredients": "FLUCONAZOLE",
    "fr_ingredients": "Fluconazole",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1000mL, 2mg/mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 9057,
    "drug": {
      "current_status": "MARKETED",
      "id": 338,
      "drug_code": 10867,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251428,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251427,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251426,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00786306",
      "brand_name": "POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70988",
      "number_of_ais": "3",
      "ai_group_no": "0300097007"
    },
    "created_date": "2017-05-04T18:16:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786306",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BB",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2017-05-01T00:00:00-04:00",
    "estimated_end_date": "2017-09-25T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-09-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-26T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Possible alternatives available in 1000mL size are as follows:\r\nJB1674\t40 mmol Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP\r\nJB1434\t40 mmol Potassium Chloride in 3.3% Dextrose and 0.3% Sodium Chloride Injection USP\r\nJB1264\t40 mmol Potassium Chloride in 5% Dextrose Injection  USP\r\nJB1984\t40 mmol Potassium Chloride in 0.9% Sodium Chloride Injection USP",
    "fr_comments": "Alternatives possibles disponibles\r\nJB1674\t40 mmol Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection USP\r\nJB1434\t40 mmol Potassium Chloride in 3.3% Dextrose and 0.3% Sodium Chloride Injection USP\r\nJB1264\t40 mmol Potassium Chloride in 5% Dextrose Injection  USP\r\nJB1984\t40 mmol Potassium Chloride in 0.9% Sodium Chloride Injection USP",
    "en_drug_brand_name": "POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR",
    "en_drug_common_name": "40 mmol Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP",
    "fr_drug_brand_name": "POTASS CHLOR 40MEQ 5% DEX AND 0.9% SOD CHLOR",
    "fr_drug_common_name": "40 mmol Potassium Chloride in 5% Dextrose and 0.9% Sodium Chloride Injection USP",
    "en_ingredients": "DEXTROSE\r\nPOTASSIUM CHLORIDE\r\nSODIUM CHLORIDE",
    "fr_ingredients": "Dextrose\r\nChlorure de potassium\r\nChlorure de sodium",
    "drug_strength": "5G\r\n300MG\r\n900MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1000mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 9101,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24380,
      "drug_code": 87013,
      "updated_date": "2025-05-15T04:20:06-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351518,
          "ingredient": {
            "id": 3044,
            "ingredient_code": 1218,
            "en_name": "BISOPROLOL FUMARATE",
            "fr_name": "Fumarate de bisoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02384418",
      "brand_name": "MYLAN-BISOPROLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122418001"
    },
    "created_date": "2017-05-05T15:12:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02384418",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T13:56:06-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 15811.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 15811.",
    "en_drug_brand_name": "MYLAN-BISOPROLOL",
    "en_drug_common_name": "BISOPROLOL",
    "fr_drug_brand_name": "MYLAN-BISOPROLOL",
    "fr_drug_common_name": "BISOPROLOL",
    "en_ingredients": "BISOPROLOL FUMARATE",
    "fr_ingredients": "Fumarate de bisoprolol",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9105,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21062,
      "drug_code": 83296,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348652,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347571",
      "brand_name": "MYLAN-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683001"
    },
    "created_date": "2017-05-05T15:14:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347571",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T14:05:15-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 15824.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 15824.",
    "en_drug_brand_name": "MYLAN-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "MYLAN-CARVEDILOL",
    "fr_drug_common_name": "Carvédilol",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9108,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6532,
      "drug_code": 43459,
      "updated_date": "2025-05-15T03:49:54-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8312985,
          "ingredient": {
            "id": 2194,
            "ingredient_code": 2165,
            "en_name": "CIMETIDINE",
            "fr_name": "Cimétidine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "600",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02227460",
      "brand_name": "MYLAN-CIMETIDINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9798",
      "number_of_ais": "1",
      "ai_group_no": "0111925004"
    },
    "created_date": "2017-05-05T15:16:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02227460",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-08T13:43:24-04:00",
    "status": "resolved",
    "en_comments": "Discontinuation reported under ID 16096.",
    "fr_comments": "Discontinuation reported under ID 16096.",
    "en_drug_brand_name": "MYLAN-CIMETIDINE",
    "en_drug_common_name": "CIMETIDINE",
    "fr_drug_brand_name": "MYLAN-CIMETIDINE",
    "fr_drug_common_name": "CIMETIDINE",
    "en_ingredients": "CIMETIDINE",
    "fr_ingredients": "Cimétidine",
    "drug_strength": "600MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9111,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11926,
      "drug_code": 69749,
      "updated_date": "2025-05-15T04:04:41-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8336250,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245649",
      "brand_name": "MYLAN-CIPROFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207002"
    },
    "created_date": "2017-05-05T15:18:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245649",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "discontinued under ID 20278",
    "fr_comments": "discontinued under ID 20278",
    "en_drug_brand_name": "MYLAN-CIPROFLOXACIN",
    "en_drug_common_name": "CIPROFLOXACIN",
    "fr_drug_brand_name": "MYLAN-CIPROFLOXACIN",
    "fr_drug_common_name": "CIPROFLOXACIN",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9115,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13504,
      "drug_code": 73227,
      "updated_date": "2025-05-15T04:08:03-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8339492,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248856",
      "brand_name": "MYLAN-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752001"
    },
    "created_date": "2017-05-05T15:19:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248856",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T17:13:57-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 15833.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 15833.",
    "en_drug_brand_name": "MYLAN-CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "MYLAN-CLARITHROMYCIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9118,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13506,
      "drug_code": 73228,
      "updated_date": "2025-05-15T04:08:03-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8339493,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248857",
      "brand_name": "MYLAN-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752002"
    },
    "created_date": "2017-05-05T15:20:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248857",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T17:17:05-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 15872.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 15872.",
    "en_drug_brand_name": "MYLAN-CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "MYLAN-CLARITHROMYCIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9124,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14500,
      "drug_code": 74778,
      "updated_date": "2025-05-15T04:09:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340785,
          "ingredient": {
            "id": 3064,
            "ingredient_code": 1744,
            "en_name": "FOSINOPRIL SODIUM",
            "fr_name": "Fosinopril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02262401",
      "brand_name": "MYLAN-FOSINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122777001"
    },
    "created_date": "2017-05-05T15:26:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02262401",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T17:34:03-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 15913.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 15913.",
    "en_drug_brand_name": "MYLAN-FOSINOPRIL",
    "en_drug_common_name": "FOSINOPRIL",
    "fr_drug_brand_name": "MYLAN-FOSINOPRIL",
    "fr_drug_common_name": "FOSINOPRIL",
    "en_ingredients": "FOSINOPRIL SODIUM",
    "fr_ingredients": "Fosinopril sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9154,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24242,
      "drug_code": 86853,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351437,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382717",
      "brand_name": "MYLAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2017-05-05T16:04:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382717",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T18:34:36-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 16012.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 16012.",
    "en_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9158,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24244,
      "drug_code": 86854,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351438,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382725",
      "brand_name": "MYLAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783005"
    },
    "created_date": "2017-05-05T16:10:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382725",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T18:35:51-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 16015.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 16015.",
    "en_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9162,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24246,
      "drug_code": 86855,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351439,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382733",
      "brand_name": "MYLAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2017-05-05T16:13:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382733",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T18:37:09-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 16018.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 16018.",
    "en_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9165,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24240,
      "drug_code": 86852,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351436,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382709",
      "brand_name": "MYLAN-OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783003"
    },
    "created_date": "2017-05-05T16:15:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382709",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T18:33:15-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 16009.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 16009.",
    "en_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE ODT",
    "fr_drug_brand_name": "MYLAN-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE ODT",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9176,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9080,
      "drug_code": 61760,
      "updated_date": "2025-05-15T03:57:23-04:00",
      "company": {
        "id": 144,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 14255,
        "mfr_code": "",
        "name": "VIIV HEALTHCARE ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "1400",
        "street_name": "75 RUE QUEEN",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3C 2N6",
        "post_office_box": "",
        "contact_information": "1-877-393-8448"
      },
      "drug_ingredients": [
        {
          "id": 8326412,
          "ingredient": {
            "id": 2584,
            "ingredient_code": 11786,
            "en_name": "DELAVIRDINE MESYLATE",
            "fr_name": "Mésylate de délavirdine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02238348",
      "brand_name": "RESCRIPTOR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134000001"
    },
    "created_date": "2017-05-05T16:54:24-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02238348",
    "company_name": "VIIV HEALTHCARE ULC",
    "atc_number": "J05AG",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2018-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 2,
      "en_reason": "Raw material availability",
      "fr_reason": "Disponibilité des matières premières",
      "active": true
    },
    "updated_date": "2018-11-02T05:00:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "RESCRIPTOR",
    "en_drug_common_name": "delavirdine mesylate tablet",
    "fr_drug_brand_name": "RESCRIPTOR",
    "fr_drug_common_name": "Comprimé de mésylate de délavirdine",
    "en_ingredients": "DELAVIRDINE MESYLATE",
    "fr_ingredients": "Mésylate de délavirdine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "360s",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9179,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14170,
      "drug_code": 74231,
      "updated_date": "2025-05-15T04:09:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340303,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257092",
      "brand_name": "MYLAN-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2017-05-05T17:09:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257092",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T18:41:31-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 16029.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 16029.",
    "en_drug_brand_name": "MYLAN-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "MYLAN-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9182,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14172,
      "drug_code": 74232,
      "updated_date": "2025-05-15T04:09:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340304,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257106",
      "brand_name": "MYLAN-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2017-05-05T17:10:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257106",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-07-15T00:00:00-04:00",
    "actual_end_date": "2017-09-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-08T14:04:39-04:00",
    "status": "resolved",
    "en_comments": "Discontinuation reported under ID 16148.",
    "fr_comments": "Discontinuation reported under ID 16148.",
    "en_drug_brand_name": "MYLAN-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "MYLAN-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9185,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14174,
      "drug_code": 74233,
      "updated_date": "2025-05-15T04:09:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340305,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257114",
      "brand_name": "MYLAN-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2017-05-05T17:11:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257114",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T18:42:23-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 16032.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 16032.",
    "en_drug_brand_name": "MYLAN-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "MYLAN-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATINE",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9188,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27068,
      "drug_code": 89316,
      "updated_date": "2025-05-15T04:21:19-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8353265,
          "ingredient": {
            "id": 2884,
            "ingredient_code": 12149,
            "en_name": "RABEPRAZOLE SODIUM",
            "fr_name": "Rabéprazole sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02408406",
      "brand_name": "MYLAN-RABEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143681002"
    },
    "created_date": "2017-05-05T17:14:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02408406",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T19:01:20-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 16042.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 16042.",
    "en_drug_brand_name": "MYLAN-RABEPRAZOLE",
    "en_drug_common_name": "RABEPRAZOLE",
    "fr_drug_brand_name": "MYLAN-RABEPRAZOLE",
    "fr_drug_common_name": "RABEPRAZOLE",
    "en_ingredients": "RABEPRAZOLE SODIUM",
    "fr_ingredients": "Rabéprazole sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9195,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18310,
      "drug_code": 79592,
      "updated_date": "2025-05-15T04:13:47-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8345505,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02310279",
      "brand_name": "MYLAN-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294002"
    },
    "created_date": "2017-05-05T17:21:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310279",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-10-22T00:00:00-04:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2018-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-15T19:23:39-05:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 20259",
    "fr_comments": "Discontinued in ID 20259",
    "en_drug_brand_name": "MYLAN-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE XR",
    "fr_drug_brand_name": "MYLAN-VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "37.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9198,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24338,
      "drug_code": 86929,
      "updated_date": "2025-05-15T04:20:04-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351489,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02383535",
      "brand_name": "MYLAN-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2017-05-05T17:24:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02383535",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T14:06:02-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 44919",
    "fr_comments": "discontinued in ID 44919",
    "en_drug_brand_name": "MYLAN-VALSARTAN",
    "en_drug_common_name": "VALSARTAN",
    "fr_drug_brand_name": "MYLAN-VALSARTAN",
    "fr_drug_common_name": "VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9203,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21040,
      "drug_code": 83270,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348628,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347318",
      "brand_name": "MYLAN-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700002"
    },
    "created_date": "2017-05-05T17:31:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347318",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "estimated_end_date": "2018-08-10T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2018-08-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-11T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in report 44867",
    "fr_comments": "Discontinued in ID 44867",
    "en_drug_brand_name": "MYLAN-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "MYLAN-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9210,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21042,
      "drug_code": 83271,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348629,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347326",
      "brand_name": "MYLAN-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700003"
    },
    "created_date": "2017-05-05T17:34:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347326",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2017-07-19T00:00:00-04:00",
    "actual_end_date": "2017-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-03T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Discontinuation reported under ID 20271.",
    "fr_comments": "Discontinuation reported under ID 20271.",
    "en_drug_brand_name": "MYLAN-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "MYLAN-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9217,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21038,
      "drug_code": 83269,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348627,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347296",
      "brand_name": "MYLAN-IRBESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131700001"
    },
    "created_date": "2017-05-05T17:46:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347296",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T13:39:33-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 44870",
    "fr_comments": "discontinued in ID 44870",
    "en_drug_brand_name": "MYLAN-IRBESARTAN",
    "en_drug_common_name": "IRBESARTAN",
    "fr_drug_brand_name": "MYLAN-IRBESARTAN",
    "fr_drug_common_name": "IRBESARTAN",
    "en_ingredients": "IRBESARTAN",
    "fr_ingredients": "Irbésartan",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9220,
    "drug": {
      "current_status": "MARKETED",
      "id": 23940,
      "drug_code": 86593,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258619,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380099",
      "brand_name": "TARO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294005"
    },
    "created_date": "2017-05-05T17:48:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380099",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2018-05-25T00:00:00-04:00",
    "actual_end_date": "2018-09-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-28T20:35:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-VENLAFAXINE XR",
    "en_drug_common_name": "RAN-VENLAFAXINE XR",
    "fr_drug_brand_name": "RAN-VENLAFAXINE XR",
    "fr_drug_common_name": "RAN-VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9222,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15440,
      "drug_code": 76039,
      "updated_date": "2025-05-15T04:10:48-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8342026,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274868",
      "brand_name": "MYLAN-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121550002"
    },
    "created_date": "2017-05-05T17:48:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274868",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-04-02T00:00:00-04:00",
    "actual_end_date": "2018-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-03T05:00:09-04:00",
    "status": "resolved",
    "en_comments": "Discontinued under ID 16129. Mar-2018 Last lot 3055901 expires 30-jun-18",
    "fr_comments": "Discontinued under ID 16129. Mar-2018 Last lot 3055901 expires 30-jun-18",
    "en_drug_brand_name": "MYLAN-LISINOPRIL",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "MYLAN-LISINOPRIL",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9236,
    "drug": {
      "current_status": "MARKETED",
      "id": 24236,
      "drug_code": 86848,
      "updated_date": "2025-12-03T00:31:56-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258721,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382660",
      "brand_name": "TARO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963002"
    },
    "created_date": "2017-05-05T18:00:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382660",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-04-28T00:00:00-04:00",
    "estimated_end_date": "2017-11-22T00:00:00-05:00",
    "actual_start_date": "2017-04-28T00:00:00-04:00",
    "actual_end_date": "2017-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:45:00-05:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinué",
    "en_drug_brand_name": "RAN-ROSUVASTATIN",
    "en_drug_common_name": "RAN-ROSUVASTATIN",
    "fr_drug_brand_name": "RAN-ROSUVASTATIN",
    "fr_drug_common_name": "RAN-ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 9241,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24016,
      "drug_code": 86653,
      "updated_date": "2025-05-15T04:19:53-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351283,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380757",
      "brand_name": "MYLAN-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823001"
    },
    "created_date": "2017-05-05T18:04:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380757",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2018-02-01T00:00:00-05:00",
    "actual_end_date": "2018-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-15T19:11:16-05:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 16142",
    "fr_comments": "Discontinued in ID 16142",
    "en_drug_brand_name": "MYLAN-MONTELUKAST",
    "en_drug_common_name": "MONTELUKAST",
    "fr_drug_brand_name": "MYLAN-MONTELUKAST",
    "fr_drug_common_name": "MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9252,
    "drug": {
      "current_status": "MARKETED",
      "id": 18350,
      "drug_code": 79614,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256434,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310511",
      "brand_name": "TARO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2017-05-05T18:23:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310511",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-04-28T00:00:00-04:00",
    "actual_start_date": "2017-04-28T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T19:39:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-RAMIPRIL",
    "en_drug_common_name": "RAN-RAMIPRIL",
    "fr_drug_brand_name": "RAN-RAMIPRIL",
    "fr_drug_common_name": "RAN-RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 9259,
    "drug": {
      "current_status": "MARKETED",
      "id": 28748,
      "drug_code": 90871,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260428,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423987",
      "brand_name": "TARO-ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2017-05-05T18:32:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423987",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2018-11-28T00:00:00-05:00",
    "estimated_end_date": "2020-10-30T00:00:00-04:00",
    "actual_start_date": "2018-11-28T00:00:00-05:00",
    "actual_end_date": "2020-10-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-10-28T18:35:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-ESOMEPRAZOLE",
    "en_drug_common_name": "RAN-ESOMEPRAZOLE",
    "fr_drug_brand_name": "RAN-ESOMEPRAZOLE",
    "fr_drug_common_name": "RAN-ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9261,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21056,
      "drug_code": 83290,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348649,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347512",
      "brand_name": "MYLAN-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683003"
    },
    "created_date": "2017-05-05T18:33:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347512",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-12-01T00:00:00-05:00",
    "actual_end_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "discontinued under ID 16105",
    "fr_comments": "discontinued under ID 16105",
    "en_drug_brand_name": "MYLAN-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "MYLAN-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "3.125MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9271,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21058,
      "drug_code": 83292,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348650,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347520",
      "brand_name": "MYLAN-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683004"
    },
    "created_date": "2017-05-05T18:49:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347520",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-12-01T00:00:00-05:00",
    "actual_end_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "discontinued uder ID 16108",
    "fr_comments": "discontinued uder ID 16108",
    "en_drug_brand_name": "MYLAN-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "MYLAN-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "6.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9276,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21060,
      "drug_code": 83294,
      "updated_date": "2025-05-15T04:16:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8348651,
          "ingredient": {
            "id": 2984,
            "ingredient_code": 1188,
            "en_name": "CARVEDILOL",
            "fr_name": "Carvédilol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347555",
      "brand_name": "MYLAN-CARVEDILOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122683005"
    },
    "created_date": "2017-05-05T18:50:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347555",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-12-01T00:00:00-05:00",
    "actual_end_date": "2017-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-02T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "discontinued under ID 16111",
    "fr_comments": "discontinued under ID 16111",
    "en_drug_brand_name": "MYLAN-CARVEDILOL",
    "en_drug_common_name": "CARVEDILOL",
    "fr_drug_brand_name": "MYLAN-CARVEDILOL",
    "fr_drug_common_name": "CARVEDILOL",
    "en_ingredients": "CARVEDILOL",
    "fr_ingredients": "Carvédilol",
    "drug_strength": "12.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9297,
    "drug": {
      "current_status": "MARKETED",
      "id": 22418,
      "drug_code": 84813,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258044,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02363119",
      "brand_name": "TARO-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885002"
    },
    "created_date": "2017-05-05T19:04:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02363119",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2017-04-28T00:00:00-04:00",
    "actual_start_date": "2017-04-28T00:00:00-04:00",
    "actual_end_date": "2017-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T19:16:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-VALSARTAN",
    "en_drug_common_name": "RAN-VALSARTAN",
    "fr_drug_brand_name": "RAN-VALSARTAN",
    "fr_drug_common_name": "RAN-VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 9300,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7534,
      "drug_code": 50229,
      "updated_date": "2025-05-15T03:51:20-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8315812,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230951",
      "brand_name": "MYLAN-CLONAZEPAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0111558002"
    },
    "created_date": "2017-05-05T19:14:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230951",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N03AE",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2018-04-02T00:00:00-04:00",
    "actual_end_date": "2018-04-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-03T05:00:09-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 20312 . Last lot 8035540 expiry date June 30, 2018",
    "fr_comments": "Discontinued in ID 20312 . Last lot 8035540 expiry date June 30, 2018",
    "en_drug_brand_name": "MYLAN-CLONAZEPAM",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "MYLAN-CLONAZEPAM",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT, 500BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9303,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22062,
      "drug_code": 84449,
      "updated_date": "2025-05-15T04:17:42-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8349532,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359472",
      "brand_name": "MYLAN-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548001"
    },
    "created_date": "2017-05-05T19:18:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359472",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2018-05-01T00:00:00-04:00",
    "actual_start_date": "2018-05-02T00:00:00-04:00",
    "actual_end_date": "2018-05-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-18T12:14:28-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in 16117",
    "fr_comments": "Discontinued in 16117",
    "en_drug_brand_name": "MYLAN-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "MYLAN-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9306,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25066,
      "drug_code": 87578,
      "updated_date": "2025-05-15T04:20:23-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351867,
          "ingredient": {
            "id": 2882,
            "ingredient_code": 12126,
            "en_name": "ENTACAPONE",
            "fr_name": "Entacapone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02390337",
      "brand_name": "MYLAN-ENTACAPONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143623001"
    },
    "created_date": "2017-05-05T19:20:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02390337",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N04BX",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2017-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-02T18:04:47-04:00",
    "status": "resolved",
    "en_comments": "Discontinuation date entered as per ID 16123",
    "fr_comments": "Discontinuation date entered as per ID 16123",
    "en_drug_brand_name": "MYLAN-ENTACAPONE",
    "en_drug_common_name": "ENTACAPONE",
    "fr_drug_brand_name": "MYLAN-ENTACAPONE",
    "fr_drug_common_name": "ENTACAPONE",
    "en_ingredients": "ENTACAPONE",
    "fr_ingredients": "Entacapone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9317,
    "drug": {
      "current_status": "MARKETED",
      "id": 22416,
      "drug_code": 84812,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258043,
          "ingredient": {
            "id": 2520,
            "ingredient_code": 11702,
            "en_name": "VALSARTAN",
            "fr_name": "Valsartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02363100",
      "brand_name": "TARO-VALSARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131885001"
    },
    "created_date": "2017-05-05T19:33:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02363100",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "anticipated_start_date": "2017-04-28T00:00:00-04:00",
    "actual_start_date": "2017-04-28T00:00:00-04:00",
    "actual_end_date": "2017-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T20:08:00-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-VALSARTAN",
    "en_drug_common_name": "RAN-VALSARTAN",
    "fr_drug_brand_name": "RAN-VALSARTAN",
    "fr_drug_common_name": "RAN-VALSARTAN",
    "en_ingredients": "VALSARTAN",
    "fr_ingredients": "Valsartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 9368,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25906,
      "drug_code": 88270,
      "updated_date": "2025-05-15T04:20:46-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8352455,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02397773",
      "brand_name": "MYLAN-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301005"
    },
    "created_date": "2017-05-05T20:51:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02397773",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-17T19:05:19-04:00",
    "status": "resolved",
    "en_comments": "This product is discontinued and reported under discontinuation ID 16049.",
    "fr_comments": "This product is discontinued and reported under discontinuation ID 16049.",
    "en_drug_brand_name": "MYLAN-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "MYLAN-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1BL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9382,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9822,
      "drug_code": 63894,
      "updated_date": "2025-05-15T03:59:38-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8329435,
          "ingredient": {
            "id": 2702,
            "ingredient_code": 11891,
            "en_name": "EPTIFIBATIDE",
            "fr_name": "Eptifibatide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240352",
      "brand_name": "INTEGRILIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137621002"
    },
    "created_date": "2017-05-08T13:10:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240352",
    "company_name": "MERCK CANADA INC",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2017-08-11T00:00:00-04:00",
    "actual_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2017-08-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-08-10T05:00:03-04:00",
    "status": "resolved",
    "fr_comments": "Quantités limitées disponibles",
    "en_drug_brand_name": "INTEGRILIN",
    "en_drug_common_name": "Eptifibatide Injection",
    "fr_drug_brand_name": "INTEGRILIN",
    "fr_drug_common_name": "eptifibatide injectable",
    "en_ingredients": "EPTIFIBATIDE",
    "fr_ingredients": "Eptifibatide",
    "drug_strength": "2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "20MG/10ML vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9451,
    "drug": {
      "current_status": "MARKETED",
      "id": 31912,
      "drug_code": 94437,
      "updated_date": "2025-12-03T00:33:11-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262103,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02457318",
      "brand_name": "SANDOZ AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310003"
    },
    "created_date": "2017-05-08T14:38:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02457318",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2017-07-17T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-07T14:59:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AMPHETAMINE XR",
    "en_drug_common_name": "SANDOZ AMPHETAMINE XR",
    "fr_drug_brand_name": "SANDOZ AMPHETAMINE XR",
    "fr_drug_common_name": "SANDOZ AMPHETAMINE XR",
    "en_ingredients": "DEXTROAMPHETAMINE SACCHARATE\r\nDEXTROAMPHETAMINE SULFATE\r\nAMPHETAMINE ASPARTATE MONOHYDRATE\r\nAMPHETAMINE SULFATE",
    "fr_ingredients": "Saccharate de dextroamphétamine\r\nSulfate de dextroamphétamine\r\nAspartate d'amphétamine monohydraté\r\nSulfate d'amphétamine",
    "drug_strength": "3.75MG\r\n3.75MG\r\n3.75MG\r\n3.75MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9454,
    "drug": {
      "current_status": "MARKETED",
      "id": 20642,
      "drug_code": 82412,
      "updated_date": "2025-12-03T00:31:30-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257293,
          "ingredient": {
            "id": 2182,
            "ingredient_code": 27,
            "en_name": "ANASTROZOLE",
            "fr_name": "Anastrozole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338467",
      "brand_name": "SANDOZ ANASTROZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128681001"
    },
    "created_date": "2017-05-08T14:40:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338467",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L02BG",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-05-15T13:21:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ANASTROZOLE",
    "en_drug_common_name": "SANDOZ ANASTAZOLE",
    "fr_drug_brand_name": "SANDOZ ANASTAZOLE",
    "fr_drug_common_name": "SANDOZ ANASTAZOLE",
    "en_ingredients": "ANASTROZOLE",
    "fr_ingredients": "Anastrozole",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10BP",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9457,
    "drug": {
      "current_status": "MARKETED",
      "id": 19680,
      "drug_code": 81037,
      "updated_date": "2025-12-03T00:31:26-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256870,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324954",
      "brand_name": "SANDOZ ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055002"
    },
    "created_date": "2017-05-08T14:44:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324954",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-05-22T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-26T13:28:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ATORVASTATIN",
    "en_drug_common_name": "SANDOZ ATORVASTATIN",
    "fr_drug_brand_name": "SANDOZ ATORVASTATIN",
    "fr_drug_common_name": "SANDOZ ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9461,
    "drug": {
      "current_status": "MARKETED",
      "id": 19684,
      "drug_code": 81039,
      "updated_date": "2025-12-03T00:31:26-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256872,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324970",
      "brand_name": "SANDOZ ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2017-05-08T14:46:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324970",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-09-22T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-25T21:56:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ATORVASTATIN",
    "en_drug_common_name": "SANDOZ ATORVASTATIN",
    "fr_drug_brand_name": "SANDOZ ATORVASTATIN",
    "fr_drug_common_name": "SANDOZ ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9467,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15708,
      "drug_code": 76420,
      "updated_date": "2025-05-15T04:11:19-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8342532,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278634",
      "brand_name": "SANDOZ FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885003"
    },
    "created_date": "2017-05-08T14:53:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02278634",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-05-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-05-16T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FAMCICLOVIR",
    "en_drug_common_name": "SANDOZ FAMCICLOVIR",
    "fr_drug_brand_name": "SANDOZ FAMCICLOVIR",
    "fr_drug_common_name": "SANDOZ FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "125MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1X10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9470,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15712,
      "drug_code": 76422,
      "updated_date": "2025-05-15T04:11:19-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8342534,
          "ingredient": {
            "id": 1474,
            "ingredient_code": 156,
            "en_name": "FAMCICLOVIR",
            "fr_name": "Famciclovir"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278650",
      "brand_name": "SANDOZ FAMCICLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127885002"
    },
    "created_date": "2017-05-08T14:55:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02278650",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2017-05-15T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-06T21:53:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ FAMCICLOVIR",
    "en_drug_common_name": "SANDOZ FAMCICLOVIR",
    "fr_drug_brand_name": "SANDOZ FAMCICLOVIR",
    "fr_drug_common_name": "SANDOZ FAMCICLOVIR",
    "en_ingredients": "FAMCICLOVIR",
    "fr_ingredients": "Famciclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9473,
    "drug": {
      "current_status": "MARKETED",
      "id": 15062,
      "drug_code": 75494,
      "updated_date": "2025-05-15T02:31:40-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255386,
          "ingredient": {
            "id": 2948,
            "ingredient_code": 12597,
            "en_name": "GLIMEPIRIDE",
            "fr_name": "Glimépiride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02269589",
      "brand_name": "SANDOZ GLIMEPIRIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0146247001"
    },
    "created_date": "2017-05-08T15:01:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02269589",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2017-07-17T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-07-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-06T20:42:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ GLIMEPIRIDE",
    "en_drug_common_name": "SANDOZ GLIMEPIRIDE",
    "fr_drug_brand_name": "SANDOZ GLIMEPIRIDE",
    "fr_drug_common_name": "SANDOZ GLIMEPIRIDE",
    "en_ingredients": "GLIMEPIRIDE",
    "fr_ingredients": "Glimépiride",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9475,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 302,
      "drug_code": 10806,
      "updated_date": "2025-05-15T03:37:19-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8287055,
          "ingredient": {
            "id": 152,
            "ingredient_code": 20230,
            "en_name": "AMILORIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiloride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8287054,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00870943",
      "brand_name": "AMI-HYDRO TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70890",
      "number_of_ais": "2",
      "ai_group_no": "0213868001"
    },
    "created_date": "2017-05-08T15:02:45-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00870943",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C03EA",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T15:05:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "AMI-HYDRO TAB",
    "en_drug_common_name": "AMI-HYDRO",
    "fr_drug_brand_name": "AMI-HYDRO TAB",
    "fr_drug_common_name": "AMI-HYDRO",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nAMILORIDE HYDROCHLORIDE",
    "fr_ingredients": "Hydrochlorothiazide\r\nChlorhydrate d'amiloride",
    "drug_strength": "50MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9481,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13250,
      "drug_code": 72805,
      "updated_date": "2025-05-15T04:07:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8339117,
          "ingredient": {
            "id": 2164,
            "ingredient_code": 1995,
            "en_name": "CLOBAZAM",
            "fr_name": "Clobazam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248454",
      "brand_name": "CLOBAZAM-10",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114637001"
    },
    "created_date": "2017-05-08T15:08:02-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02248454",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T15:08:33-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "CLOBAZAM-10",
    "en_drug_common_name": "CLOBAZAM",
    "fr_drug_brand_name": "CLOBAZAM-10",
    "fr_drug_common_name": "CLOBAZAM",
    "en_ingredients": "CLOBAZAM",
    "fr_ingredients": "Clobazam",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9484,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4360,
      "drug_code": 2037,
      "updated_date": "2025-05-15T03:25:00-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8272815,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00313580",
      "brand_name": "DIAZEPAM 5 TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "46611",
      "number_of_ais": "1",
      "ai_group_no": "0103614001"
    },
    "created_date": "2017-05-08T15:10:32-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00313580",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T15:11:57-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DIAZEPAM 5 TAB",
    "en_drug_common_name": "DIAZEPAM",
    "fr_drug_brand_name": "DIAZEPAM 5 TAB",
    "fr_drug_common_name": "DIAZEPAM",
    "en_ingredients": "DIAZEPAM",
    "fr_ingredients": "Diazépam",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9488,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9804,
      "drug_code": 63881,
      "updated_date": "2025-05-15T03:59:38-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8329426,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240341",
      "brand_name": "DIVALPROEX-125",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996004"
    },
    "created_date": "2017-05-08T15:14:27-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240341",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T15:15:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DIVALPROEX-125",
    "en_drug_common_name": "DIVALPROEX",
    "fr_drug_brand_name": "DIVALPROEX-125",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "125MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9491,
    "drug": {
      "current_status": "MARKETED",
      "id": 21018,
      "drug_code": 83249,
      "updated_date": "2025-05-15T02:32:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257457,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02347091",
      "brand_name": "SANDOZ VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626001"
    },
    "created_date": "2017-05-08T15:15:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02347091",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2018-05-04T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-07T23:09:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ VALACYCLOVIR",
    "en_drug_common_name": "SANDOZ VALACYCLOVIR",
    "fr_drug_brand_name": "SANDOZ VALACYCLOVIR",
    "fr_drug_common_name": "SANDOZ VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9494,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9806,
      "drug_code": 63882,
      "updated_date": "2025-05-15T03:59:38-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8329427,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240342",
      "brand_name": "DIVALPROEX-250",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996001"
    },
    "created_date": "2017-05-08T15:16:42-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240342",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T15:17:15-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DIVALPROEX-250",
    "en_drug_common_name": "DIVALPROEX",
    "fr_drug_brand_name": "DIVALPROEX-250",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100-500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9497,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14206,
      "drug_code": 74282,
      "updated_date": "2025-05-15T04:09:10-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8340359,
          "ingredient": {
            "id": 602,
            "ingredient_code": 1200,
            "en_name": "ZOPICLONE",
            "fr_name": "Zopiclone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02257572",
      "brand_name": "SANDOZ ZOPICLONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122562002"
    },
    "created_date": "2017-05-08T15:17:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257572",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05CF",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-05-15T13:58:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ZOPICLONE",
    "en_drug_common_name": "SANDOZ ZOPICLONE",
    "fr_drug_brand_name": "SANDOZ ZOPICLONE",
    "fr_drug_common_name": "SANDOZ ZOPICLONE",
    "en_ingredients": "ZOPICLONE",
    "fr_ingredients": "Zopiclone",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9502,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9808,
      "drug_code": 63883,
      "updated_date": "2025-05-15T03:59:38-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8329428,
          "ingredient": {
            "id": 1486,
            "ingredient_code": 2115,
            "en_name": "VALPROIC ACID",
            "fr_name": "Acide valproïque (Valproate de sodium)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240343",
      "brand_name": "DIVALPROEX-500",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112996003"
    },
    "created_date": "2017-05-08T15:18:23-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240343",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N03AG",
    "atc_description": "ANTIEPILEPTICS",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T15:18:47-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DIVALPROEX-500",
    "en_drug_common_name": "DIVALPROEX",
    "fr_drug_brand_name": "DIVALPROEX-500",
    "fr_drug_common_name": "DIVALPROEX",
    "en_ingredients": "VALPROIC ACID",
    "fr_ingredients": "Acide valproïque",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9505,
    "drug": {
      "current_status": "DORMANT",
      "id": 18126,
      "drug_code": 79356,
      "updated_date": "2025-12-03T02:32:24-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8368146,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8368145,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02307898",
      "brand_name": "SANDOZ OXYCODONE/ACETAMINOPHEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2017-05-08T15:21:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02307898",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AJ",
    "estimated_end_date": "2017-09-18T00:00:00-04:00",
    "actual_start_date": "2017-04-28T00:00:00-04:00",
    "actual_end_date": "2017-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-25T22:10:59-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ OXYCODONE/ACETAMINOPHEN",
    "en_drug_common_name": "sandoz OXYCODONE+ACET",
    "fr_drug_brand_name": "SANDOZ OXYCODONE+ACET",
    "fr_drug_common_name": "SANDOZ OXYCODONE+ACET",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 9508,
    "drug": {
      "current_status": "DORMANT",
      "id": 18126,
      "drug_code": 79356,
      "updated_date": "2025-12-03T02:32:24-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8368146,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8368145,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02307898",
      "brand_name": "SANDOZ OXYCODONE/ACETAMINOPHEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2017-05-08T15:22:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02307898",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02AJ",
    "estimated_end_date": "2017-10-16T00:00:00-04:00",
    "actual_start_date": "2017-04-28T00:00:00-04:00",
    "actual_end_date": "2017-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-25T22:11:24-04:00",
    "status": "resolved",
    "en_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "fr_comments": "Stock available at some wholesalers/Inventaire disponible chez certains grossistes",
    "en_drug_brand_name": "SANDOZ OXYCODONE/ACETAMINOPHEN",
    "en_drug_common_name": "SANDOZ OXYCODONE+ACET",
    "fr_drug_brand_name": "sandoz OXYCODONE+ACET",
    "fr_drug_common_name": "sandoz OXYCODONE+ACET",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 9511,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10040,
      "drug_code": 64570,
      "updated_date": "2025-05-15T04:00:14-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8330398,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240978",
      "brand_name": "DOXAZOSIN-1",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131431001"
    },
    "created_date": "2017-05-08T16:16:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240978",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:16:57-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DOXAZOSIN-1",
    "en_drug_common_name": "DOXAZOSIN",
    "fr_drug_brand_name": "DOXAZOSIN-1",
    "fr_drug_common_name": "DOXAZOSIN",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "DOXAZOSIN",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9515,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10042,
      "drug_code": 64571,
      "updated_date": "2025-05-15T04:00:14-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8330399,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240979",
      "brand_name": "DOXAZOSIN-2",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131431003"
    },
    "created_date": "2017-05-08T16:17:46-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240979",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:18:32-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DOXAZOSIN-2",
    "en_drug_common_name": "DOXAZOSIN",
    "fr_drug_brand_name": "DOXAZOSIN-2",
    "fr_drug_common_name": "DOXAZOSIN",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "DOXAZOSIN",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9519,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10044,
      "drug_code": 64572,
      "updated_date": "2025-05-15T04:00:14-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8330400,
          "ingredient": {
            "id": 608,
            "ingredient_code": 11258,
            "en_name": "DOXAZOSIN",
            "fr_name": "Doxazosine (Mésylate de doxazosine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240980",
      "brand_name": "DOXAZOSIN-4",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131431002"
    },
    "created_date": "2017-05-08T16:19:24-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02240980",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C02CA",
    "atc_description": "ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:20:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DOXAZOSIN-4",
    "en_drug_common_name": "DOXAZOSIN",
    "fr_drug_brand_name": "DOXAZOSIN-4",
    "fr_drug_common_name": "DOXAZOSIN",
    "en_ingredients": "DOXAZOSIN",
    "fr_ingredients": "DOXAZOSIN",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9522,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18364,
      "drug_code": 79631,
      "updated_date": "2025-05-15T04:13:49-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345531,
          "ingredient": {
            "id": 286,
            "ingredient_code": 1204,
            "en_name": "FLUCONAZOLE",
            "fr_name": "Fluconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310694",
      "brand_name": "PRO-FLUCONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122529004"
    },
    "created_date": "2017-05-08T16:21:23-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02310694",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:21:44-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-FLUCONAZOLE",
    "en_drug_common_name": "FLUCONAZOLE",
    "fr_drug_brand_name": "PRO-FLUCONAZOLE",
    "fr_drug_common_name": "FLUCONAZOLE",
    "en_ingredients": "FLUCONAZOLE",
    "fr_ingredients": "Fluconazole",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9525,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9034,
      "drug_code": 6161,
      "updated_date": "2025-05-15T03:29:34-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8279902,
          "ingredient": {
            "id": 102,
            "ingredient_code": 2609,
            "en_name": "IBUPROFEN",
            "fr_name": "Ibuprofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00636533",
      "brand_name": "IBUPROFEN TAB 400MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62454",
      "number_of_ais": "1",
      "ai_group_no": "0108883002"
    },
    "created_date": "2017-05-08T16:22:51-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00636533",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:23:20-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "IBUPROFEN TAB 400MG",
    "en_drug_common_name": "IBUPROFEN",
    "fr_drug_brand_name": "IBUPROFEN TAB 400MG",
    "fr_drug_common_name": "IBUPROFEN",
    "en_ingredients": "IBUPROFEN",
    "fr_ingredients": "Ibuprofène",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9528,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18526,
      "drug_code": 79804,
      "updated_date": "2025-05-15T04:13:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345674,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312549",
      "brand_name": "PRO-INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115402001"
    },
    "created_date": "2017-05-08T16:25:13-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02312549",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:25:45-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-INDAPAMIDE",
    "en_drug_common_name": "INDAPAMIDE",
    "fr_drug_brand_name": "PRO-INDAPAMIDE",
    "fr_drug_common_name": "INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9531,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18526,
      "drug_code": 79804,
      "updated_date": "2025-05-15T04:13:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345674,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312549",
      "brand_name": "PRO-INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115402001"
    },
    "created_date": "2017-05-08T16:26:34-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02312549",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:26:59-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-INDAPAMIDE",
    "en_drug_common_name": "INDAPAMIDE",
    "fr_drug_brand_name": "PRO-INDAPAMIDE",
    "fr_drug_common_name": "INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9534,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18524,
      "drug_code": 79803,
      "updated_date": "2025-05-15T04:13:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345673,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312530",
      "brand_name": "PRO-INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115402002"
    },
    "created_date": "2017-05-08T16:27:52-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02312530",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:28:21-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-INDAPAMIDE",
    "en_drug_common_name": "INDAPAMIDE",
    "fr_drug_brand_name": "PRO-INDAPAMIDE",
    "fr_drug_common_name": "INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9537,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18524,
      "drug_code": 79803,
      "updated_date": "2025-05-15T04:13:55-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8345673,
          "ingredient": {
            "id": 1366,
            "ingredient_code": 1960,
            "en_name": "INDAPAMIDE",
            "fr_name": "Indapamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312530",
      "brand_name": "PRO-INDAPAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115402002"
    },
    "created_date": "2017-05-08T16:29:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02312530",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C03BA",
    "atc_description": "LOW-CEILING DIURETICS, EXCL THIAZIDES",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:29:25-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-INDAPAMIDE",
    "en_drug_common_name": "INDAPAMIDE",
    "fr_drug_brand_name": "PRO-INDAPAMIDE",
    "fr_drug_common_name": "INDAPAMIDE",
    "en_ingredients": "INDAPAMIDE",
    "fr_ingredients": "Indapamide",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9540,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19610,
      "drug_code": 80978,
      "updated_date": "2025-05-15T04:14:31-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346900,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324326",
      "brand_name": "MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676003"
    },
    "created_date": "2017-05-08T16:30:52-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324326",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "M01AC",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:31:42-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9544,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19612,
      "drug_code": 80979,
      "updated_date": "2025-05-15T04:14:31-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346901,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324334",
      "brand_name": "MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676004"
    },
    "created_date": "2017-05-08T16:34:44-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324334",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "M01AC",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:35:07-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9547,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8642,
      "drug_code": 6037,
      "updated_date": "2025-05-15T03:29:24-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8279645,
          "ingredient": {
            "id": 174,
            "ingredient_code": 8174,
            "en_name": "SULFAMETHOXAZOLE",
            "fr_name": "Sulfaméthoxazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "800",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8279644,
          "ingredient": {
            "id": 176,
            "ingredient_code": 8452,
            "en_name": "TRIMETHOPRIM",
            "fr_name": "Triméthoprime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "160",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00512524",
      "brand_name": "PROTRIN DF TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62167",
      "number_of_ais": "2",
      "ai_group_no": "0208901003"
    },
    "created_date": "2017-05-08T16:36:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00512524",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J01EE",
    "atc_description": "SULFONAMIDES AND TRIMETHOPRIM",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:37:00-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PROTRIN DF TAB",
    "en_drug_common_name": "PROTRIN DF",
    "fr_drug_brand_name": "PROTRIN DF TAB",
    "fr_drug_common_name": "PROTRIN DF",
    "en_ingredients": "SULFAMETHOXAZOLE\r\nTRIMETHOPRIM",
    "fr_ingredients": "Sulfaméthoxazole\r\nTriméthoprime",
    "drug_strength": "800MG\r\n160MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9551,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7084,
      "drug_code": 47988,
      "updated_date": "2025-05-15T03:50:22-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8313935,
          "ingredient": {
            "id": 2188,
            "ingredient_code": 2014,
            "en_name": "TEMAZEPAM",
            "fr_name": "Témazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229760",
      "brand_name": "TEMAZEPAM-15",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114415002"
    },
    "created_date": "2017-05-08T16:37:52-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02229760",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:38:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEMAZEPAM-15",
    "en_drug_common_name": "TEMAZEPAM",
    "fr_drug_brand_name": "TEMAZEPAM-15",
    "fr_drug_common_name": "TEMAZEPAM",
    "en_ingredients": "TEMAZEPAM",
    "fr_ingredients": "Témazépam",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9554,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7086,
      "drug_code": 47989,
      "updated_date": "2025-05-15T03:50:22-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8313936,
          "ingredient": {
            "id": 2188,
            "ingredient_code": 2014,
            "en_name": "TEMAZEPAM",
            "fr_name": "Témazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229761",
      "brand_name": "TEMAZEPAM-30",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0114415001"
    },
    "created_date": "2017-05-08T16:39:06-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02229761",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:39:59-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "TEMAZEPAM-30",
    "en_drug_common_name": "TEMAZEPAM",
    "fr_drug_brand_name": "TEMAZEPAM-30",
    "fr_drug_common_name": "TEMAZEPAM",
    "en_ingredients": "TEMAZEPAM",
    "fr_ingredients": "Témazépam",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9558,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9828,
      "drug_code": 6390,
      "updated_date": "2025-05-15T03:29:49-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8280255,
          "ingredient": {
            "id": 2256,
            "ingredient_code": 10190,
            "en_name": "TRIAMTERENE",
            "fr_name": "Triamtérène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8280254,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00519367",
      "brand_name": "PRO-TRIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62930",
      "number_of_ais": "2",
      "ai_group_no": "0201052001"
    },
    "created_date": "2017-05-08T16:41:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00519367",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C03EA",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:41:50-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-TRIAZIDE",
    "en_drug_common_name": "TRIAZIDE",
    "fr_drug_brand_name": "PRO-TRIAZIDE",
    "fr_drug_common_name": "TRIAZIDE",
    "en_ingredients": "TRIAMTERENE\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Triamtérène\r\nHydrochlorothiazide",
    "drug_strength": "50MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1000",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9561,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19592,
      "drug_code": 80963,
      "updated_date": "2025-05-15T04:14:31-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346885,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324156",
      "brand_name": "PRO-VERAPAMIL SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113846001"
    },
    "created_date": "2017-05-08T16:43:06-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324156",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C08DA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:49:08-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-VERAPAMIL SR",
    "en_drug_common_name": "VERAPAMIL SR",
    "fr_drug_brand_name": "PRO-VERAPAMIL SR",
    "fr_drug_common_name": "VERAPAMIL SR",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "120MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9564,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19594,
      "drug_code": 80964,
      "updated_date": "2025-05-15T04:14:31-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346886,
          "ingredient": {
            "id": 38,
            "ingredient_code": 10110,
            "en_name": "VERAPAMIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de vérapamil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324164",
      "brand_name": "PRO-VERAPAMIL SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113846004"
    },
    "created_date": "2017-05-08T16:51:04-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02324164",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C08DA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "discontinuation_date": "2017-05-05T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-05-08T16:51:30-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-VERAPAMIL SR",
    "en_drug_common_name": "VERAPAMIL SR",
    "fr_drug_brand_name": "PRO-VERAPAMIL SR",
    "fr_drug_common_name": "VERAPAMIL SR",
    "en_ingredients": "VERAPAMIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de vérapamil",
    "drug_strength": "180MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9567,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8210,
      "drug_code": 5561,
      "updated_date": "2025-05-15T03:28:55-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8278782,
          "ingredient": {
            "id": 838,
            "ingredient_code": 9766,
            "en_name": "SALICYLIC ACID",
            "fr_name": "Acide salicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        },
        {
          "id": 8278781,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "00578428",
      "brand_name": "DIPROSALIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60995",
      "number_of_ais": "2",
      "ai_group_no": "0215695003"
    },
    "created_date": "2017-05-08T16:52:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00578428",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D07XC",
    "atc_description": "CORTICOSTEROIDS, OTHER COMBINATIONS",
    "anticipated_start_date": "2017-05-12T00:00:00-04:00",
    "estimated_end_date": "2017-07-14T00:00:00-04:00",
    "actual_start_date": "2017-05-11T00:00:00-04:00",
    "actual_end_date": "2017-07-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-07-08T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DIPROSALIC",
    "en_drug_common_name": "Betamethasone Dipropionate and Salicylic Acid Lotion",
    "fr_drug_brand_name": "DIPROSALIC LOTION",
    "fr_drug_common_name": "Lotion de Dipropionate de Bétaméthasone avec Acide Salicylique",
    "en_ingredients": "BETAMETHASONE\r\nSALICYLIC ACID",
    "fr_ingredients": "Bétaméthasone\r\nAcide salicylique",
    "drug_strength": "0.5MG\r\n20MG",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 9580,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 524,
      "drug_code": 11102,
      "updated_date": "2025-05-15T03:37:32-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8287516,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00839396",
      "brand_name": "PRINIVIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71369",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2017-05-08T18:52:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00839396",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-05-18T00:00:00-04:00",
    "estimated_end_date": "2017-06-01T00:00:00-04:00",
    "actual_start_date": "2017-05-23T00:00:00-04:00",
    "actual_end_date": "2017-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T19:09:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRINIVIL",
    "en_drug_common_name": "lisinopril tablets",
    "fr_drug_brand_name": "PRINIVIL",
    "fr_drug_common_name": "comprimés de lisinopril",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9600,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 5094,
      "drug_code": 3084,
      "updated_date": "2025-05-15T03:25:50-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8274408,
          "ingredient": {
            "id": 810,
            "ingredient_code": 9418,
            "en_name": "DIAZEPAM",
            "fr_name": "Diazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00434388",
      "brand_name": "DIAZEPAM 10TAB 10MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "52781",
      "number_of_ais": "1",
      "ai_group_no": "0103614003"
    },
    "created_date": "2017-05-08T19:53:07-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00434388",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05BA",
    "atc_description": "ANXIOLYTICS",
    "discontinuation_date": "2017-07-26T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-07-27T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "DIAZEPAM 10TAB 10MG",
    "en_drug_common_name": "DIAZEPAM",
    "fr_drug_brand_name": "DIAZEPAM 10TAB 10MG",
    "fr_drug_common_name": "DIAZEPAM",
    "en_ingredients": "DIAZEPAM",
    "fr_ingredients": "Diazépam",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 9603,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7866,
      "drug_code": 5109,
      "updated_date": "2025-05-15T03:28:17-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8277914,
          "ingredient": {
            "id": 2264,
            "ingredient_code": 4015,
            "en_name": "FLURAZEPAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de flurazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00578487",
      "brand_name": "FLURAZEPAM 30",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59705",
      "number_of_ais": "1",
      "ai_group_no": "0108704001"
    },
    "created_date": "2017-05-08T19:55:55-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "00578487",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05CD",
    "atc_description": "HYPNOTICS AND SEDATIVES",
    "discontinuation_date": "2017-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-10-05T14:54:13-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "FLURAZEPAM 30",
    "en_drug_common_name": "FLURAZEPAM",
    "fr_drug_brand_name": "FLURAZEPAM 30",
    "fr_drug_common_name": "FLURAZEPAM",
    "en_ingredients": "FLURAZEPAM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de flurazépam",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9606,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18942,
      "drug_code": 80203,
      "updated_date": "2025-05-15T04:14:07-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346130,
          "ingredient": {
            "id": 240,
            "ingredient_code": 4007,
            "en_name": "GLYBURIDE",
            "fr_name": "Glyburide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316544",
      "brand_name": "PRO-GLYBURIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108708001"
    },
    "created_date": "2017-05-08T19:58:15-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02316544",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2017-07-04T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-08-08T15:35:35-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-GLYBURIDE",
    "en_drug_common_name": "GLYBURIDE",
    "fr_drug_brand_name": "PRO-GLYBURIDE",
    "fr_drug_common_name": "GLYBURIDE",
    "en_ingredients": "GLYBURIDE",
    "fr_ingredients": "Glyburide",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9617,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 18942,
      "drug_code": 80203,
      "updated_date": "2025-05-15T04:14:07-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8346130,
          "ingredient": {
            "id": 240,
            "ingredient_code": 4007,
            "en_name": "GLYBURIDE",
            "fr_name": "Glyburide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02316544",
      "brand_name": "PRO-GLYBURIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108708001"
    },
    "created_date": "2017-05-08T20:05:56-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02316544",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A10BB",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "discontinuation_date": "2017-08-08T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-08-09T05:00:05-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PRO-GLYBURIDE",
    "en_drug_common_name": "GLYBURIDE",
    "fr_drug_brand_name": "PRO-GLYBURIDE",
    "fr_drug_common_name": "GLYBURIDE",
    "en_ingredients": "GLYBURIDE",
    "fr_ingredients": "Glyburide",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a3": false,
    "tier_3": false
  },
  {
    "id": 9644,
    "drug": {
      "current_status": "MARKETED",
      "id": 16802,
      "drug_code": 77762,
      "updated_date": "2025-05-15T02:31:54-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255936,
          "ingredient": {
            "id": 3122,
            "ingredient_code": 11309,
            "en_name": "CEFTRIAXONE",
            "fr_name": "Ceftriaxone (Ceftriaxone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02292262",
      "brand_name": "CEFTRIAXONE SODIUM FOR INJECTION BP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0117292001"
    },
    "created_date": "2017-05-09T13:47:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02292262",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01DD",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_start_date": "2017-05-09T00:00:00-04:00",
    "actual_end_date": "2017-08-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-18T21:08:51-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFTRIAXONE FOR INJECTION USP",
    "en_drug_common_name": "CEFTRIAXONE",
    "fr_drug_brand_name": "SANDOZ CEFTRIAXONE",
    "fr_drug_common_name": "CEFTRIAXONE",
    "en_ingredients": "CEFTRIAXONE",
    "fr_ingredients": "CEFTRIAXONE",
    "drug_strength": "0.25G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10 VIALS/FIOLES",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9673,
    "drug": {
      "current_status": "MARKETED",
      "id": 29852,
      "drug_code": 91896,
      "updated_date": "2025-05-15T02:34:35-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8260823,
          "ingredient": {
            "id": 3198,
            "ingredient_code": 13585,
            "en_name": "ESCITALOPRAM",
            "fr_name": "Escitalopram (Oxalate d'escitalopram)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02434652",
      "brand_name": "ACH-ESCITALOPRAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150435002"
    },
    "created_date": "2017-05-09T18:42:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02434652",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-05-09T00:00:00-04:00",
    "estimated_end_date": "2017-11-03T00:00:00-04:00",
    "actual_start_date": "2017-05-09T00:00:00-04:00",
    "actual_end_date": "2017-10-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-27T17:43:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-ESCITALOPRAM",
    "en_drug_common_name": "ESCITALOPRAM",
    "fr_drug_brand_name": "ACH-ESCITALOPRAM",
    "fr_drug_common_name": "ESCITALOPRAM",
    "en_ingredients": "ESCITALOPRAM",
    "fr_ingredients": "Escitalopram",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 TABS PER BOTTLE   |   BOUTEILLE DE 100 COMPRIMÉS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9689,
    "drug": {
      "current_status": "MARKETED",
      "id": 26412,
      "drug_code": 88750,
      "updated_date": "2025-12-03T00:32:13-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8259537,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402653",
      "brand_name": "ACH-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2017-05-09T18:47:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402653",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2017-04-21T00:00:00-04:00",
    "estimated_end_date": "2017-08-04T00:00:00-04:00",
    "actual_start_date": "2017-04-21T00:00:00-04:00",
    "actual_end_date": "2017-07-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-22T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DONEPEZIL HYDROCHLORIDE TABLETS",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 9695,
    "drug": {
      "current_status": "MARKETED",
      "id": 21642,
      "drug_code": 84031,
      "updated_date": "2025-05-15T02:32:47-04:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8257733,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355043",
      "brand_name": "ACH-FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2017-05-09T18:51:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355043",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2017-05-08T00:00:00-04:00",
    "estimated_end_date": "2017-06-16T00:00:00-04:00",
    "actual_start_date": "2017-05-08T00:00:00-04:00",
    "actual_end_date": "2017-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-19T20:29:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACH-FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE",
    "fr_drug_brand_name": "ACH-FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 TABS PER BOTTLE     |     BOUTEILLE DE 100 COMPRIMÉS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 9700,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22944,
      "drug_code": 85506,
      "updated_date": "2025-12-03T01:29:11-05:00",
      "company": {
        "id": 1452,
        "created_date": "2017-03-09T13:24:28-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13032,
        "mfr_code": "",
        "name": "ACCORD HEALTHCARE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "3535 BOULEVARD ST-CHARLES, SUITE 704",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 5B9",
        "post_office_box": "",
        "contact_information": "Customer Service at (514)  505-4159 ext. 203     |     Service à la clientèle à (514) 505-4159 poste 203"
      },
      "drug_ingredients": [
        {
          "id": 8350390,
          "ingredient": {
            "id": 2334,
            "ingredient_code": 11262,
            "en_name": "GEMCITABINE",
            "fr_name": "Gemcitabine (Chlorhydrate de gemcitabine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02370034",
      "brand_name": "GEMCITABINE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133122004"
    },
    "created_date": "2017-05-09T18:57:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370034",
    "company_name": "ACCORD HEALTHCARE INC",
    "atc_number": "L01BC",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2017-05-09T00:00:00-04:00",
    "estimated_end_date": "2017-07-07T00:00:00-04:00",
    "actual_start_date": "2017-05-09T00:00:00-04:00",
    "actual_end_date": "2017-07-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-13T14:57:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "GEMCITABINE FOR INJECTION",
    "en_drug_common_name": "GEMCITABINE",
    "fr_drug_brand_name": "GEMCITABINE",
    "fr_drug_common_name": "GEMCITABINE",
    "en_ingredients": "GEMCITABINE",
    "fr_ingredients": "CHLOHYDRATE DE GEMCITABINE",
    "drug_strength": "2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "2 G (POWDER) PER VIAL   |   FLACON DE 2 G (POUDRE)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 9702,
    "drug": {
      "current_status": "MARKETED",
      "id": 25818,
      "drug_code": 88195,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8259312,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396947",
      "brand_name": "ATOMOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434005"
    },
    "created_date": "2017-05-09T19:00:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396947",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "actual_start_date": "2017-05-30T00:00:00-04:00",
    "actual_end_date": "2017-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-07-19T15:32:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ATOMOXETINE",
    "en_drug_common_name": "ATOMOXETINE",
    "fr_drug_brand_name": "ATOMOXETINE",
    "fr_drug_common_name": "ATOMOXETINE",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "ATOMOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9705,
    "drug": {
      "current_status": "MARKETED",
      "id": 22520,
      "drug_code": 85001,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8258084,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258083,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02365162",
      "brand_name": "IRBESARTAN-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086001"
    },
    "created_date": "2017-05-09T19:02:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02365162",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2017-06-01T00:00:00-04:00",
    "actual_end_date": "2017-11-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-11-22T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IRBESARTAN-HCTZ",
    "en_drug_common_name": "IRBESARTAN-HCTZ",
    "fr_drug_brand_name": "IRBESARTAN-HCTZ",
    "fr_drug_common_name": "IRBESARTAN-HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9709,
    "drug": {
      "current_status": "MARKETED",
      "id": 18806,
      "drug_code": 80073,
      "updated_date": "2025-05-15T02:32:14-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256574,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02315173",
      "brand_name": "PRO-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626001"
    },
    "created_date": "2017-05-09T19:07:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02315173",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "actual_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2017-10-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-06T20:03:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRO-VALACYCLOVIR",
    "en_drug_common_name": "PRO-VALACYCLOVIR",
    "fr_drug_brand_name": "PRO-VALACYCLOVIR",
    "fr_drug_common_name": "PRO-VALACYCLOVIR",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "VALACYCLOVIR",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9713,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7080,
      "drug_code": 47956,
      "updated_date": "2025-05-15T03:50:21-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8313921,
          "ingredient": {
            "id": 582,
            "ingredient_code": 8231,
            "en_name": "BUTALBITAL",
            "fr_name": "Butalbital"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8313920,
          "ingredient": {
            "id": 100,
            "ingredient_code": 9358,
            "en_name": "CAFFEINE",
            "fr_name": "Caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8313919,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "330",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229736",
      "brand_name": "PRONAL TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0301241001"
    },
    "created_date": "2017-05-09T19:10:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229736",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N02BA",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "actual_start_date": "2017-05-24T00:00:00-04:00",
    "actual_end_date": "2018-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-05-31T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Discontinued as of November 22, 2017",
    "fr_comments": "Discontinué depuis le 22 novembre 2017",
    "en_drug_brand_name": "PRONAL TABLETS",
    "en_drug_common_name": "PRONAL",
    "fr_drug_brand_name": "PRONAL TABLETS",
    "fr_drug_common_name": "PRONAL",
    "en_ingredients": "ACETYLSALICYLIC ACID\r\nBUTALBITAL\r\nCAFFEINE",
    "fr_ingredients": "Acide acétylsalicylique\r\nButalbital\r\nCaféine",
    "drug_strength": "330MG\r\n50MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9729,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27846,
      "drug_code": 90048,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8353944,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8353943,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415887",
      "brand_name": "RAMIPRIL-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251649001"
    },
    "created_date": "2017-05-09T19:29:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415887",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "actual_start_date": "2017-06-13T00:00:00-04:00",
    "actual_end_date": "2018-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2018-12-22T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinué",
    "en_drug_brand_name": "RAMIPRIL-HCTZ",
    "en_drug_common_name": "RAMIPRIL-HCTZ",
    "fr_drug_brand_name": "RAMIPRIL-HCTZ",
    "fr_drug_common_name": "RAMIPRIL-HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nRAMIPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nRamipril",
    "drug_strength": "12.5MG\r\n5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9732,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27848,
      "drug_code": 90049,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8353946,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8353945,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02415895",
      "brand_name": "RAMIPRIL-HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251649003"
    },
    "created_date": "2017-05-09T19:31:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02415895",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "actual_start_date": "2017-08-08T00:00:00-04:00",
    "actual_end_date": "2017-08-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T15:01:31-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAMIPRIL-HCTZ",
    "en_drug_common_name": "RAMIPRIL-HCTZ",
    "fr_drug_brand_name": "RAMIPRIL-HCTZ",
    "fr_drug_common_name": "RAMIPRIL-HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nRAMIPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nRamipril",
    "drug_strength": "12.5MG\r\n10.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9735,
    "drug": {
      "current_status": "MARKETED",
      "id": 18548,
      "drug_code": 79826,
      "updated_date": "2025-05-15T02:32:11-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8256494,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.0",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02312735",
      "brand_name": "PRO-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332004"
    },
    "created_date": "2017-05-09T19:33:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02312735",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-07-20T00:00:00-04:00",
    "actual_end_date": "2017-07-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-07-31T20:25:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PRO-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "PRO-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "2.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9738,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23918,
      "drug_code": 86578,
      "updated_date": "2025-05-15T04:19:50-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8351230,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379929",
      "brand_name": "ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2017-05-09T19:35:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379929",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "actual_start_date": "2017-07-14T00:00:00-04:00",
    "actual_end_date": "2017-12-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-12-07T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ZOLMITRIPTAN",
    "en_drug_common_name": "ZOLMITRIPTAN",
    "fr_drug_brand_name": "ZOLMITRIPTAN",
    "fr_drug_common_name": "ZOLMITRIPTAN",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9785,
    "drug": {
      "current_status": "MARKETED",
      "id": 20188,
      "drug_code": 81625,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257160,
          "ingredient": {
            "id": 2568,
            "ingredient_code": 11776,
            "en_name": "IRBESARTAN",
            "fr_name": "Irbésartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8257159,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330520",
      "brand_name": "TEVA-IRBESARTAN HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0240086002"
    },
    "created_date": "2017-05-10T15:03:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330520",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2017-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:15:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RATIO-IRBESARTAN HCTZ",
    "en_drug_common_name": "IRBESARTAN HCTZ",
    "fr_drug_brand_name": "RATIO-IRBESARTAN HCTZ",
    "fr_drug_common_name": "IRBESARTAN HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nIRBESARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nIrbésartan",
    "drug_strength": "12.5MG\r\n300MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9788,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13686,
      "drug_code": 73529,
      "updated_date": "2025-05-15T04:08:23-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8339760,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250497",
      "brand_name": "TEVA-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437002"
    },
    "created_date": "2017-05-10T15:05:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250497",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2018-01-30T00:00:00-05:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2018-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-03-13T11:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE",
    "fr_drug_brand_name": "TEVA-AMLODIPINE",
    "fr_drug_common_name": "AMLODIPINE",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "Amlodipine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9791,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 13686,
      "drug_code": 73529,
      "updated_date": "2025-05-15T04:08:23-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8339760,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02250497",
      "brand_name": "TEVA-AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437002"
    },
    "created_date": "2017-05-10T15:12:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02250497",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2018-01-30T00:00:00-05:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2018-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-03-13T11:01:25-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE",
    "fr_drug_brand_name": "TEVA-AMLODIPINE",
    "fr_drug_common_name": "AMLODIPINE",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "Amlodipine",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9796,
    "drug": {
      "current_status": "MARKETED",
      "id": 21538,
      "drug_code": 83931,
      "updated_date": "2025-05-15T02:32:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257694,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02354101",
      "brand_name": "TEVA-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2017-05-10T15:14:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02354101",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-06-05T00:00:00-04:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2017-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:03:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-EZETIMIBE",
    "en_drug_common_name": "EZETIMIBE",
    "fr_drug_brand_name": "TEVA-EZETIMIBE",
    "fr_drug_common_name": "EZETIMIBE",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9799,
    "drug": {
      "current_status": "MARKETED",
      "id": 12528,
      "drug_code": 71243,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254602,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247010",
      "brand_name": "TEVA-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2017-05-10T15:15:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247010",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-01-26T00:00:00-05:00",
    "actual_start_date": "2017-09-01T00:00:00-04:00",
    "actual_end_date": "2018-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-21T21:11:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "TEVA-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9802,
    "drug": {
      "current_status": "MARKETED",
      "id": 13000,
      "drug_code": 72255,
      "updated_date": "2025-05-15T02:31:28-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254749,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247945",
      "brand_name": "TEVA-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2017-05-10T15:17:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247945",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2017-11-30T00:00:00-05:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2017-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-03T15:28:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "TEVA-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9805,
    "drug": {
      "current_status": "MARKETED",
      "id": 25788,
      "drug_code": 88171,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259304,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396688",
      "brand_name": "TEVA-RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841002"
    },
    "created_date": "2017-05-10T15:18:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396688",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2017-06-29T00:00:00-04:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2017-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:04:46-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "TEVA-RIZATRIPTAN ODT",
    "fr_drug_common_name": "RISATRIPTAN",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "Rizatriptan",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9843,
    "drug": {
      "current_status": "MARKETED",
      "id": 28860,
      "drug_code": 90968,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260480,
          "ingredient": {
            "id": 510,
            "ingredient_code": 7572,
            "en_name": "CYPROTERONE ACETATE",
            "fr_name": "Acétate de cyprotérone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8260479,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.035",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02425017",
      "brand_name": "TARO-CYPROTERONE/ETHINYL ESTRADIOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0232337001"
    },
    "created_date": "2017-05-10T15:53:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02425017",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "G03HB",
    "atc_description": "ANTIANDROGENS",
    "anticipated_start_date": "2017-03-01T00:00:00-05:00",
    "estimated_end_date": "2017-05-28T00:00:00-04:00",
    "actual_start_date": "2017-03-01T00:00:00-05:00",
    "actual_end_date": "2017-05-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:41:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-CYPROTERONE/ETHINYL ESTRADIOL",
    "en_drug_common_name": "RAN-CYPROTERONE/ETHINYL ESTRADIOL",
    "fr_drug_brand_name": "RAN-CYPROTERONE/ETHINYL ESTRADIOL",
    "fr_drug_common_name": "RAN-CYPROTERONE/ETHINYL ESTRADIOL",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nCYPROTERONE ACETATE",
    "fr_ingredients": "Éthinylestradiol\r\nAcétate de cyprotérone",
    "drug_strength": "0.035MG\r\n2.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 9849,
    "drug": {
      "current_status": "MARKETED",
      "id": 13416,
      "drug_code": 73098,
      "updated_date": "2025-05-15T02:31:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254867,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02248730",
      "brand_name": "APO-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2017-05-10T15:56:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248730",
    "company_name": "APOTEX INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2017-07-20T00:00:00-04:00",
    "actual_start_date": "2017-05-08T00:00:00-04:00",
    "actual_end_date": "2017-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-19T13:37:21-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "APO-ALENDRONATE",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONATE",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9877,
    "drug": {
      "current_status": "MARKETED",
      "id": 24834,
      "drug_code": 87374,
      "updated_date": "2025-05-15T02:33:33-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258981,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258980,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388197",
      "brand_name": "TARO-TRAMADOL/ACET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250601001"
    },
    "created_date": "2017-05-10T16:26:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388197",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N02AJ",
    "anticipated_start_date": "2017-03-01T00:00:00-05:00",
    "estimated_end_date": "2017-06-21T00:00:00-04:00",
    "actual_start_date": "2017-03-01T00:00:00-05:00",
    "actual_end_date": "2017-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:40:40-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-TRAMADOL/ACET",
    "en_drug_common_name": "RAN-TRAMADOL/ACET",
    "fr_drug_brand_name": "RAN-TRAMADOL/ACET",
    "fr_drug_common_name": "RAN-TRAMADOL/ACET",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE\r\nACETAMINOPHEN",
    "fr_ingredients": "Chlorhydrate de tramadol\r\nAcétaminophène",
    "drug_strength": "37.5MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 9901,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23000,
      "drug_code": 85576,
      "updated_date": "2025-12-03T01:29:15-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8350463,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "180",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02370638",
      "brand_name": "ACT DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863007"
    },
    "created_date": "2017-05-10T16:37:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02370638",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "estimated_end_date": "2017-05-31T00:00:00-04:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2017-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T11:38:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM CD",
    "fr_drug_brand_name": "ACT DILTIAZEM CD",
    "fr_drug_common_name": "DILTIAZEM CD",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "180MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9906,
    "drug": {
      "current_status": "MARKETED",
      "id": 15990,
      "drug_code": 76779,
      "updated_date": "2025-05-15T02:31:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255716,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282127",
      "brand_name": "APO-RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332007"
    },
    "created_date": "2017-05-10T16:39:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282127",
    "company_name": "APOTEX INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2017-06-07T00:00:00-04:00",
    "actual_start_date": "2017-05-08T00:00:00-04:00",
    "actual_end_date": "2017-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-06-01T12:14:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "APO-RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "0.50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9912,
    "drug": {
      "current_status": "MARKETED",
      "id": 28730,
      "drug_code": 90861,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260425,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02423863",
      "brand_name": "TEVA-ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2017-05-10T16:43:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02423863",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2018-06-30T00:00:00-04:00",
    "actual_start_date": "2017-08-01T00:00:00-04:00",
    "actual_end_date": "2018-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T17:58:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT ESOMEPRAZOLE",
    "en_drug_common_name": "ESOMEPRAZOLE",
    "fr_drug_brand_name": "ACT ESOMEPRAZOLE",
    "fr_drug_common_name": "ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "Esomeprazole",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9917,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27698,
      "drug_code": 89935,
      "updated_date": "2025-05-15T04:21:43-04:00",
      "company": {
        "id": 1034,
        "created_date": "2017-03-09T13:23:38-05:00",
        "updated_date": "2025-05-15T03:22:13-04:00",
        "company_code": 15772,
        "mfr_code": "",
        "name": "ACTAVIS PHARMA COMPANY",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8353821,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02414716",
      "brand_name": "ACT EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2017-05-10T16:46:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02414716",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-05-30T00:00:00-04:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2017-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-05-24T11:20:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT EZETIMIBE",
    "en_drug_common_name": "EZETIMIBE",
    "fr_drug_brand_name": "ACT EZETIMIBE",
    "fr_drug_common_name": "EZETIMIBE",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9922,
    "drug": {
      "current_status": "MARKETED",
      "id": 15396,
      "drug_code": 75965,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255511,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274191",
      "brand_name": "TEVA-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843002"
    },
    "created_date": "2017-05-10T16:51:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274191",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-09-01T00:00:00-04:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2018-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-11T17:42:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "ACT LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9925,
    "drug": {
      "current_status": "MARKETED",
      "id": 15434,
      "drug_code": 76022,
      "updated_date": "2025-12-03T00:31:05-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255524,
          "ingredient": {
            "id": 688,
            "ingredient_code": 8318,
            "en_name": "CLARITHROMYCIN",
            "fr_name": "Clarithromycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274752",
      "brand_name": "APO-CLARITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123752002"
    },
    "created_date": "2017-05-10T16:56:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274752",
    "company_name": "APOTEX INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2017-06-27T00:00:00-04:00",
    "actual_start_date": "2017-05-08T00:00:00-04:00",
    "actual_end_date": "2017-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CLARITHROMYCIN",
    "en_drug_common_name": "CLARITHROMYCIN",
    "fr_drug_brand_name": "APO-CLARITHROMYCIN",
    "fr_drug_common_name": "CLARITHROMYCIN",
    "en_ingredients": "CLARITHROMYCIN",
    "fr_ingredients": "Clarithromycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9928,
    "drug": {
      "current_status": "MARKETED",
      "id": 22332,
      "drug_code": 84729,
      "updated_date": "2025-12-03T00:31:43-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257988,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362279",
      "brand_name": "APO-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2017-05-10T16:58:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362279",
    "company_name": "APOTEX INC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "estimated_end_date": "2017-09-27T00:00:00-04:00",
    "actual_start_date": "2017-08-07T00:00:00-04:00",
    "actual_end_date": "2017-09-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-04T12:15:45-04:00",
    "status": "resolved",
    "en_comments": "100 btl available",
    "en_drug_brand_name": "APO-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "APO-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9933,
    "drug": {
      "current_status": "MARKETED",
      "id": 15966,
      "drug_code": 76747,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255702,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281813",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783004"
    },
    "created_date": "2017-05-10T17:06:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281813",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2017-06-12T00:00:00-04:00",
    "actual_start_date": "2017-05-08T00:00:00-04:00",
    "actual_end_date": "2017-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-13T14:30:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9936,
    "drug": {
      "current_status": "MARKETED",
      "id": 19648,
      "drug_code": 81005,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8256864,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256863,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324628",
      "brand_name": "APO-OXYCODONE/ACET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2017-05-10T17:08:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324628",
    "company_name": "APOTEX INC",
    "atc_number": "N02AJ",
    "estimated_end_date": "2017-06-30T00:00:00-04:00",
    "actual_start_date": "2017-06-01T00:00:00-04:00",
    "actual_end_date": "2017-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-04T18:10:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OXYCODONE/ACET",
    "en_drug_common_name": "OXYCODONE+ACETAMINOPHEN",
    "fr_drug_brand_name": "APO-OXYCODONE/ACET",
    "fr_drug_common_name": "OXYCODONE+ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9939,
    "drug": {
      "current_status": "MARKETED",
      "id": 15398,
      "drug_code": 75966,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255512,
          "ingredient": {
            "id": 3016,
            "ingredient_code": 13107,
            "en_name": "LEVETIRACETAM",
            "fr_name": "Lévétiracétam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274205",
      "brand_name": "TEVA-LEVETIRACETAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148843003"
    },
    "created_date": "2017-05-10T17:10:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02274205",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2018-09-30T00:00:00-04:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2018-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-11T17:37:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT LEVETIRACETAM",
    "en_drug_common_name": "LEVETIRACETAM",
    "fr_drug_brand_name": "ACT LEVETIRACETAM",
    "fr_drug_common_name": "LEVETIRACETAM",
    "en_ingredients": "LEVETIRACETAM",
    "fr_ingredients": "Lévétiracétam",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 9946,
    "drug": {
      "current_status": "MARKETED",
      "id": 22344,
      "drug_code": 84741,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257998,
          "ingredient": {
            "id": 3240,
            "ingredient_code": 11780,
            "en_name": "TAMSULOSIN HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tamsulosine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362406",
      "brand_name": "APO-TAMSULOSIN CR",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED-RELEASE TABLET",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133680001"
    },
    "created_date": "2017-05-10T17:36:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362406",
    "company_name": "APOTEX INC",
    "atc_number": "G04CA",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2017-05-29T00:00:00-04:00",
    "actual_start_date": "2017-05-08T00:00:00-04:00",
    "actual_end_date": "2017-05-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-05-13T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "APO-TAMSULOSIN CR FCT 0.4MG 100 BTL available",
    "fr_comments": "APO-TAMSULOSIN CR FCT 0.4MG 100 BTL  disponible",
    "en_drug_brand_name": "APO-TAMSULOSIN CR",
    "en_drug_common_name": "TAMSULOSIN",
    "fr_drug_brand_name": "APO-TAMSULOSIN CR",
    "fr_drug_common_name": "TAMSULOSIN",
    "en_ingredients": "TAMSULOSIN HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tamsulosine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9951,
    "drug": {
      "current_status": "MARKETED",
      "id": 28210,
      "drug_code": 90347,
      "updated_date": "2025-05-15T02:34:11-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8260237,
          "ingredient": {
            "id": 2680,
            "ingredient_code": 11865,
            "en_name": "CELECOXIB",
            "fr_name": "Célécoxib"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02418932",
      "brand_name": "APO-CELECOXIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137043001"
    },
    "created_date": "2017-05-10T17:47:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418932",
    "company_name": "APOTEX INC",
    "atc_number": "M01AH",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2017-12-04T00:00:00-05:00",
    "actual_start_date": "2017-10-02T00:00:00-04:00",
    "actual_end_date": "2017-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-20T16:38:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-CELECOXIB",
    "en_drug_common_name": "CELECOXIB",
    "fr_drug_brand_name": "APO-CELECOXIB",
    "fr_drug_common_name": "CELECOXIB",
    "en_ingredients": "CELECOXIB",
    "fr_ingredients": "Célécoxib",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 9954,
    "drug": {
      "current_status": "MARKETED",
      "id": 20358,
      "drug_code": 81866,
      "updated_date": "2025-12-03T00:31:29-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8257208,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02333015",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2017-05-10T17:50:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02333015",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2017-06-03T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-06-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-05T18:19:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9957,
    "drug": {
      "current_status": "MARKETED",
      "id": 15784,
      "drug_code": 76524,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255650,
          "ingredient": {
            "id": 2382,
            "ingredient_code": 11384,
            "en_name": "TOPIRAMATE",
            "fr_name": "Topiramate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279630",
      "brand_name": "APO-TOPIRAMATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132938002"
    },
    "created_date": "2017-05-10T17:52:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279630",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-05-26T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-05-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-05-25T12:00:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TOPIRAMATE",
    "en_drug_common_name": "TOPIRAMATE",
    "fr_drug_brand_name": "APO-TOPIRAMATE",
    "fr_drug_common_name": "TOPIRAMATE",
    "en_ingredients": "TOPIRAMATE",
    "fr_ingredients": "Topiramate",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 9960,
    "drug": {
      "current_status": "MARKETED",
      "id": 16216,
      "drug_code": 77001,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255787,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284448",
      "brand_name": "TARO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2017-05-10T18:14:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284448",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2016-10-01T00:00:00-04:00",
    "actual_start_date": "2016-10-01T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T17:28:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-PRAVASTATIN",
    "en_drug_common_name": "RAN-PRAVASTATIN",
    "fr_drug_brand_name": "RAN-PRAVASTATIN",
    "fr_drug_common_name": "RAN-PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 9975,
    "drug": {
      "current_status": "MARKETED",
      "id": 19868,
      "drug_code": 81202,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 17091,
        "created_date": "2021-07-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 18353,
        "mfr_code": "",
        "name": "STERI-MED PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "242, RUE SAINT-CYRILLE OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "UPTON",
        "postal_code": "J0H 2E0",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256946,
          "ingredient": {
            "id": 206,
            "ingredient_code": 8618,
            "en_name": "ERYTHROMYCIN",
            "fr_name": "Érythromycine (Stéarate d'érythromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02326663",
      "brand_name": "ERYTHROMYCIN OPHTHALMIC OINTMENT USP",
      "brand_name_fr": "ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105708019"
    },
    "created_date": "2017-05-10T18:57:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326663",
    "company_name": "LABORATOIRES STERIGEN INC",
    "atc_number": "S01AA",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2021-12-15T00:00:00-05:00",
    "actual_start_date": "2017-03-09T00:00:00-05:00",
    "actual_end_date": "2021-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2021-12-16T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP",
    "en_drug_common_name": "Erythromycin Ophthalmic Ointment USP",
    "fr_drug_brand_name": "ONGUENT OPHTALMIQUE D'ÉRYTHROMYICINE USP",
    "fr_drug_common_name": "Onguent Ophtalmique d'Érythromycine USP",
    "en_ingredients": "ERYTHROMYCIN",
    "fr_ingredients": "Érythromycine",
    "drug_strength": "5MG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "1 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 9978,
    "drug": {
      "current_status": "MARKETED",
      "id": 19868,
      "drug_code": 81202,
      "updated_date": "2025-05-15T02:32:23-04:00",
      "company": {
        "id": 17091,
        "created_date": "2021-07-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 18353,
        "mfr_code": "",
        "name": "STERI-MED PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "242, RUE SAINT-CYRILLE OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "UPTON",
        "postal_code": "J0H 2E0",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256946,
          "ingredient": {
            "id": 206,
            "ingredient_code": 8618,
            "en_name": "ERYTHROMYCIN",
            "fr_name": "Érythromycine (Stéarate d'érythromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02326663",
      "brand_name": "ERYTHROMYCIN OPHTHALMIC OINTMENT USP",
      "brand_name_fr": "ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105708019"
    },
    "created_date": "2017-05-10T18:59:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326663",
    "company_name": "LABORATOIRES STERIGEN INC",
    "atc_number": "S01AA",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2017-08-31T00:00:00-04:00",
    "actual_start_date": "2017-04-20T00:00:00-04:00",
    "actual_end_date": "2017-08-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-06T11:42:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ONGUENT OPHTALMIQUE D'ERYTHROMYCINE USP",
    "en_drug_common_name": "Erythromycin Ophthalmic Ointment USP",
    "fr_drug_brand_name": "ONGUENT OPHTALMIQUE D'ÉRYTHROMYICINE USP",
    "fr_drug_common_name": "Onguent Ophtalmique d'Érythromycine USP",
    "en_ingredients": "ERYTHROMYCIN",
    "fr_ingredients": "Érythromycine",
    "drug_strength": "5MG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3.5 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 9987,
    "drug": {
      "current_status": "MARKETED",
      "id": 26404,
      "drug_code": 88746,
      "updated_date": "2025-05-15T02:33:50-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259534,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402610",
      "brand_name": "TARO-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666003"
    },
    "created_date": "2017-05-10T19:19:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402610",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-03-01T00:00:00-05:00",
    "estimated_end_date": "2018-05-15T00:00:00-04:00",
    "actual_start_date": "2017-03-01T00:00:00-05:00",
    "actual_end_date": "2018-08-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T21:46:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-LANSOPRAZOLE",
    "en_drug_common_name": "RAN-LANSOPRAZOLE",
    "fr_drug_brand_name": "RAN-LANSOPRAZOLE",
    "fr_drug_common_name": "RAN-LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "15MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 9992,
    "drug": {
      "current_status": "MARKETED",
      "id": 24232,
      "drug_code": 86846,
      "updated_date": "2025-12-03T00:31:56-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258719,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382644",
      "brand_name": "TARO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2017-05-10T19:27:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382644",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-03-13T00:00:00-04:00",
    "actual_start_date": "2017-03-13T00:00:00-04:00",
    "actual_end_date": "2018-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-11-28T20:51:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-ROSUVASTATIN",
    "en_drug_common_name": "RAN-ROSUVASTATIN",
    "fr_drug_brand_name": "RAN-ROSUVASTATIN",
    "fr_drug_common_name": "RAN-ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 10000,
    "drug": {
      "current_status": "MARKETED",
      "id": 3868,
      "drug_code": 19442,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252489,
          "ingredient": {
            "id": 158,
            "ingredient_code": 5319,
            "en_name": "POTASSIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de potassium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "236",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252488,
          "ingredient": {
            "id": 160,
            "ingredient_code": 6337,
            "en_name": "POTASSIUM PHOSPHATE MONOBASIC",
            "fr_name": "Phosphate de potassium monobasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "224",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139545",
      "brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81739",
      "number_of_ais": "2",
      "ai_group_no": "0207483001"
    },
    "created_date": "2017-05-10T19:41:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139545",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2017-05-12T00:00:00-04:00",
    "estimated_end_date": "2017-06-09T00:00:00-04:00",
    "actual_end_date": "2017-05-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-05-27T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Available at all locations Friday May 26th.",
    "fr_comments": "Disponible dans tous les entrepôts vendredi le 26 mai.",
    "en_drug_brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
    "en_drug_common_name": "Potassium Phosphate",
    "fr_drug_brand_name": "Phosphate de potassium",
    "fr_drug_common_name": "Phosphate de potassium",
    "en_ingredients": "POTASSIUM PHOSPHATE DIBASIC\r\nPOTASSIUM PHOSPHATE MONOBASIC",
    "fr_ingredients": "Phosphate de potassium dibasique\r\nPhosphate de potassium monobasique",
    "drug_strength": "236MG\r\n224MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "50mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 10019,
    "drug": {
      "current_status": "MARKETED",
      "id": 4288,
      "drug_code": 20218,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8252687,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02219492",
      "brand_name": "VALTREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82521",
      "number_of_ais": "1",
      "ai_group_no": "0128626001"
    },
    "created_date": "2017-05-11T00:59:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02219492",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2017-06-26T00:00:00-04:00",
    "estimated_end_date": "2017-07-18T00:00:00-04:00",
    "actual_end_date": "2017-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-05-31T14:37:24-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "VALTREX",
    "en_drug_common_name": "valacyclovir caplets",
    "fr_drug_brand_name": "VALTREX",
    "fr_drug_common_name": "Caplets de valacyclovir",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "Valacyclovir",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 10043,
    "drug": {
      "current_status": "MARKETED",
      "id": 15714,
      "drug_code": 76425,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255618,
          "ingredient": {
            "id": 3284,
            "ingredient_code": 918,
            "en_name": "MIDODRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de midodrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02278677",
      "brand_name": "APO-MIDODRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123066001"
    },
    "created_date": "2017-05-11T14:50:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02278677",
    "company_name": "AA PHARMA INC",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "estimated_end_date": "2017-05-16T00:00:00-04:00",
    "actual_start_date": "2017-05-10T00:00:00-04:00",
    "actual_end_date": "2017-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-05-17T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIDODRINE",
    "en_drug_common_name": "MIDODRINE",
    "fr_drug_brand_name": "MIDODRINE",
    "fr_drug_common_name": "MIDODRINE",
    "en_ingredients": "MIDODRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de midodrine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10054,
    "drug": {
      "current_status": "MARKETED",
      "id": 16146,
      "drug_code": 76935,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8255759,
          "ingredient": {
            "id": 958,
            "ingredient_code": 951,
            "en_name": "CILAZAPRIL",
            "fr_name": "Cilazapril (Monohydrate de Cilazapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02283778",
      "brand_name": "MYLAN-CILAZAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122806001"
    },
    "created_date": "2017-05-11T19:39:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02283778",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2018-08-29T00:00:00-04:00",
    "estimated_end_date": "2018-08-30T00:00:00-04:00",
    "actual_end_date": "2018-08-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-08-21T16:55:32-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-CILAZAPRIL",
    "en_drug_common_name": "CILAZAPRIL",
    "fr_drug_brand_name": "MYLAN-CILAZAPRIL",
    "fr_drug_common_name": "CILAZAPRIL",
    "en_ingredients": "CILAZAPRIL",
    "fr_ingredients": "Cilazapril",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10059,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25798,
      "drug_code": 88176,
      "updated_date": "2025-05-15T04:20:41-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8352398,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02396742",
      "brand_name": "MYLAN-FENTANYL MATRIX PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2017-05-11T19:45:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396742",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2017-05-08T00:00:00-04:00",
    "actual_end_date": "2017-05-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-02T19:00:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-FENTANYL MATRIX PATCH",
    "en_drug_common_name": "FENTANYL MATRIX PATCH",
    "fr_drug_brand_name": "MYLAN-FENTANYL MATRIX PATCH",
    "fr_drug_common_name": "FENTANYL MATRIX PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10066,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22064,
      "drug_code": 84450,
      "updated_date": "2025-05-15T04:17:42-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8349533,
          "ingredient": {
            "id": 2434,
            "ingredient_code": 11485,
            "en_name": "DONEPEZIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de donépézil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359480",
      "brand_name": "MYLAN-DONEPEZIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131548002"
    },
    "created_date": "2017-05-11T20:13:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359480",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "N06DA",
    "atc_description": "ANTI-DEMENTIA DRUGS",
    "anticipated_start_date": "2018-03-01T00:00:00-05:00",
    "actual_end_date": "2018-03-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-02T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 16120.",
    "fr_comments": "Discontinued in ID 16120.",
    "en_drug_brand_name": "MYLAN-DONEPEZIL",
    "en_drug_common_name": "DONEPEZIL",
    "fr_drug_brand_name": "MYLAN-DONEPEZIL",
    "fr_drug_common_name": "DONEPEZIL",
    "en_ingredients": "DONEPEZIL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de donépézil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10070,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14096,
      "drug_code": 74121,
      "updated_date": "2025-05-15T04:09:01-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8340208,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02255995",
      "brand_name": "MYLAN-MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676004"
    },
    "created_date": "2017-05-11T20:15:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02255995",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AC",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2018-06-01T00:00:00-04:00",
    "actual_start_date": "2018-06-01T00:00:00-04:00",
    "actual_end_date": "2018-06-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-08T14:33:15-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 16135.",
    "fr_comments": "discontinued in ID 16135.",
    "en_drug_brand_name": "MYLAN-MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "MYLAN-MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10074,
    "drug": {
      "current_status": "MARKETED",
      "id": 14136,
      "drug_code": 74172,
      "updated_date": "2025-12-03T00:31:00-05:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8255106,
          "ingredient": {
            "id": 3158,
            "ingredient_code": 13348,
            "en_name": "VORICONAZOLE",
            "fr_name": "Voriconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02256487",
      "brand_name": "VFEND",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150242002"
    },
    "created_date": "2017-05-11T20:21:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02256487",
    "company_name": "PFIZER CANADA INC",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "anticipated_start_date": "2017-05-31T00:00:00-04:00",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_end_date": "2017-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-19T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Released August 18, 2017. \r\nInventory is currently available through the CPDN network and projected to cover  \r\n  demand to early June.",
    "fr_comments": "Résolu le 18 août 2017. \r\nInventaire présentement disponible au centre de distribution CPDN, qui devrait couvrir la demande jusqu'au début juin.",
    "en_drug_brand_name": "VFEND FOR INJECTION",
    "en_drug_common_name": "VFEND",
    "fr_drug_brand_name": "VFEND",
    "fr_drug_common_name": "VFEND",
    "en_ingredients": "VORICONAZOLE",
    "fr_ingredients": "Voriconazole",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "each",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 10081,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28158,
      "drug_code": 90303,
      "updated_date": "2025-12-03T01:32:01-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8354152,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02418460",
      "brand_name": "PMS-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072003"
    },
    "created_date": "2017-05-11T20:29:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418460",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "hc_updated_date": "2020-06-09T14:59:01-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2020-06-09T14:59:04-04:00",
    "status": "resolved",
    "en_comments": "Product in deactivation process\r\nProduct to be discontinued",
    "fr_comments": "produit en processus de désactivation",
    "en_drug_brand_name": "PMS-AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "PMS-AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "5 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10086,
    "drug": {
      "current_status": "MARKETED",
      "id": 2368,
      "drug_code": 15547,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252040,
          "ingredient": {
            "id": 1148,
            "ingredient_code": 2104,
            "en_name": "BACLOFEN",
            "fr_name": "Baclofène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02063735",
      "brand_name": "PMS-BACLOFEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77242",
      "number_of_ais": "1",
      "ai_group_no": "0113246001"
    },
    "created_date": "2017-05-11T20:31:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02063735",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M03BX",
    "atc_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
    "anticipated_start_date": "2017-05-01T00:00:00-04:00",
    "estimated_end_date": "2017-07-23T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-07-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T17:46:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-BACLOFEN",
    "en_drug_common_name": "BACLOFEN",
    "fr_drug_brand_name": "PMS-BACLOFEN",
    "fr_drug_common_name": "BACLOFEN",
    "en_ingredients": "BACLOFEN",
    "fr_ingredients": "Baclofène",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10089,
    "drug": {
      "current_status": "MARKETED",
      "id": 32136,
      "drug_code": 9825,
      "updated_date": "2025-05-15T02:30:48-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251216,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00786160",
      "brand_name": "0.9% SODIUM CHLORIDE IRRIGATION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69132",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2017-05-11T20:32:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786160",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2017-05-11T00:00:00-04:00",
    "estimated_end_date": "2017-09-06T00:00:00-04:00",
    "actual_start_date": "2017-05-11T00:00:00-04:00",
    "actual_end_date": "2017-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-07T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "product (0.9% Sodium Chloride Irrigation, USP in the Baxter Sterile Container\r\nSystem) is a sterile, nonpyrogenic, isotonic solution for the preparation\r\nof slushed solution. For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368",
    "fr_comments": "product (0.9% Sodium Chloride Irrigation, USP in the Baxter Sterile Container\r\nSystem) is a sterile, nonpyrogenic, isotonic solution for the preparation\r\nof slushed solution. For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368",
    "en_drug_brand_name": "SODIUM CHLORIDE LIQ IRIGATION 900MG/100ML USP",
    "en_drug_common_name": "SODIUM CHLORIDE LIQ IRIGATION 900MG/100ML USP",
    "fr_drug_brand_name": "SODIUM CHLORIDE LIQ IRIGATION 900MG/100ML USP",
    "fr_drug_common_name": "SODIUM CHLORIDE LIQ IRIGATION 900MG/100ML USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "IRRIGATION",
    "drug_route_fr": "Irrigation",
    "drug_package_quantity": "1000mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 10091,
    "drug": {
      "current_status": "DORMANT",
      "id": 5530,
      "drug_code": 36798,
      "updated_date": "2025-05-15T06:55:25-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367154,
          "ingredient": {
            "id": 126,
            "ingredient_code": 7531,
            "en_name": "HYDROCORTISONE ACETATE",
            "fr_name": "Acétate d'hydrocortisone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8367153,
          "ingredient": {
            "id": 686,
            "ingredient_code": 8746,
            "en_name": "ZINC SULFATE",
            "fr_name": "Sulfate de zinc"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02209764",
      "brand_name": "EGOZINC-HC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4168",
      "number_of_ais": "2",
      "ai_group_no": "0214222001"
    },
    "created_date": "2017-05-11T20:32:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02209764",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C05AA",
    "atc_description": "AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2020-06-08T13:57:30-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued.",
    "fr_comments": "Product to be discontinued.",
    "en_drug_brand_name": "EGOZINC-HC",
    "en_drug_common_name": "EGOZING",
    "fr_drug_brand_name": "EGOZINC-HC",
    "fr_drug_common_name": "EGOZINC",
    "en_ingredients": "HYDROCORTISONE ACETATE\r\nZINC SULFATE",
    "fr_ingredients": "Acétate d'hydrocortisone\r\nSulfate de zinc",
    "drug_strength": "0.5%\r\n0.5%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "RECTAL\r\nTOPICAL",
    "drug_route_fr": "Rectale\r\nTopique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10097,
    "drug": {
      "current_status": "MARKETED",
      "id": 7660,
      "drug_code": 50551,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253369,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231244",
      "brand_name": "PMS-IPRATROPIUM",
      "brand_name_fr": "",
      "descriptor": "1ML UNIT DOSE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2017-05-11T20:35:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231244",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "anticipated_start_date": "2017-06-12T00:00:00-04:00",
    "actual_end_date": "2017-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2017-06-16T15:30:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-IPRATROPIUM",
    "en_drug_common_name": "IPRAPROTIUM",
    "fr_drug_brand_name": "PMS-IPRATROPIUM",
    "fr_drug_common_name": "IPRATROPIUM",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10100,
    "drug": {
      "current_status": "MARKETED",
      "id": 17614,
      "drug_code": 78661,
      "updated_date": "2025-05-15T02:32:01-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256189,
          "ingredient": {
            "id": 1284,
            "ingredient_code": 1298,
            "en_name": "ISOSORBIDE-5-MONONITRATE",
            "fr_name": "5-mononitrate d'isosorbide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02301288",
      "brand_name": "PMS-ISMN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0120456002"
    },
    "created_date": "2017-05-11T20:37:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02301288",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "estimated_end_date": "2018-05-30T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2018-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2018-06-07T05:00:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ISMN",
    "en_drug_common_name": "ISOSORBIDE",
    "fr_drug_brand_name": "PMS-ISMN",
    "fr_drug_common_name": "ISOSORBIDE",
    "en_ingredients": "ISOSORBIDE-5-MONONITRATE",
    "fr_ingredients": "5-mononitrate d'isosorbide",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10103,
    "drug": {
      "current_status": "MARKETED",
      "id": 13174,
      "drug_code": 72606,
      "updated_date": "2025-05-15T02:31:29-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254788,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248267",
      "brand_name": "PMS-MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676003"
    },
    "created_date": "2017-05-11T20:38:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248267",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M01AC",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2017-07-13T00:00:00-04:00",
    "actual_start_date": "2017-07-13T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2020-06-10T11:03:48-04:00",
    "status": "resolved",
    "en_comments": "Format to be discontinued.",
    "fr_comments": "Format to be discontinued.",
    "en_drug_brand_name": "PMS-MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "PMS-MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10106,
    "drug": {
      "current_status": "MARKETED",
      "id": 22090,
      "drug_code": 84463,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257914,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359634",
      "brand_name": "PMS-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121005"
    },
    "created_date": "2017-05-11T20:39:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359634",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-05-19T00:00:00-04:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2017-06-16T14:34:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PMS-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "3X10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10109,
    "drug": {
      "current_status": "MARKETED",
      "id": 17686,
      "drug_code": 78754,
      "updated_date": "2025-05-15T02:32:03-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256211,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02302209",
      "brand_name": "PMS-RISEDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301003"
    },
    "created_date": "2017-05-11T20:40:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02302209",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2017-12-18T00:00:00-05:00",
    "actual_start_date": "2017-05-01T00:00:00-04:00",
    "actual_end_date": "2017-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-17T17:28:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-RISEDRONATE",
    "en_drug_common_name": "RISEDRONATE",
    "fr_drug_brand_name": "PMS-RISEDRONATE",
    "fr_drug_common_name": "RISEDRONATE",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "35MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10112,
    "drug": {
      "current_status": "MARKETED",
      "id": 23774,
      "drug_code": 86433,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258566,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378531",
      "brand_name": "PMS-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2017-05-11T20:42:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378531",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-10-10T00:00:00-04:00",
    "actual_start_date": "2017-05-25T00:00:00-04:00",
    "actual_end_date": "2017-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T19:09:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "PMS-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10115,
    "drug": {
      "current_status": "MARKETED",
      "id": 23772,
      "drug_code": 86432,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258565,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02378523",
      "brand_name": "PMS-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963004"
    },
    "created_date": "2017-05-11T20:44:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378523",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-01-29T00:00:00-05:00",
    "actual_start_date": "2017-06-20T00:00:00-04:00",
    "actual_end_date": "2018-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-12T20:05:09-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "PMS-ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10118,
    "drug": {
      "current_status": "MARKETED",
      "id": 27438,
      "drug_code": 89674,
      "updated_date": "2025-05-15T02:34:02-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259927,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02412179",
      "brand_name": "PMS-SILDENAFIL R",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261004"
    },
    "created_date": "2017-05-11T20:45:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02412179",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C02",
    "atc_description": "OTHER ANTIHYPERTENSIVES",
    "estimated_end_date": "2017-11-20T00:00:00-05:00",
    "actual_start_date": "2017-09-18T00:00:00-04:00",
    "actual_end_date": "2017-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-05-18T21:45:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SILDENAFIL R",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "PMS-SILDENAFIL R",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "SILDENAFIL",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10121,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15032,
      "drug_code": 75466,
      "updated_date": "2025-12-03T01:23:44-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8341407,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02269287",
      "brand_name": "PMS-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415002"
    },
    "created_date": "2017-05-11T20:46:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02269287",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-05-04T00:00:00-04:00",
    "actual_start_date": "2017-05-04T00:00:00-04:00",
    "actual_end_date": "2020-06-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-06-10T10:50:46-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued. Transitioned to phama-SIMVASTATIN DIN (02470004)",
    "fr_comments": "Product to be discontinued. Transitioned to phama-SIMVASTATIN DIN (02470004)",
    "en_drug_brand_name": "PMS-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "PMS-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10124,
    "drug": {
      "current_status": "MARKETED",
      "id": 28070,
      "drug_code": 90236,
      "updated_date": "2025-05-15T02:34:10-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260206,
          "ingredient": {
            "id": 3272,
            "ingredient_code": 18175,
            "en_name": "SOLIFENACIN SUCCINATE",
            "fr_name": "Succinate de solifénacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02417731",
      "brand_name": "PMS-SOLIFENACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151584002"
    },
    "created_date": "2017-05-11T20:47:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02417731",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "anticipated_start_date": "2017-07-21T00:00:00-04:00",
    "actual_start_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-SOLIFENACIN",
    "en_drug_common_name": "SOLIFENACIN",
    "fr_drug_brand_name": "PMS-SOLIFENACIN",
    "fr_drug_common_name": "SOLIFENACIN",
    "en_ingredients": "SOLIFENACIN SUCCINATE",
    "fr_ingredients": "Succinate de solifénacine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10149,
    "drug": {
      "current_status": "MARKETED",
      "id": 6494,
      "drug_code": 43417,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253078,
          "ingredient": {
            "id": 2186,
            "ingredient_code": 11250,
            "en_name": "BUSERELIN",
            "fr_name": "Buséréline (Acétate de buséréline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02225166",
      "brand_name": "SUPREFACT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9755",
      "number_of_ais": "1",
      "ai_group_no": "0117891001"
    },
    "created_date": "2017-05-12T13:13:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02225166",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "L02AE",
    "atc_description": "HORMONES AND RELATED AGENTS",
    "estimated_end_date": "2017-06-09T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-07-06T20:31:14-04:00",
    "status": "resolved",
    "en_comments": "Manufacturing Delay",
    "fr_comments": "Délai de fabrication",
    "en_drug_brand_name": "SUPREFACT",
    "en_drug_common_name": "Suprefact Inj. M.D. 1mg/ml - vials",
    "fr_drug_brand_name": "Suprefact",
    "fr_drug_common_name": "Suprefact Inj. M.D. 1mg/ml - vials",
    "en_ingredients": "BUSERELIN",
    "fr_ingredients": "Buserelin Acetate",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2 X 5.5ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10295,
    "drug": {
      "current_status": "MARKETED",
      "id": 28802,
      "drug_code": 90912,
      "updated_date": "2025-05-15T02:34:19-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260451,
          "ingredient": {
            "id": 3066,
            "ingredient_code": 12580,
            "en_name": "DUTASTERIDE",
            "fr_name": "Dutastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02424444",
      "brand_name": "SANDOZ DUTASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149361001"
    },
    "created_date": "2017-05-15T13:28:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02424444",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "anticipated_start_date": "2017-05-12T00:00:00-04:00",
    "estimated_end_date": "2017-06-26T00:00:00-04:00",
    "actual_end_date": "2017-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-10-25T22:01:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DUTASTERIDE CAPSULE",
    "en_drug_common_name": "SANDOZ DUTASTERIDE",
    "fr_drug_brand_name": "SANDOZ DUTASTERIDE CAPSULES",
    "fr_drug_common_name": "SANDOZ DUTASTERIDE",
    "en_ingredients": "DUTASTERIDE",
    "fr_ingredients": "Dutastéride",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10310,
    "drug": {
      "current_status": "MARKETED",
      "id": 21894,
      "drug_code": 84259,
      "updated_date": "2025-05-15T02:32:49-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257832,
          "ingredient": {
            "id": 2678,
            "ingredient_code": 11860,
            "en_name": "REPAGLINIDE",
            "fr_name": "Répaglinide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02357453",
      "brand_name": "SANDOZ REPAGLINIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137035001"
    },
    "created_date": "2017-05-15T13:52:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02357453",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A10BX",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "estimated_end_date": "2017-06-19T00:00:00-04:00",
    "actual_start_date": "2017-05-12T00:00:00-04:00",
    "actual_end_date": "2017-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-26T18:15:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ REPAGLINIDE",
    "en_drug_common_name": "SANDOZ REPAGLINIDE",
    "fr_drug_brand_name": "SANDOZ REPAGLINIDE",
    "fr_drug_common_name": "SANDOZ REPAGLINIDE",
    "en_ingredients": "REPAGLINIDE",
    "fr_ingredients": "Répaglinide",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10317,
    "drug": {
      "current_status": "MARKETED",
      "id": 23550,
      "drug_code": 86141,
      "updated_date": "2025-05-15T02:33:06-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258498,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02375958",
      "brand_name": "SANDOZ TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223001"
    },
    "created_date": "2017-05-15T13:57:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02375958",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2017-05-22T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-13T19:20:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TELMISARTAN",
    "en_drug_common_name": "SANDOZ TELMISARTAN",
    "fr_drug_brand_name": "SANDOZ TELMISARTAN",
    "fr_drug_common_name": "SANDOZ TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10326,
    "drug": {
      "current_status": "DORMANT",
      "id": 30850,
      "drug_code": 92979,
      "updated_date": "2025-05-15T06:55:55-04:00",
      "company": {
        "id": 17092,
        "created_date": "2021-07-08T04:00:06-04:00",
        "updated_date": "2025-05-15T06:55:18-04:00",
        "company_code": 18096,
        "mfr_code": "",
        "name": "ATHENA PHARMACEUTIQUES SAS",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ESPACE ARNOLD DE VILLE, 12 RUE GEORGES BLANDON",
        "province": "--",
        "country": "FRANCE",
        "city": "LOUVECIENNES",
        "postal_code": "78430",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369317,
          "ingredient": {
            "id": 2138,
            "ingredient_code": 11104,
            "en_name": "ONDANSETRON",
            "fr_name": "Ondansétron"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02444674",
      "brand_name": "ATHENA-ONDANSETRON ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131120003"
    },
    "created_date": "2017-05-15T14:16:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02444674",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A04AA",
    "atc_description": "ANTIEMETICS AND ANTINAUSEANTS",
    "estimated_end_date": "2017-07-10T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-07T14:57:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ONDANSETRON ODT",
    "en_drug_common_name": "SANDOZ ONDANSETRON ODT",
    "fr_drug_brand_name": "SANDOZ ONDANSETRON ODT",
    "fr_drug_common_name": "SANDOZ ONDANSETRON ODT",
    "en_ingredients": "ONDANSETRON",
    "fr_ingredients": "Ondansétron",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1X10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10329,
    "drug": {
      "current_status": "MARKETED",
      "id": 27372,
      "drug_code": 89614,
      "updated_date": "2025-05-15T02:34:02-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259903,
          "ingredient": {
            "id": 2840,
            "ingredient_code": 12034,
            "en_name": "MOXIFLOXACIN",
            "fr_name": "Moxifloxacine (Chlorhydrate de moxifloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02411520",
      "brand_name": "SANDOZ MOXIFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142242003"
    },
    "created_date": "2017-05-15T14:22:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02411520",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01AE",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2017-05-22T00:00:00-04:00",
    "actual_start_date": "2017-05-12T00:00:00-04:00",
    "actual_end_date": "2017-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-26T12:42:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MOXIFLOXACIN",
    "en_drug_common_name": "SANDOZ MOXIFLOXACIN",
    "fr_drug_brand_name": "SANDOZ MOXIFLOXACIN",
    "fr_drug_common_name": "SANDOZ MOXIFLOXACIN",
    "en_ingredients": "MOXIFLOXACIN",
    "fr_ingredients": "MOXIFLOXACIN",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "3ML BTL/BOUT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10333,
    "drug": {
      "current_status": "MARKETED",
      "id": 3754,
      "drug_code": 19242,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252466,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02166720",
      "brand_name": "SANDOZ TIMOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81533",
      "number_of_ais": "1",
      "ai_group_no": "0131275002"
    },
    "created_date": "2017-05-15T14:27:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02166720",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2017-05-29T00:00:00-04:00",
    "actual_start_date": "2017-05-05T00:00:00-04:00",
    "actual_end_date": "2017-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-26T12:43:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TIMOLOL",
    "en_drug_common_name": "SANDOZ TIMOLOL",
    "fr_drug_brand_name": "SANDOZ TIMOLOL",
    "fr_drug_common_name": "SANDOZ TIMOLOL",
    "en_ingredients": "TIMOLOL",
    "fr_ingredients": "TIMOLOL",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "10ML BTL/BOUT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10336,
    "drug": {
      "current_status": "MARKETED",
      "id": 10324,
      "drug_code": 65418,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253902,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241755",
      "brand_name": "SANDOZ TOBRAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110230005"
    },
    "created_date": "2017-05-15T14:29:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241755",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01AA",
    "atc_description": "ANTIINFECTIVES",
    "estimated_end_date": "2017-05-22T00:00:00-04:00",
    "actual_start_date": "2017-05-12T00:00:00-04:00",
    "actual_end_date": "2017-08-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-07T15:49:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TOBRAMYCIN 0.3%",
    "en_drug_common_name": "SANDOZ TOBRAMYCIN",
    "fr_drug_brand_name": "SANDOZ TOBRAMYCIN 0.3%",
    "fr_drug_common_name": "SANDOZ TOBRAMYCIN",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "0.3%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "5ML BTL/BOUT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10355,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22284,
      "drug_code": 84686,
      "updated_date": "2025-05-15T04:17:52-04:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8349777,
          "ingredient": {
            "id": 3702,
            "ingredient_code": 20660,
            "en_name": "EXENATIDE",
            "fr_name": "Exénatide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02361817",
      "brand_name": "BYETTA",
      "brand_name_fr": "",
      "descriptor": "2.4ML PREFILLED PEN. 60 DOSES OF 10¿CG/DOSE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152872004"
    },
    "created_date": "2017-05-15T20:45:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361817",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "A10BJ",
    "anticipated_start_date": "2017-06-12T00:00:00-04:00",
    "estimated_end_date": "2017-06-20T00:00:00-04:00",
    "actual_end_date": "2017-06-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-21T12:05:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "BYETTA",
    "en_drug_common_name": "exenatide injection",
    "fr_drug_brand_name": "BYETTA",
    "fr_drug_common_name": "exénatide injectable",
    "en_ingredients": "EXENATIDE",
    "fr_ingredients": "Exénatide",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2.4 mL prefilled pen",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 10357,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2952,
      "drug_code": 17235,
      "updated_date": "2025-05-15T03:43:18-04:00",
      "company": {
        "id": 74,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3798,
        "mfr_code": "BQC07",
        "name": "BRISTOL-MYERS SQUIBB CANADA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2344 BOUL. ALFRED-NOBEL, SUITE 300",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "ST-LAURENT",
        "postal_code": "H4S 0A4",
        "post_office_box": "",
        "contact_information": "For more information please contact the Customer Service Desk at 1-800-267-0005"
      },
      "drug_ingredients": [
        {
          "id": 8298742,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        },
        {
          "id": 8298741,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01916548",
      "brand_name": "ENDOCET",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79388",
      "number_of_ais": "2",
      "ai_group_no": "0215596001"
    },
    "created_date": "2017-05-15T21:20:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01916548",
    "company_name": "BRISTOL-MYERS SQUIBB CANADA",
    "atc_number": "N02AJ",
    "anticipated_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2017-07-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-07-04T20:13:27-04:00",
    "status": "avoided_shortage",
    "en_comments": "Stock is now available. For more information please contact the Customer Service Desk at 1-800-267-0005.",
    "fr_comments": "Le produit est maintenant disponibles.  Veuillez appeler notre bureau de commandes au 1-800-267-0005.",
    "en_drug_brand_name": "ENDOCET",
    "en_drug_common_name": "Oxycocet (Oxycodone and Acetaminophen)",
    "fr_drug_brand_name": "ENDOCET",
    "fr_drug_common_name": "Oxycocet (Oxycodone et acétaminophène)",
    "en_ingredients": "ACETAMINOPHEN\r\nOXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Acétaminophène\r\nChlorhydrate d'oxycodone",
    "drug_strength": "325MG\r\n5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "Bottles of 100's and 500's",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10400,
    "drug": {
      "current_status": "DORMANT",
      "id": 29202,
      "drug_code": 91232,
      "updated_date": "2025-05-15T06:55:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8369149,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02427826",
      "brand_name": "APO-EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2017-05-16T12:56:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02427826",
    "company_name": "APOTEX INC",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-07-20T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-18T17:00:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-EZETIMIBE",
    "en_drug_common_name": "EZETIMIBE",
    "fr_drug_brand_name": "APO-EZETIMIBE",
    "fr_drug_common_name": "EZETIMIBE",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10403,
    "drug": {
      "current_status": "MARKETED",
      "id": 16920,
      "drug_code": 77920,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255977,
          "ingredient": {
            "id": 1412,
            "ingredient_code": 180,
            "en_name": "LANSOPRAZOLE",
            "fr_name": "Lansoprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02293838",
      "brand_name": "APO-LANSOPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127666001"
    },
    "created_date": "2017-05-16T12:58:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02293838",
    "company_name": "APOTEX INC",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-10-10T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T11:42:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LANSOPRAZOLE",
    "en_drug_common_name": "LANSOPRAZOLE",
    "fr_drug_brand_name": "APO-LANSOPRAZOLE",
    "fr_drug_common_name": "LANSOPRAZOLE",
    "en_ingredients": "LANSOPRAZOLE",
    "fr_ingredients": "Lansoprazole",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTl & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10406,
    "drug": {
      "current_status": "MARKETED",
      "id": 11772,
      "drug_code": 69226,
      "updated_date": "2025-05-15T02:31:17-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254372,
          "ingredient": {
            "id": 450,
            "ingredient_code": 2370,
            "en_name": "CARBIDOPA",
            "fr_name": "Carbidopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254371,
          "ingredient": {
            "id": 452,
            "ingredient_code": 4068,
            "en_name": "LEVODOPA",
            "fr_name": "Lévodopa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245211",
      "brand_name": "AA-LEVOCARB CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0210315004"
    },
    "created_date": "2017-05-16T13:00:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245211",
    "company_name": "APOTEX INC",
    "atc_number": "N04BA",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2017-06-07T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-02T12:55:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LEVOCARB CR",
    "en_drug_common_name": "LEVOCARB",
    "fr_drug_brand_name": "APO-LEVOCARB CR",
    "fr_drug_common_name": "LEVOCARB CR",
    "en_ingredients": "CARBIDOPA\r\nLEVODOPA",
    "fr_ingredients": "Carbidopa\r\nLévodopa",
    "drug_strength": "50MG\r\n200MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10415,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 22480,
      "drug_code": 84911,
      "updated_date": "2025-05-15T04:18:12-04:00",
      "company": {
        "id": 58,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 8481,
        "mfr_code": "PIA08",
        "name": "PALADIN PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 BLVD ALEXIS-NIHON, SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": "",
        "contact_information": "1-866-340-1112\r\npaladincs@endo.com"
      },
      "drug_ingredients": [
        {
          "id": 8349946,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02364182",
      "brand_name": "ABSTRAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302017"
    },
    "created_date": "2017-05-16T13:08:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02364182",
    "company_name": "PALADIN LABS INC",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "actual_start_date": "2015-11-27T00:00:00-05:00",
    "actual_end_date": "2015-11-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-11-30T15:27:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ABSTRAL",
    "en_drug_common_name": "FENTANYL",
    "fr_drug_brand_name": "ABSTRAL",
    "fr_drug_common_name": "FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "200MCG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "SUBLINGUAL",
    "drug_route_fr": "Sublinguale",
    "drug_package_quantity": "10 Tabs",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 10424,
    "drug": {
      "current_status": "MARKETED",
      "id": 13566,
      "drug_code": 73355,
      "updated_date": "2025-05-15T02:31:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254906,
          "ingredient": {
            "id": 2560,
            "ingredient_code": 11764,
            "en_name": "MELOXICAM",
            "fr_name": "Méloxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248973",
      "brand_name": "APO-MELOXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131676003"
    },
    "created_date": "2017-05-16T13:22:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248973",
    "company_name": "APOTEX INC",
    "atc_number": "M01AC",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-13T14:19:52-04:00",
    "status": "resolved",
    "en_comments": "APO-MELOXICAM TAB 7.5MG 100 BTL  is available",
    "fr_comments": "APO-MELOXICAM TAB 7.5MG 100 BTL est disponible",
    "en_drug_brand_name": "APO-MELOXICAM",
    "en_drug_common_name": "MELOXICAM",
    "fr_drug_brand_name": "APO-MELOXICAM",
    "fr_drug_common_name": "MELOXICAM",
    "en_ingredients": "MELOXICAM",
    "fr_ingredients": "Méloxicam",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10429,
    "drug": {
      "current_status": "MARKETED",
      "id": 16412,
      "drug_code": 77207,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255851,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286629",
      "brand_name": "APO-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928002"
    },
    "created_date": "2017-05-16T13:38:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286629",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-06-23T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-06-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-15T12:55:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "APO-MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10434,
    "drug": {
      "current_status": "MARKETED",
      "id": 10032,
      "drug_code": 64500,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253821,
          "ingredient": {
            "id": 1004,
            "ingredient_code": 11340,
            "en_name": "PAROXETINE",
            "fr_name": "Paroxétine (Chlorhydrate de paroxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240909",
      "brand_name": "APO-PAROXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123131001"
    },
    "created_date": "2017-05-16T13:48:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240909",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2017-10-31T00:00:00-04:00",
    "actual_start_date": "2017-08-21T00:00:00-04:00",
    "actual_end_date": "2017-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-27T13:29:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PAROXETINE",
    "en_drug_common_name": "PAROXETINE",
    "fr_drug_brand_name": "APO-PAROXETINE",
    "fr_drug_common_name": "PAROXETINE",
    "en_ingredients": "PAROXETINE",
    "fr_ingredients": "PAROXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10439,
    "drug": {
      "current_status": "MARKETED",
      "id": 8286,
      "drug_code": 5672,
      "updated_date": "2025-05-15T02:30:34-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250796,
          "ingredient": {
            "id": 2256,
            "ingredient_code": 10190,
            "en_name": "TRIAMTERENE",
            "fr_name": "Triamtérène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8250795,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00441775",
      "brand_name": "APO TRIAZIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "61270",
      "number_of_ais": "2",
      "ai_group_no": "0201052001"
    },
    "created_date": "2017-05-16T13:52:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00441775",
    "company_name": "APOTEX INC",
    "atc_number": "C03EA",
    "atc_description": "DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB",
    "estimated_end_date": "2017-08-04T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-07-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-20T12:42:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO TRIAZIDE",
    "en_drug_common_name": "TRIAZIDE",
    "fr_drug_brand_name": "APO TRIAZIDE",
    "fr_drug_common_name": "TRIAZIDE",
    "en_ingredients": "TRIAMTERENE\r\nHYDROCHLOROTHIAZIDE",
    "fr_ingredients": "Triamtérène\r\nHydrochlorothiazide",
    "drug_strength": "50MG\r\n25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10442,
    "drug": {
      "current_status": "DORMANT",
      "id": 20290,
      "drug_code": 81739,
      "updated_date": "2025-05-15T06:55:40-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368359,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02331691",
      "brand_name": "APO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2017-05-16T13:54:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02331691",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2018-03-23T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2018-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-03-08T15:22:32-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-VENLAFAXINE XR",
    "en_drug_common_name": "VENLAFAXINE",
    "fr_drug_brand_name": "APO-VENLAFAXINE XR",
    "fr_drug_common_name": "VENLAFAXINE",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE",
    "drug_strength": "75.0MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL & 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10466,
    "drug": {
      "current_status": "MARKETED",
      "id": 6582,
      "drug_code": 43536,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253104,
          "ingredient": {
            "id": 1932,
            "ingredient_code": 7512,
            "en_name": "DESONIDE",
            "fr_name": "Désonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02229315",
      "brand_name": "PDP-DESONIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9877",
      "number_of_ais": "1",
      "ai_group_no": "0106367001"
    },
    "created_date": "2017-05-16T14:40:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229315",
    "company_name": "PENDOPHARM DIVISION OF DE PHARMASCIENCE INC",
    "atc_number": "D07AB",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2017-06-06T00:00:00-04:00",
    "estimated_end_date": "2018-01-19T00:00:00-05:00",
    "actual_start_date": "2017-06-12T00:00:00-04:00",
    "actual_end_date": "2018-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-01-19T20:49:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PDP-DESONIDE",
    "en_drug_common_name": "pdp-DESONIDE 0.05% CR 60g",
    "fr_drug_brand_name": "pdp-DESONIDE",
    "fr_drug_common_name": "pdp-DESONIDE 0.05% CR 60g",
    "en_ingredients": "DESONIDE",
    "fr_ingredients": "Désonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10471,
    "drug": {
      "current_status": "MARKETED",
      "id": 29712,
      "drug_code": 91729,
      "updated_date": "2025-05-15T02:34:33-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260766,
          "ingredient": {
            "id": 4012,
            "ingredient_code": 22525,
            "en_name": "AZELASTINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'azélastine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "137",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8260765,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02432889",
      "brand_name": "DYMISTA",
      "brand_name_fr": "",
      "descriptor": "SUSPENSION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0256150001"
    },
    "created_date": "2017-05-16T17:49:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02432889",
    "company_name": "MEDA PHARMACEUTICALS LTD",
    "atc_number": "R01AD",
    "atc_description": "DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-08-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-14T18:09:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DYMISTA",
    "en_drug_common_name": "Dymista",
    "fr_drug_brand_name": "DYMISTA",
    "fr_drug_common_name": "DYMISTA",
    "en_ingredients": "FLUTICASONE PROPIONATE\r\nazelastine hydrochloride",
    "fr_ingredients": "Propionate de fluticasone / chlorhydrate d'azélastine",
    "drug_strength": "50MCG\r\n137MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "25ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10530,
    "drug": {
      "current_status": "MARKETED",
      "id": 24234,
      "drug_code": 86847,
      "updated_date": "2025-12-03T00:31:56-05:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258720,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02382652",
      "brand_name": "TARO-ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963001"
    },
    "created_date": "2017-05-16T22:17:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02382652",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-03-13T00:00:00-04:00",
    "estimated_end_date": "2018-11-30T00:00:00-05:00",
    "actual_start_date": "2017-03-13T00:00:00-04:00",
    "actual_end_date": "2017-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-04T19:49:46-05:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-ROSUVASTATIN",
    "en_drug_common_name": "RAN-ROSUVASTATIN",
    "fr_drug_brand_name": "RAN-ROSUVASTATIN",
    "fr_drug_common_name": "RAN-ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 10567,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 20128,
      "drug_code": 81586,
      "updated_date": "2025-05-15T04:15:05-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8347335,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02330105",
      "brand_name": "RAN-FENTANYL MATRIX PATCH",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302015"
    },
    "created_date": "2017-05-17T13:58:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330105",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2017-05-10T00:00:00-04:00",
    "actual_start_date": "2017-05-10T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T17:18:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-FENTANYL MATRIX PATCH",
    "en_drug_common_name": "RAN-FENTANYL MATRIX PATCH",
    "fr_drug_brand_name": "RAN-FENTANYL MATRIX PATCH",
    "fr_drug_common_name": "RAN-FENTANYL MATRIX PATCH",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "12MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10599,
    "drug": {
      "current_status": "MARKETED",
      "id": 30080,
      "drug_code": 92127,
      "updated_date": "2025-05-15T02:34:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260953,
          "ingredient": {
            "id": 3398,
            "ingredient_code": 20139,
            "en_name": "OXALIPLATIN",
            "fr_name": "Oxaliplatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02436957",
      "brand_name": "OXALIPLATIN INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152220003"
    },
    "created_date": "2017-05-17T18:27:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436957",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01XA",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-07-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-08-03T01:25:36-04:00",
    "status": "resolved",
    "en_comments": "Limited inventory available for our customers",
    "fr_comments": "Inventaire limité pour nos clients",
    "en_drug_brand_name": "OXALIPLATIN INJECTION",
    "en_drug_common_name": "Oxaliplatin Injection",
    "fr_drug_brand_name": "OXALIPLATIN INJECTION",
    "fr_drug_common_name": "OXALIPLATIN INJECTION",
    "en_ingredients": "OXALIPLATIN",
    "fr_ingredients": "Oxaliplatine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "20mLV",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10602,
    "drug": {
      "current_status": "MARKETED",
      "id": 30080,
      "drug_code": 92127,
      "updated_date": "2025-05-15T02:34:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260953,
          "ingredient": {
            "id": 3398,
            "ingredient_code": 20139,
            "en_name": "OXALIPLATIN",
            "fr_name": "Oxaliplatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02436957",
      "brand_name": "OXALIPLATIN INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIALS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152220003"
    },
    "created_date": "2017-05-17T18:30:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02436957",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L01XA",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-25T21:21:03-04:00",
    "status": "resolved",
    "en_comments": "limited inventory for our customers",
    "fr_comments": "Inventaire limité pour nos clients",
    "en_drug_brand_name": "OXALIPLATIN INJECTION",
    "en_drug_common_name": "Oxaliplatin Injection",
    "fr_drug_brand_name": "Oxaliplatine injection",
    "fr_drug_common_name": "Oxaliplatine injection",
    "en_ingredients": "OXALIPLATIN",
    "fr_ingredients": "Oxaliplatine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "40mLV",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10626,
    "drug": {
      "current_status": "MARKETED",
      "id": 10090,
      "drug_code": 64699,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8253835,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241096",
      "brand_name": "TEMODAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781004"
    },
    "created_date": "2017-05-18T17:29:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241096",
    "company_name": "MERCK CANADA INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2017-05-18T00:00:00-04:00",
    "estimated_end_date": "2017-06-16T00:00:00-04:00",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2017-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-06-07T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "limited quantity available",
    "fr_comments": "Quantités limitées disponibles",
    "en_drug_brand_name": "TEMODAL",
    "en_drug_common_name": "temozolomide capsules",
    "fr_drug_brand_name": "TEMODAL",
    "fr_drug_common_name": "capsules de témozolomide",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "5 cap",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 10629,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15418,
      "drug_code": 75998,
      "updated_date": "2025-05-15T04:10:47-04:00",
      "company": {
        "id": 1216,
        "created_date": "2017-03-09T13:23:57-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 12463,
        "mfr_code": "",
        "name": "GENMED A DIVISION OF PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-800-387-4974\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8341989,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02274531",
      "brand_name": "GD-AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072001"
    },
    "created_date": "2017-05-18T18:47:37-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02274531",
    "company_name": "GENMED A DIVISION OF PFIZER CANADA INC",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "discontinuation_date": "2017-06-28T00:00:00-04:00",
    "anticipated_discontinuation_date": "2017-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2017-09-27T17:46:07-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "GD-AZITHROMYCIN",
    "en_drug_common_name": "GD-Azithromycin",
    "fr_drug_brand_name": "GD-AZITHROMYCIN",
    "fr_drug_common_name": "GD-Azithromycin",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 10648,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 23758,
      "drug_code": 86416,
      "updated_date": "2025-05-15T04:19:48-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8351136,
          "ingredient": {
            "id": 1596,
            "ingredient_code": 8541,
            "en_name": "VANCOMYCIN",
            "fr_name": "Vancomycine (Chlorhydrate de vancomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02378345",
      "brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
      "brand_name_fr": "CHLORHYDRATE DE VANCOMYCINE POUR INJECTION, USP",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131315008"
    },
    "created_date": "2017-05-18T19:46:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02378345",
    "company_name": "HOSPIRA HEALTHCARE CORPORATION",
    "atc_number": "J01XA",
    "atc_description": "OTHER ANTIBACTERIALS",
    "anticipated_start_date": "2017-06-01T00:00:00-04:00",
    "actual_end_date": "2017-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-10-21T05:00:06-04:00",
    "status": "resolved",
    "en_comments": "Product importation is currently on hold in accordance with new Health Canada terms and conditions related to its manufacturing site of origin. This importation hold is on future lots and does not impact any existing inventories or those already distributed on the market. The inventory on hand remains available and will be allocated to customers based on their monthly average order quantity. Alternate suppliers have been contacted in order to minimize potential supply disruptions.\r\n\r\n\r\nEXPIRY DATE: September 1st, 2017 Short dated product will remain available until \r\nAugust 15th, 2017.\r\n\r\n**Vancomycin HCL 5g is available with an EXPIRY DATE of October 1st, 2017**",
    "fr_comments": "Le produit est actuellement en restriction d’importation conformément aux nouvelles conditions de Santé Canada relatives à son site de fabrication d'origine. Cette restriction d’importation s'applique aux lots futurs et n'impacte aucun inventaires existants ou ceux déjà distribués sur le marché. L’inventaire en stock reste disponible et sera alloué aux clients basé sur leur quantité de commande moyenne mensuelle. D’autres fournisseurs  ont été contactés afin de réduire au minimum les possibles ruptures de stock.\r\n\r\n\r\nDate d’expiration: 1er september 2017, le produit avec une date de péremption rapprochée demeure disponible jusqu’au 15 août 2017.\r\n\r\n** Vancomycine 5g est disponible avec une date d’expiration du 1er octobre 2017**",
    "en_drug_brand_name": "VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP",
    "en_drug_common_name": "Vancomycin HCL",
    "fr_drug_brand_name": "VANCOMYCINE HCL",
    "fr_drug_common_name": "VANCOMYCINE HCL",
    "en_ingredients": "VANCOMYCIN",
    "fr_ingredients": "VANCOMYCINE",
    "drug_strength": "10G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "1 x 10g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10654,
    "drug": {
      "current_status": "MARKETED",
      "id": 24940,
      "drug_code": 87450,
      "updated_date": "2025-12-03T00:32:03-05:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259023,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259022,
          "ingredient": {
            "id": 1534,
            "ingredient_code": 144,
            "en_name": "LOSARTAN POTASSIUM",
            "fr_name": "Losartan potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02388979",
      "brand_name": "LOSARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0233168003"
    },
    "created_date": "2017-05-18T19:58:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02388979",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2017-05-18T00:00:00-04:00",
    "estimated_end_date": "2017-06-06T00:00:00-04:00",
    "actual_end_date": "2017-06-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-11-03T15:11:06-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOSARTAN HCT",
    "en_drug_common_name": "LOSARTAN HCT",
    "fr_drug_brand_name": "LOSARTAN HCT",
    "fr_drug_common_name": "LOSARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nLOSARTAN POTASSIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nLosartan potassique",
    "drug_strength": "12.5MG\r\n100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10665,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9598,
      "drug_code": 63235,
      "updated_date": "2025-05-15T03:58:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8328542,
          "ingredient": {
            "id": 954,
            "ingredient_code": 1205,
            "en_name": "DICLOFENAC POTASSIUM",
            "fr_name": "Diclofénac potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239753",
      "brand_name": "PMS-DICLOFENAC K",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122516001"
    },
    "created_date": "2017-05-18T20:59:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239753",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2017-06-30T00:00:00-04:00",
    "estimated_end_date": "2017-07-21T00:00:00-04:00",
    "actual_end_date": "2017-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-19T20:02:38-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-DICLOFENAC K",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "PMS-DICLOFENAC",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC POTASSIUM",
    "fr_ingredients": "Diclofénac potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 10668,
    "drug": {
      "current_status": "MARKETED",
      "id": 12830,
      "drug_code": 71920,
      "updated_date": "2025-05-15T02:31:26-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254686,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02247657",
      "brand_name": "PMS-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2017-05-18T21:00:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247657",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-11-07T00:00:00-05:00",
    "actual_start_date": "2017-08-14T00:00:00-04:00",
    "actual_end_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-28T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "PMS-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10671,
    "drug": {
      "current_status": "MARKETED",
      "id": 22086,
      "drug_code": 84461,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257912,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359618",
      "brand_name": "PMS-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2017-05-18T21:02:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359618",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2017-09-02T00:00:00-04:00",
    "estimated_end_date": "2017-11-27T00:00:00-05:00",
    "actual_start_date": "2017-09-02T00:00:00-04:00",
    "actual_end_date": "2017-10-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T20:51:48-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PMS-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10674,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19662,
      "drug_code": 81019,
      "updated_date": "2025-12-03T01:26:35-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8346928,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02324768",
      "brand_name": "PMS-ZOLMITRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2017-05-18T21:03:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02324768",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "anticipated_start_date": "2017-07-11T00:00:00-04:00",
    "estimated_end_date": "2018-12-21T00:00:00-05:00",
    "actual_start_date": "2017-07-11T00:00:00-04:00",
    "actual_end_date": "2018-12-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-12T06:00:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ZOLMITRIPTAN ODT",
    "en_drug_common_name": "ZOLMITRIPTAN",
    "fr_drug_brand_name": "PMS-ZOLMITRIPTAN",
    "fr_drug_common_name": "ZOLMITRIPTAN",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10677,
    "drug": {
      "current_status": "DORMANT",
      "id": 21722,
      "drug_code": 84095,
      "updated_date": "2025-05-15T06:55:42-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368477,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02355752",
      "brand_name": "PMS-DILTIAZEM CD",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115863004"
    },
    "created_date": "2017-05-18T21:04:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02355752",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "hc_updated_date": "2020-06-09T15:10:30-04:00",
    "anticipated_start_date": "2017-08-28T00:00:00-04:00",
    "actual_start_date": "2017-08-28T00:00:00-04:00",
    "actual_end_date": "2020-06-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2020-06-09T15:10:33-04:00",
    "status": "resolved",
    "en_comments": "Product to be discontinued",
    "en_drug_brand_name": "PMS-DILTIAZEM CD",
    "en_drug_common_name": "DILTIAZEM",
    "fr_drug_brand_name": "PMS-DILTIAZEM",
    "fr_drug_common_name": "DILTIAZEM",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "120MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED-DELIVERY)",
    "drug_dosage_form_fr": "Capsule (à libération contrôlée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10680,
    "drug": {
      "current_status": "DORMANT",
      "id": 13452,
      "drug_code": 73130,
      "updated_date": "2025-12-03T02:32:20-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367672,
          "ingredient": {
            "id": 2898,
            "ingredient_code": 12209,
            "en_name": "MIRTAZAPINE",
            "fr_name": "Mirtazapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02248762",
      "brand_name": "PMS-MIRTAZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143928002"
    },
    "created_date": "2017-05-18T21:06:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248762",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-07-05T00:00:00-04:00",
    "estimated_end_date": "2019-02-20T00:00:00-05:00",
    "actual_start_date": "2017-07-05T00:00:00-04:00",
    "actual_end_date": "2019-02-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-26T17:37:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-MIRTAZAPINE",
    "en_drug_common_name": "MIRTAZAPINE",
    "fr_drug_brand_name": "PMS-0MIRTAZAPINE",
    "fr_drug_common_name": "MIRTAZAPINE",
    "en_ingredients": "MIRTAZAPINE",
    "fr_ingredients": "Mirtazapine",
    "drug_strength": "30MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10683,
    "drug": {
      "current_status": "MARKETED",
      "id": 8726,
      "drug_code": 60663,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253518,
          "ingredient": {
            "id": 946,
            "ingredient_code": 1939,
            "en_name": "TRAZODONE HYDROCHLORIDE",
            "fr_name": "Chlohydrate de trazodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237339",
      "brand_name": "PMS-TRAZODONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0115713008"
    },
    "created_date": "2017-05-18T21:13:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237339",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-07-04T00:00:00-04:00",
    "estimated_end_date": "2018-04-20T00:00:00-04:00",
    "actual_start_date": "2017-07-04T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-04-19T15:06:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-TRAZODONE",
    "en_drug_common_name": "TRAZODONE",
    "fr_drug_brand_name": "PMS-TRAZODONE",
    "fr_drug_common_name": "TRAZODONE",
    "en_ingredients": "TRAZODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlohydrate de trazodone",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10686,
    "drug": {
      "current_status": "MARKETED",
      "id": 24074,
      "drug_code": 86701,
      "updated_date": "2025-05-15T02:33:14-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258665,
          "ingredient": {
            "id": 1648,
            "ingredient_code": 11114,
            "en_name": "VALACYCLOVIR",
            "fr_name": "Valaciclovir (Chlorhydrate de valacyclovir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02381230",
      "brand_name": "PMS-VALACYCLOVIR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128626003"
    },
    "created_date": "2017-05-18T21:15:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381230",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "J05AB",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "anticipated_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-16T14:44:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-VALACYCLOVIR",
    "en_drug_common_name": "VALACYCLOVIR",
    "fr_drug_brand_name": "PMS-5760602239",
    "fr_drug_common_name": "5760602239",
    "en_ingredients": "VALACYCLOVIR",
    "fr_ingredients": "5760602239",
    "drug_strength": "1000MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10711,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17836,
      "drug_code": 78896,
      "updated_date": "2025-05-15T04:13:16-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8344888,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303647",
      "brand_name": "MYLAN-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847004"
    },
    "created_date": "2017-05-19T12:06:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303647",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2018-05-25T00:00:00-04:00",
    "actual_start_date": "2018-05-25T00:00:00-04:00",
    "actual_end_date": "2018-06-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-08T14:08:34-04:00",
    "status": "resolved",
    "en_comments": "discontinued in ID 51245",
    "fr_comments": "discontinued in ID 51245",
    "en_drug_brand_name": "MYLAN-ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "MYLAN-ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10714,
    "drug": {
      "current_status": "MARKETED",
      "id": 25354,
      "drug_code": 87823,
      "updated_date": "2025-12-03T00:32:06-05:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259192,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02392976",
      "brand_name": "MYLAN-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2017-05-19T12:12:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02392976",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "anticipated_start_date": "2017-08-17T00:00:00-04:00",
    "actual_end_date": "2017-07-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-07-25T16:54:08-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "MYLAN-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "MYLAN-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "ATORVASTATIN",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10718,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 24736,
      "drug_code": 87304,
      "updated_date": "2025-05-15T04:20:17-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8351705,
          "ingredient": {
            "id": 1838,
            "ingredient_code": 1896,
            "en_name": "LABETALOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de labétalol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02387468",
      "brand_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116170002"
    },
    "created_date": "2017-05-19T12:30:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387468",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C07AG",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-05-01T00:00:00-04:00",
    "actual_start_date": "2018-05-05T00:00:00-04:00",
    "actual_end_date": "2019-03-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-03-09T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
    "en_drug_common_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
    "fr_drug_brand_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
    "fr_drug_common_name": "LABETALOL HYDROCHLORIDE INJECTION, USP",
    "en_ingredients": "LABETALOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de labétalol",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "20ML 1VL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10722,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17308,
      "drug_code": 78357,
      "updated_date": "2025-05-15T04:12:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8344420,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298279",
      "brand_name": "MYLAN-PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541001"
    },
    "created_date": "2017-05-19T12:33:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298279",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T13:57:28-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 51551",
    "fr_comments": "Discontinued in ID 51551",
    "en_drug_brand_name": "MYLAN-PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "MYLAN-PIOGLITAZONE",
    "fr_drug_common_name": "PIOGLITAZONE",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10725,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17312,
      "drug_code": 78359,
      "updated_date": "2025-05-15T04:12:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8344422,
          "ingredient": {
            "id": 2812,
            "ingredient_code": 12012,
            "en_name": "PIOGLITAZONE",
            "fr_name": "Pioglitazone (Chlorhydrate de pioglitazone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "45",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298295",
      "brand_name": "MYLAN-PIOGLITAZONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0141541003"
    },
    "created_date": "2017-05-19T12:36:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298295",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "A10BG",
    "atc_description": "BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS",
    "anticipated_start_date": "2018-07-03T00:00:00-04:00",
    "actual_start_date": "2018-07-03T00:00:00-04:00",
    "actual_end_date": "2018-07-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2018-07-05T13:59:15-04:00",
    "status": "resolved",
    "en_comments": "Discontinued in ID 51554",
    "fr_comments": "Discontinued in ID 51554",
    "en_drug_brand_name": "MYLAN-PIOGLITAZONE",
    "en_drug_common_name": "PIOGLITAZONE",
    "fr_drug_brand_name": "MYLAN-PIOGLITAZONE",
    "fr_drug_common_name": "PIOGLITAZONE",
    "en_ingredients": "PIOGLITAZONE",
    "fr_ingredients": "PIOGLITAZONE",
    "drug_strength": "45MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "90BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10741,
    "drug": {
      "current_status": "MARKETED",
      "id": 7292,
      "drug_code": 49288,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253267,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230418",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238003"
    },
    "created_date": "2017-05-19T19:10:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230418",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-02-09T00:00:00-05:00",
    "actual_start_date": "2017-06-12T00:00:00-04:00",
    "actual_end_date": "2018-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-02-08T16:03:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX NASAL SPRAY",
    "en_drug_common_name": "Sumatriptan nasal spray",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Vaporisation nasale de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan",
    "drug_strength": "5MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL",
    "drug_route_fr": "Nasale",
    "drug_package_quantity": "2's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10850,
    "drug": {
      "current_status": "MARKETED",
      "id": 21168,
      "drug_code": 83549,
      "updated_date": "2025-05-15T02:32:40-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8257519,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350270",
      "brand_name": "FINASTERIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2017-05-23T14:27:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02350270",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-07-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-07-14T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE",
    "fr_drug_brand_name": "FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10855,
    "drug": {
      "current_status": "MARKETED",
      "id": 392,
      "drug_code": 10913,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251442,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251441,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00657298",
      "brand_name": "VASERETIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71053",
      "number_of_ais": "2",
      "ai_group_no": "0252326001"
    },
    "created_date": "2017-05-23T15:10:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00657298",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "anticipated_start_date": "2017-06-05T00:00:00-04:00",
    "estimated_end_date": "2017-06-09T00:00:00-04:00",
    "actual_start_date": "2017-05-26T00:00:00-04:00",
    "actual_end_date": "2017-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-06-07T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VASERETIC",
    "en_drug_common_name": "Enalapril and Hydrochlorothiazide Tablets",
    "fr_drug_brand_name": "VASERETIC",
    "fr_drug_common_name": "Comprimés d’Énalapril et d’Hydrochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nENALAPRIL SODIUM",
    "fr_ingredients": "Hydrochlorothiazide\r\nÉnalapril sodique",
    "drug_strength": "25MG\r\n8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 10860,
    "drug": {
      "current_status": "MARKETED",
      "id": 19670,
      "drug_code": 8103,
      "updated_date": "2025-05-15T02:30:40-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251051,
          "ingredient": {
            "id": 272,
            "ingredient_code": 20170,
            "en_name": "ENALAPRIL SODIUM",
            "fr_name": "Énalapril sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00670928",
      "brand_name": "VASOTEC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "66368",
      "number_of_ais": "1",
      "ai_group_no": "0152325003"
    },
    "created_date": "2017-05-23T15:26:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00670928",
    "company_name": "MERCK CANADA INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-05-31T00:00:00-04:00",
    "estimated_end_date": "2017-05-30T00:00:00-04:00",
    "actual_end_date": "2017-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-11T19:32:07-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "VASOTEC",
    "en_drug_common_name": "Enalapril tablets",
    "fr_drug_brand_name": "VASOTEC",
    "fr_drug_common_name": "Comprimés d’Énalapril",
    "en_ingredients": "ENALAPRIL SODIUM",
    "fr_ingredients": "Énalapril sodique",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "28",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10868,
    "drug": {
      "current_status": "MARKETED",
      "id": 19002,
      "drug_code": 80270,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256652,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256651,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317192",
      "brand_name": "APRI 21",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2017-05-23T18:34:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317192",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2017-09-19T10:20:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APRI 21",
    "en_drug_common_name": "DESOGESTREL ETHINYL ESTRADIOL",
    "fr_drug_brand_name": "APRI 21",
    "fr_drug_common_name": "DESOGESTREL ETHINYL ESTRADIOL",
    "en_ingredients": "DESOGESTREL\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Désogestrel\r\nÉthinylestradiol",
    "drug_strength": "0.15MG\r\n0.03MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10871,
    "drug": {
      "current_status": "MARKETED",
      "id": 19004,
      "drug_code": 80272,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256654,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256653,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317206",
      "brand_name": "APRI 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2017-05-23T18:35:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317206",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2017-08-04T00:00:00-04:00",
    "actual_start_date": "2017-05-15T00:00:00-04:00",
    "actual_end_date": "2017-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2017-09-19T10:20:26-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APRI 28",
    "en_drug_common_name": "DESOGESTREL ETHINYL ESTRADIOL",
    "fr_drug_brand_name": "APRI 28",
    "fr_drug_common_name": "Désogestrel Éthinyl Estradiol",
    "en_ingredients": "DESOGESTREL\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Désogestrel\r\nÉthinylestradiol",
    "drug_strength": "0.15MG\r\n0.03MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10874,
    "drug": {
      "current_status": "MARKETED",
      "id": 3078,
      "drug_code": 17830,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252222,
          "ingredient": {
            "id": 1348,
            "ingredient_code": 1755,
            "en_name": "CARBOPLATIN",
            "fr_name": "Carboplatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02125439",
      "brand_name": "CARBOPLATIN INJECTION",
      "brand_name_fr": "",
      "descriptor": "LIQ  IV  10MG/ML",
      "pediatric_flag": false,
      "accession_number": "80037",
      "number_of_ais": "1",
      "ai_group_no": "0117892002"
    },
    "created_date": "2017-05-23T18:37:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02125439",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01XA",
    "atc_description": "OTHER ANTINEOPLASTIC AGENTS",
    "estimated_end_date": "2017-07-27T00:00:00-04:00",
    "actual_start_date": "2017-05-18T00:00:00-04:00",
    "actual_end_date": "2017-08-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:05:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CARBOPLATIN INJECTION",
    "en_drug_common_name": "CARBOPLATIN",
    "fr_drug_brand_name": "CARBOPLATIN INJECTION",
    "fr_drug_common_name": "CARBOPLATIN",
    "en_ingredients": "CARBOPLATIN",
    "fr_ingredients": "Carboplatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "45ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10877,
    "drug": {
      "current_status": "MARKETED",
      "id": 3904,
      "drug_code": 19521,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252504,
          "ingredient": {
            "id": 1568,
            "ingredient_code": 11180,
            "en_name": "CEFAZOLIN",
            "fr_name": "Céfazoline (Céfazoline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02108119",
      "brand_name": "CEFAZOLIN FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81818",
      "number_of_ais": "1",
      "ai_group_no": "0109442002"
    },
    "created_date": "2017-05-23T18:39:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02108119",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2017-07-30T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:20:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CEFAZOLIN FOR INJECTION",
    "en_drug_common_name": "CEFAZOLIN",
    "fr_drug_brand_name": "CEFAZOLIN INJECTION",
    "fr_drug_common_name": "CEFAZOLIN",
    "en_ingredients": "CEFAZOLIN",
    "fr_ingredients": "Cefazolin",
    "drug_strength": "0.5G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAVENOUS",
    "drug_route_fr": "Intramusculaire\r\nIntraveineuse",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10880,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12590,
      "drug_code": 71334,
      "updated_date": "2025-05-15T04:06:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8337851,
          "ingredient": {
            "id": 1956,
            "ingredient_code": 7508,
            "en_name": "AMCINONIDE",
            "fr_name": "Amcinonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247097",
      "brand_name": "RATIO-AMCINONIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113040001"
    },
    "created_date": "2017-05-23T18:40:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247097",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "D07AC",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-05T05:00:05-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "RATIO-AMCINONIDE",
    "en_drug_common_name": "AMCINONIDE",
    "fr_drug_brand_name": "RATIO-AMCINONIDE",
    "fr_drug_common_name": "AMCINONIDE",
    "en_ingredients": "AMCINONIDE",
    "fr_ingredients": "Amcinonide",
    "drug_strength": "0.1%",
    "drug_dosage_form": "LOTION",
    "drug_dosage_form_fr": "Lotion",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60ML",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10883,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 21176,
      "drug_code": 83555,
      "updated_date": "2025-05-15T04:16:56-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8348808,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02350335",
      "brand_name": "RATIO-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2017-05-23T18:41:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02350335",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-10-05T05:00:05-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "RATIO-ATORVASTATIN",
    "en_drug_common_name": "ATORVASTATIN",
    "fr_drug_brand_name": "RATIO-ATORVASTATIN",
    "fr_drug_common_name": "ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "Atorvastatin",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10886,
    "drug": {
      "current_status": "MARKETED",
      "id": 14444,
      "drug_code": 74709,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255202,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261715",
      "brand_name": "TEVA-ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2017-05-23T18:45:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261715",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2017-06-30T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:23:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "TEVA-ALENDRONATE",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "Alendronate",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10889,
    "drug": {
      "current_status": "MARKETED",
      "id": 11568,
      "drug_code": 68491,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254313,
          "ingredient": {
            "id": 1190,
            "ingredient_code": 470,
            "en_name": "GABAPENTIN",
            "fr_name": "Gabapentine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02244514",
      "brand_name": "TEVA-GABAPENTIN",
      "brand_name_fr": "",
      "descriptor": "300MG",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0125929003"
    },
    "created_date": "2017-05-23T18:48:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244514",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-06-12T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:23:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-GABAPENTIN",
    "en_drug_common_name": "GABAPENTIN",
    "fr_drug_brand_name": "TEVA-GABAPENTIN",
    "fr_drug_common_name": "GABAPENTIN",
    "en_ingredients": "GABAPENTIN",
    "fr_ingredients": "Gabapentine",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10892,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4062,
      "drug_code": 19798,
      "updated_date": "2025-05-15T03:45:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8304057,
          "ingredient": {
            "id": 1298,
            "ingredient_code": 1945,
            "en_name": "IPRATROPIUM BROMIDE",
            "fr_name": "Bromure d'ipratropium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02097168",
      "brand_name": "RATIO-IPRATROPIUM UDV",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82095",
      "number_of_ais": "1",
      "ai_group_no": "0115643001"
    },
    "created_date": "2017-05-23T19:00:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02097168",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "R03BB",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2017-07-19T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:24:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RATIO-IPRATROPIUM UDV",
    "en_drug_common_name": "IPRATROPIUM BROMIDE",
    "fr_drug_brand_name": "TEVA-IPRATROPIUM UDV",
    "fr_drug_common_name": "IPRATROPIUM BROMIDE",
    "en_ingredients": "IPRATROPIUM BROMIDE",
    "fr_ingredients": "Bromure d'ipratropium",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "20X1ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10896,
    "drug": {
      "current_status": "MARKETED",
      "id": 12526,
      "drug_code": 71242,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254601,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247009",
      "brand_name": "TEVA-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2017-05-23T19:26:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247009",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-01-26T00:00:00-05:00",
    "actual_start_date": "2017-08-15T00:00:00-04:00",
    "actual_end_date": "2018-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-21T21:13:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "TEVA-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 10899,
    "drug": {
      "current_status": "MARKETED",
      "id": 12528,
      "drug_code": 71243,
      "updated_date": "2025-05-15T02:31:23-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254602,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247010",
      "brand_name": "TEVA-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2017-05-23T19:27:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247010",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2018-01-26T00:00:00-05:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2018-02-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-02-21T21:16:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "TEVA-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10902,
    "drug": {
      "current_status": "MARKETED",
      "id": 28154,
      "drug_code": 90301,
      "updated_date": "2025-05-15T02:34:11-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260230,
          "ingredient": {
            "id": 3336,
            "ingredient_code": 19840,
            "en_name": "RASAGILINE",
            "fr_name": "Rasagiline (Mésylate de rasagiline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02418444",
      "brand_name": "TEVA-RASAGILINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151662002"
    },
    "created_date": "2017-05-23T19:31:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02418444",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N04BD",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2017-06-30T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:27:27-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-RASAGILINE",
    "en_drug_common_name": "RASAGILINE",
    "fr_drug_brand_name": "TEVA-RASAGILINE",
    "fr_drug_common_name": "RASAGILINE",
    "en_ingredients": "RASAGILINE",
    "fr_ingredients": "Rasagiline",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10907,
    "drug": {
      "current_status": "MARKETED",
      "id": 18170,
      "drug_code": 79435,
      "updated_date": "2025-05-15T02:32:08-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256371,
          "ingredient": {
            "id": 2670,
            "ingredient_code": 11854,
            "en_name": "SILDENAFIL",
            "fr_name": "Sildénafil (Citrate de sildénafil)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02308738",
      "brand_name": "TEVA-SILDENAFIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0136261001"
    },
    "created_date": "2017-05-23T19:37:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02308738",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G04BE",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "estimated_end_date": "2017-06-17T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-07-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T10:28:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SILDENAFIL",
    "en_drug_common_name": "SILDENAFIL",
    "fr_drug_brand_name": "TEVA-SILDENAFIL",
    "fr_drug_common_name": "SILDENAFIL",
    "en_ingredients": "SILDENAFIL",
    "fr_ingredients": "Sildenafil",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "4",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10911,
    "drug": {
      "current_status": "MARKETED",
      "id": 24996,
      "drug_code": 87512,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259038,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02389622",
      "brand_name": "TEVA-TOBRAMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110230004"
    },
    "created_date": "2017-05-23T19:42:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389622",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "estimated_end_date": "2018-07-06T00:00:00-04:00",
    "actual_start_date": "2017-12-29T00:00:00-05:00",
    "actual_end_date": "2018-07-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-07-30T18:01:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TOBRAMYCIN",
    "en_drug_common_name": "TOBRAMYCIN",
    "fr_drug_brand_name": "TEVA-TOBRAMYCIN",
    "fr_drug_common_name": "TOBRAMYCIN",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "60MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 10955,
    "drug": {
      "current_status": "MARKETED",
      "id": 30896,
      "drug_code": 93028,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261417,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445077",
      "brand_name": "FINASTERIDE",
      "brand_name_fr": "FINASTERIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110001"
    },
    "created_date": "2017-05-23T20:29:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445077",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "G04CB",
    "atc_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_start_date": "2017-05-23T00:00:00-04:00",
    "actual_end_date": "2017-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-09-21T11:44:20-04:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE TABS",
    "fr_drug_brand_name": "FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE COMPRIMES",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 10972,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19980,
      "drug_code": 81289,
      "updated_date": "2025-05-15T04:14:44-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8347125,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02327570",
      "brand_name": "ACT OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2017-05-24T11:04:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327570",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-06-01T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2018-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-06-15T19:57:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "ACT-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10975,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 19984,
      "drug_code": 81291,
      "updated_date": "2025-05-15T04:14:44-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8347127,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02327597",
      "brand_name": "ACT OLANZAPINE ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783006"
    },
    "created_date": "2017-05-24T11:05:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327597",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2018-09-30T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2018-09-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-11T17:43:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT OLANZAPINE ODT",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "ACT-OLANZAPINE ODT",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10978,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 25496,
      "drug_code": 87936,
      "updated_date": "2025-05-15T04:20:34-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352194,
          "ingredient": {
            "id": 134,
            "ingredient_code": 6165,
            "en_name": "OXYCODONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'oxycodone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394200",
      "brand_name": "ACT OXYCODONE CR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107552005"
    },
    "created_date": "2017-05-24T11:07:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394200",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2017-06-30T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-07-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T11:34:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT OXYCODONE CR",
    "en_drug_common_name": "OXYCODONE",
    "fr_drug_brand_name": "ACT OXYCODONE CR",
    "fr_drug_common_name": "OXYCODONE",
    "en_ingredients": "OXYCODONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'oxycodone",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10981,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26448,
      "drug_code": 88775,
      "updated_date": "2025-05-15T04:21:01-04:00",
      "company": {
        "id": 1034,
        "created_date": "2017-03-09T13:23:38-05:00",
        "updated_date": "2025-05-15T03:22:13-04:00",
        "company_code": 15772,
        "mfr_code": "",
        "name": "ACTAVIS PHARMA COMPANY",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352870,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402920",
      "brand_name": "ACT PREGABALIN",
      "brand_name_fr": "ACT PRÉGABALINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121002"
    },
    "created_date": "2017-05-24T11:08:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402920",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-10T19:36:12-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACT PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "ACT PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10984,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 16040,
      "drug_code": 76825,
      "updated_date": "2025-05-15T04:11:30-04:00",
      "company": {
        "id": 1034,
        "created_date": "2017-03-09T13:23:38-05:00",
        "updated_date": "2025-05-15T03:22:13-04:00",
        "company_code": 15772,
        "mfr_code": "",
        "name": "ACTAVIS PHARMA COMPANY",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8342884,
          "ingredient": {
            "id": 986,
            "ingredient_code": 723,
            "en_name": "RISPERIDONE",
            "fr_name": "Rispéridone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02282615",
      "brand_name": "ACT RISPERIDONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124332004"
    },
    "created_date": "2017-05-24T11:09:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282615",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-11T17:45:13-04:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "ACT RISPERIDONE",
    "en_drug_common_name": "RISPERIDONE",
    "fr_drug_brand_name": "ACT RISPERIDONE",
    "fr_drug_common_name": "RISPERIDONE",
    "en_ingredients": "RISPERIDONE",
    "fr_ingredients": "Rispéridone",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10988,
    "drug": {
      "current_status": "MARKETED",
      "id": 24128,
      "drug_code": 86756,
      "updated_date": "2025-05-15T02:33:14-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258682,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02381702",
      "brand_name": "ACT RIZATRIPTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841002"
    },
    "created_date": "2017-05-24T11:14:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02381702",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2017-07-18T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-08-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T11:37:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT RIZATRIPTAN",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "ACT RIZATRIPTAN",
    "fr_drug_common_name": "RIZATRIPTAN",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "Rizatriptan",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 10991,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 17052,
      "drug_code": 78079,
      "updated_date": "2025-05-15T04:12:27-04:00",
      "company": {
        "id": 1034,
        "created_date": "2017-03-09T13:23:38-05:00",
        "updated_date": "2025-05-15T03:22:13-04:00",
        "company_code": 15772,
        "mfr_code": "",
        "name": "ACTAVIS PHARMA COMPANY",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8344160,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02295482",
      "brand_name": "ACT RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858001"
    },
    "created_date": "2017-05-24T11:15:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02295482",
    "company_name": "ACTAVIS PHARMA COMPANY",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2017-07-31T00:00:00-04:00",
    "actual_start_date": "2017-05-17T00:00:00-04:00",
    "actual_end_date": "2017-08-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T11:37:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "ACT RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "1.25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 11038,
    "drug": {
      "current_status": "MARKETED",
      "id": 11148,
      "drug_code": 67424,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254185,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243506",
      "brand_name": "APO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2017-05-24T13:18:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243506",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-12-22T00:00:00-05:00",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2017-12-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-20T15:17:42-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "APO-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11041,
    "drug": {
      "current_status": "DORMANT",
      "id": 25510,
      "drug_code": 87944,
      "updated_date": "2025-12-03T02:32:32-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368846,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394294",
      "brand_name": "APO-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121008"
    },
    "created_date": "2017-05-24T13:20:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394294",
    "company_name": "APOTEX INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-09-15T00:00:00-04:00",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2017-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-22T12:04:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "APO-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "300MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11044,
    "drug": {
      "current_status": "DORMANT",
      "id": 14190,
      "drug_code": 7426,
      "updated_date": "2025-05-15T06:55:21-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8366484,
          "ingredient": {
            "id": 1612,
            "ingredient_code": 11096,
            "en_name": "RANITIDINE",
            "fr_name": "Rantidine (Chlorhydrate de ranitidine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00733059",
      "brand_name": "APO-RANITIDINE TABLET 150MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65394",
      "number_of_ais": "1",
      "ai_group_no": "0115150002"
    },
    "created_date": "2017-05-24T13:22:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00733059",
    "company_name": "APOTEX INC",
    "atc_number": "A02BA",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2017-08-08T00:00:00-04:00",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2017-07-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-26T12:38:53-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RANITIDINE TABLET 150MG",
    "en_drug_common_name": "RANITIDINE",
    "fr_drug_brand_name": "APO-RANITIDINE TABLET 150MG",
    "fr_drug_common_name": "RANITIDINE",
    "en_ingredients": "RANITIDINE",
    "fr_ingredients": "ranitidine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11047,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28322,
      "drug_code": 90470,
      "updated_date": "2025-12-03T01:32:09-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8354332,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420090",
      "brand_name": "APO-TELMISARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138223002"
    },
    "created_date": "2017-05-24T13:24:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420090",
    "company_name": "APOTEX INC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2017-09-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-03T13:23:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TELMISARTAN",
    "en_drug_common_name": "TELMISARTAN",
    "fr_drug_brand_name": "APO-TELMISARTAN",
    "fr_drug_common_name": "TELMISARTAN",
    "en_ingredients": "TELMISARTAN",
    "fr_ingredients": "Telmisartan",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11050,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 28314,
      "drug_code": 90465,
      "updated_date": "2025-05-15T04:22:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8354329,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8354328,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02420031",
      "brand_name": "APO-TELMISARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783002"
    },
    "created_date": "2017-05-24T13:26:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02420031",
    "company_name": "APOTEX INC",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-12-20T06:00:02-05:00",
    "status": "active_confirmed",
    "en_drug_brand_name": "APO-TELMISARTAN/HCTZ",
    "en_drug_common_name": "TELMISARTAN/HCTZ",
    "fr_drug_brand_name": "APO-TELMISARTAN/HCTZ",
    "fr_drug_common_name": "TELMISARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nTELMISARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nTelmisartan",
    "drug_strength": "25MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 11053,
    "drug": {
      "current_status": "MARKETED",
      "id": 9640,
      "drug_code": 63385,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253725,
          "ingredient": {
            "id": 1002,
            "ingredient_code": 11385,
            "en_name": "TERBINAFINE",
            "fr_name": "Terbinafine (Chlorhydrate de terbinafine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239893",
      "brand_name": "APO-TERBINAFINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132855002"
    },
    "created_date": "2017-05-24T13:28:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239893",
    "company_name": "APOTEX INC",
    "atc_number": "D01BA",
    "atc_description": "ANTIFUNGALS FOR SYSTEMIC USE",
    "estimated_end_date": "2017-07-25T00:00:00-04:00",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2017-07-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-07-19T13:41:21-04:00",
    "status": "resolved",
    "en_comments": "APO-TERBINAFINE 250MG TAB 30 BLS  available",
    "fr_comments": "APO-TERBINAFINE 250MG TAB 30 BLS  disponible",
    "en_drug_brand_name": "APO-TERBINAFINE",
    "en_drug_common_name": "TERBINAFINE",
    "fr_drug_brand_name": "APO-TERBINAFINE",
    "fr_drug_common_name": "TERBINAFINE",
    "en_ingredients": "TERBINAFINE",
    "fr_ingredients": "Terbinafine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11056,
    "drug": {
      "current_status": "DORMANT",
      "id": 4154,
      "drug_code": 20011,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367037,
          "ingredient": {
            "id": 1618,
            "ingredient_code": 1890,
            "en_name": "BUSPIRONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de buspirone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02211076",
      "brand_name": "APO-BUSPIRONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "82310",
      "number_of_ais": "1",
      "ai_group_no": "0116263001"
    },
    "created_date": "2017-05-24T13:36:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02211076",
    "company_name": "APOTEX INC",
    "atc_number": "N05BE",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2017-06-12T00:00:00-04:00",
    "estimated_end_date": "2017-06-30T00:00:00-04:00",
    "actual_start_date": "2017-05-29T00:00:00-04:00",
    "actual_end_date": "2017-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-27T11:42:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-BUSPIRONE - TAB 10MG",
    "en_drug_common_name": "BUPIRONE",
    "fr_drug_brand_name": "APO-BUSPIRONE - TAB 10MG",
    "fr_drug_common_name": "BUSPIRONE",
    "en_ingredients": "BUSPIRONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de buspirone",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11059,
    "drug": {
      "current_status": "MARKETED",
      "id": 16168,
      "drug_code": 76960,
      "updated_date": "2025-05-15T02:31:47-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255768,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02284030",
      "brand_name": "APO-DESMOPRESSIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112050005"
    },
    "created_date": "2017-05-24T13:38:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02284030",
    "company_name": "APOTEX INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "anticipated_start_date": "2017-05-31T00:00:00-04:00",
    "estimated_end_date": "2017-06-27T00:00:00-04:00",
    "actual_start_date": "2017-05-29T00:00:00-04:00",
    "actual_end_date": "2017-06-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-21T12:49:28-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DESMOPRESSIN",
    "en_drug_common_name": "DESMOPRESSIN",
    "fr_drug_brand_name": "APO-DESMOPRESSIN",
    "fr_drug_common_name": "DESMOPRESSIN",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "0.1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11062,
    "drug": {
      "current_status": "MARKETED",
      "id": 3690,
      "drug_code": 19125,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8252438,
          "ingredient": {
            "id": 42,
            "ingredient_code": 2013,
            "en_name": "DICLOFENAC SODIUM",
            "fr_name": "Diclofénac sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02162814",
      "brand_name": "APO-DICLO SR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81416",
      "number_of_ais": "1",
      "ai_group_no": "0114417005"
    },
    "created_date": "2017-05-24T13:40:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02162814",
    "company_name": "APOTEX INC",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2017-06-19T00:00:00-04:00",
    "estimated_end_date": "2017-10-10T00:00:00-04:00",
    "actual_start_date": "2017-06-12T00:00:00-04:00",
    "actual_end_date": "2017-09-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-22T12:14:52-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DICLO SR",
    "en_drug_common_name": "DICLOFENAC",
    "fr_drug_brand_name": "APO-DICLO SR",
    "fr_drug_common_name": "DICLOFENAC",
    "en_ingredients": "DICLOFENAC SODIUM",
    "fr_ingredients": "Diclofénac sodique",
    "drug_strength": "75MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11066,
    "drug": {
      "current_status": "MARKETED",
      "id": 29714,
      "drug_code": 9173,
      "updated_date": "2025-12-03T00:30:26-05:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251126,
          "ingredient": {
            "id": 128,
            "ingredient_code": 1926,
            "en_name": "DILTIAZEM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de diltiazem"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00771384",
      "brand_name": "AA-DILTIAZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68043",
      "number_of_ais": "1",
      "ai_group_no": "0115863002"
    },
    "created_date": "2017-05-24T13:44:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00771384",
    "company_name": "APOTEX INC",
    "atc_number": "C08DB",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF",
    "anticipated_start_date": "2017-07-31T00:00:00-04:00",
    "estimated_end_date": "2018-10-19T00:00:00-04:00",
    "actual_start_date": "2017-07-31T00:00:00-04:00",
    "actual_end_date": "2018-10-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-17T22:18:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO DILTIAZ TAB 60MG",
    "en_drug_common_name": "DILTIAZEM",
    "fr_drug_brand_name": "APO DILTIAZ TAB 60MG",
    "fr_drug_common_name": "DILTIAZEM",
    "en_ingredients": "DILTIAZEM HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de diltiazem",
    "drug_strength": "60MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11069,
    "drug": {
      "current_status": "MARKETED",
      "id": 13984,
      "drug_code": 7393,
      "updated_date": "2025-05-15T02:30:39-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251015,
          "ingredient": {
            "id": 1906,
            "ingredient_code": 8008,
            "en_name": "HYDROXYZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydroxyzine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00646059",
      "brand_name": "HYDROXYZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65327",
      "number_of_ais": "1",
      "ai_group_no": "0106172003"
    },
    "created_date": "2017-05-24T13:45:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00646059",
    "company_name": "APOTEX INC",
    "atc_number": "N05BB",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2017-06-09T00:00:00-04:00",
    "estimated_end_date": "2017-08-31T00:00:00-04:00",
    "actual_start_date": "2017-06-05T00:00:00-04:00",
    "actual_end_date": "2017-08-09T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-08-10T12:35:41-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO HYDROXYZINE CAP 10MG",
    "en_drug_common_name": "HYDROXYZINE",
    "fr_drug_brand_name": "APO HYDROXYZINE CAP 10MG",
    "fr_drug_common_name": "HYDROXYZINE",
    "en_ingredients": "HYDROXYZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydroxyzine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11072,
    "drug": {
      "current_status": "MARKETED",
      "id": 13954,
      "drug_code": 7391,
      "updated_date": "2025-05-15T02:30:39-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251013,
          "ingredient": {
            "id": 1906,
            "ingredient_code": 8008,
            "en_name": "HYDROXYZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydroxyzine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00646016",
      "brand_name": "HYDROXYZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65325",
      "number_of_ais": "1",
      "ai_group_no": "0106172004"
    },
    "created_date": "2017-05-24T13:46:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00646016",
    "company_name": "APOTEX INC",
    "atc_number": "N05BB",
    "atc_description": "ANXIOLYTICS",
    "anticipated_start_date": "2017-06-26T00:00:00-04:00",
    "estimated_end_date": "2017-08-31T00:00:00-04:00",
    "actual_start_date": "2017-06-12T00:00:00-04:00",
    "actual_end_date": "2017-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-22T11:38:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO HYDROXYZINE CAP 50MG",
    "en_drug_common_name": "HYDROXYZINE",
    "fr_drug_brand_name": "APO HYDROXYZINE CAP 50MG",
    "fr_drug_common_name": "HYDROXYZINE",
    "en_ingredients": "HYDROXYZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydroxyzine",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11077,
    "drug": {
      "current_status": "DORMANT",
      "id": 6332,
      "drug_code": 43222,
      "updated_date": "2025-05-15T06:55:26-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8367206,
          "ingredient": {
            "id": 340,
            "ingredient_code": 1253,
            "en_name": "LISINOPRIL",
            "fr_name": "Lisinopril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02217503",
      "brand_name": "APO-LISINOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9549",
      "number_of_ais": "1",
      "ai_group_no": "0121550001"
    },
    "created_date": "2017-05-24T13:48:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02217503",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-06-05T00:00:00-04:00",
    "estimated_end_date": "2017-07-07T00:00:00-04:00",
    "actual_start_date": "2017-05-29T00:00:00-04:00",
    "actual_end_date": "2017-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-23T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-LISINOPRIL TABLET 10 MG",
    "en_drug_common_name": "LISINOPRIL",
    "fr_drug_brand_name": "APO-LISINOPRIL TABLET 10 MG",
    "fr_drug_common_name": "LISINOPRIL",
    "en_ingredients": "LISINOPRIL",
    "fr_ingredients": "Lisinopril",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11082,
    "drug": {
      "current_status": "MARKETED",
      "id": 1906,
      "drug_code": 14048,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251856,
          "ingredient": {
            "id": 40,
            "ingredient_code": 2037,
            "en_name": "NAPROXEN SODIUM",
            "fr_name": "Naproxène sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "550",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01940309",
      "brand_name": "APO-NAPRO-NA DS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75555",
      "number_of_ais": "1",
      "ai_group_no": "0113934002"
    },
    "created_date": "2017-05-24T13:50:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01940309",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "anticipated_start_date": "2017-11-30T00:00:00-05:00",
    "estimated_end_date": "2018-10-31T00:00:00-04:00",
    "actual_start_date": "2017-11-01T00:00:00-04:00",
    "actual_end_date": "2018-10-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-10-05T15:44:23-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPRO-NA DS TAB 550MG",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPRO-NA DS TAB 550MG",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN SODIUM",
    "fr_ingredients": "Naproxène sodique",
    "drug_strength": "550MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11087,
    "drug": {
      "current_status": "MARKETED",
      "id": 13770,
      "drug_code": 73646,
      "updated_date": "2025-05-15T02:31:36-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254957,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02251531",
      "brand_name": "APO-RAMIPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122858004"
    },
    "created_date": "2017-05-24T13:51:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02251531",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "anticipated_start_date": "2017-05-31T00:00:00-04:00",
    "estimated_end_date": "2017-06-22T00:00:00-04:00",
    "actual_start_date": "2017-06-05T00:00:00-04:00",
    "actual_end_date": "2017-06-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-21T12:52:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RAMIPRIL",
    "en_drug_common_name": "RAMIPRIL",
    "fr_drug_brand_name": "APO-RAMIPRIL",
    "fr_drug_common_name": "RAMIPRIL",
    "en_ingredients": "RAMIPRIL",
    "fr_ingredients": "Ramipril",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11090,
    "drug": {
      "current_status": "MARKETED",
      "id": 9050,
      "drug_code": 61677,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253563,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02238281",
      "brand_name": "APO-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2017-05-24T13:53:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238281",
    "company_name": "APOTEX INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-06-26T00:00:00-04:00",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_start_date": "2017-06-05T00:00:00-04:00",
    "actual_end_date": "2017-09-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-04T12:38:35-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SERTRALINE",
    "en_drug_common_name": "SERTRALINE",
    "fr_drug_brand_name": "APO-SERTRALINE",
    "fr_drug_common_name": "SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "sertraline",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11094,
    "drug": {
      "current_status": "MARKETED",
      "id": 30898,
      "drug_code": 93029,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261418,
          "ingredient": {
            "id": 862,
            "ingredient_code": 768,
            "en_name": "FINASTERIDE",
            "fr_name": "Finastéride"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445085",
      "brand_name": "FINASTERIDE",
      "brand_name_fr": "FINASTERIDE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124110002"
    },
    "created_date": "2017-05-24T13:55:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445085",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "D11AX",
    "atc_description": "OTHER DERMATOLOGICAL PREPARATIONS",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_start_date": "2017-05-23T00:00:00-04:00",
    "actual_end_date": "2017-09-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-09-22T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Delay in replenishment batch from supplier",
    "fr_comments": "Retard dans le lot de réapprovisionnement du fournisseur",
    "en_drug_brand_name": "FINASTERIDE",
    "en_drug_common_name": "FINASTERIDE TABS",
    "fr_drug_brand_name": "FINASTERIDE",
    "fr_drug_common_name": "FINASTERIDE COMPRIMES",
    "en_ingredients": "FINASTERIDE",
    "fr_ingredients": "Finastéride",
    "drug_strength": "1MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11125,
    "drug": {
      "current_status": "MARKETED",
      "id": 23938,
      "drug_code": 86592,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258618,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380080",
      "brand_name": "TARO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2017-05-24T14:46:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380080",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-03-27T00:00:00-04:00",
    "actual_start_date": "2017-03-27T00:00:00-04:00",
    "actual_end_date": "2018-08-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-08-23T19:57:37-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-VENLAFAXINE XR",
    "en_drug_common_name": "RAN-VENLAFAXINE XR",
    "fr_drug_brand_name": "RAN-VENLAFAXINE XR",
    "fr_drug_common_name": "RAN-VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE XR",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 11133,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26432,
      "drug_code": 88764,
      "updated_date": "2025-05-15T04:21:00-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352860,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402807",
      "brand_name": "RAN-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823001"
    },
    "created_date": "2017-05-24T14:59:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402807",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2016-10-01T00:00:00-04:00",
    "actual_start_date": "2016-10-01T00:00:00-04:00",
    "actual_end_date": "2017-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:51:46-05:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinué",
    "en_drug_brand_name": "RAN-MONTELUKAST",
    "en_drug_common_name": "RAN-MONTELUKAST",
    "fr_drug_brand_name": "RAN-MONTELUKAST",
    "fr_drug_common_name": "RAN-MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11154,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2198,
      "drug_code": 14601,
      "updated_date": "2025-12-03T01:06:42-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8293815,
          "ingredient": {
            "id": 1098,
            "ingredient_code": 7640,
            "en_name": "APIS MELLIFERA VENOM PROTEIN EXTRACT",
            "fr_name": "Extrait protéique de venin d'Abeille mellifère"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948911",
      "brand_name": "PHARMALGEN HONEY BEE VENOM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76255",
      "number_of_ais": "1",
      "ai_group_no": "0123304001"
    },
    "created_date": "2017-05-24T16:18:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948911",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:32:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN HONEY BEE VENOM",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Hony Bee Venom",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "APIS MELLIFERA VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extrait protéique de venin d'Abeille mellifère",
    "drug_strength": "120MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11159,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2200,
      "drug_code": 14602,
      "updated_date": "2025-12-03T01:06:42-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8293816,
          "ingredient": {
            "id": 1098,
            "ingredient_code": 7640,
            "en_name": "APIS MELLIFERA VENOM PROTEIN EXTRACT",
            "fr_name": "Extrait protéique de venin d'Abeille mellifère"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948903",
      "brand_name": "PHARMALGEN HONEY BEE VENOM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76256",
      "number_of_ais": "1",
      "ai_group_no": "0123304002"
    },
    "created_date": "2017-05-24T16:21:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948903",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:33:34-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN HONEY BEE VENOM",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Honey Bee Venom",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "APIS MELLIFERA VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extrait protéique de venin d'Abeille mellifère",
    "drug_strength": "1.1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11164,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2196,
      "drug_code": 14599,
      "updated_date": "2025-12-03T01:06:42-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8293811,
          "ingredient": {
            "id": 1032,
            "ingredient_code": 2030,
            "en_name": "YELLOW JACKET VENOM PROTEIN",
            "fr_name": "Protéine de venin de guêpe jaune"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8293810,
          "ingredient": {
            "id": 1030,
            "ingredient_code": 2029,
            "en_name": "WHITE FACED HORNET VENOM PROTEIN",
            "fr_name": "Protéine de venin de frelon à tête blanche"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8293809,
          "ingredient": {
            "id": 1034,
            "ingredient_code": 2031,
            "en_name": "YELLOW HORNET VENOM PROTEIN",
            "fr_name": "Protéine de venin de frelon jaune"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948881",
      "brand_name": "PHARMALGEN MIXED VESPID VENOM PROTEIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76253",
      "number_of_ais": "3",
      "ai_group_no": "0315776004"
    },
    "created_date": "2017-05-24T16:24:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948881",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:34:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN MIXED VESPID VENOM PROTEIN",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Mixed Vespid Venom",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "WHITE FACED HORNET VENOM PROTEIN\r\nYELLOW JACKET VENOM PROTEIN\r\nYELLOW HORNET VENOM PROTEIN",
    "fr_ingredients": "Protéine de venin de frelon à tête blanche\r\nProtéine de venin de guêpe jaune\r\nProtéine de venin de frelon jaune",
    "drug_strength": "120MCG\r\n120MCG\r\n120MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11167,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 26430,
      "drug_code": 88763,
      "updated_date": "2025-05-15T04:21:00-04:00",
      "company": {
        "id": 1184,
        "created_date": "2017-03-09T13:23:54-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 11271,
        "mfr_code": "",
        "name": "RANBAXY PHARMACEUTICALS CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8352859,
          "ingredient": {
            "id": 2580,
            "ingredient_code": 11784,
            "en_name": "MONTELUKAST",
            "fr_name": "Montélukast (Montélukast sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402793",
      "brand_name": "RAN-MONTELUKAST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133823003"
    },
    "created_date": "2017-05-24T16:29:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402793",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "R03DC",
    "atc_description": "OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES",
    "anticipated_start_date": "2016-10-01T00:00:00-04:00",
    "actual_start_date": "2016-10-01T00:00:00-04:00",
    "actual_end_date": "2017-11-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-02-01T18:52:32-05:00",
    "status": "resolved",
    "en_comments": "Discontinued",
    "fr_comments": "Discontinué",
    "en_drug_brand_name": "RAN-MONTELUKAST",
    "en_drug_common_name": "RAN-MONTELUKAST",
    "fr_drug_brand_name": "RAN-MONTELUKAST",
    "fr_drug_common_name": "RAN-MONTELUKAST",
    "en_ingredients": "MONTELUKAST",
    "fr_ingredients": "MONTELUKAST",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11169,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1926,
      "drug_code": 14101,
      "updated_date": "2025-12-03T01:06:30-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8292834,
          "ingredient": {
            "id": 1030,
            "ingredient_code": 2029,
            "en_name": "WHITE FACED HORNET VENOM PROTEIN",
            "fr_name": "Protéine de venin de frelon à tête blanche"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8292833,
          "ingredient": {
            "id": 1034,
            "ingredient_code": 2031,
            "en_name": "YELLOW HORNET VENOM PROTEIN",
            "fr_name": "Protéine de venin de frelon jaune"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        },
        {
          "id": 8292832,
          "ingredient": {
            "id": 1032,
            "ingredient_code": 2030,
            "en_name": "YELLOW JACKET VENOM PROTEIN",
            "fr_name": "Protéine de venin de guêpe jaune"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948873",
      "brand_name": "PHARMALGEN MIXED VESPID VENOM PROTEIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75609",
      "number_of_ais": "3",
      "ai_group_no": "0315776003"
    },
    "created_date": "2017-05-24T16:30:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948873",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:34:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN MIXED VESPID VENOM PROTEIN",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Mixed Vespid Venom",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "WHITE FACED HORNET VENOM PROTEIN\r\nYELLOW JACKET VENOM PROTEIN\r\nYELLOW HORNET VENOM PROTEIN",
    "fr_ingredients": "Protéine de venin de frelon à tête blanche\r\nProtéine de venin de guêpe jaune\r\nProtéine de venin de frelon jaune",
    "drug_strength": "120MCG\r\n120MCG\r\n120MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11173,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2192,
      "drug_code": 14597,
      "updated_date": "2025-12-03T01:06:42-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8293807,
          "ingredient": {
            "id": 994,
            "ingredient_code": 7639,
            "en_name": "POLISTES SPP VENOM PROTEIN EXTRACT",
            "fr_name": "Extrait protéique du venin de poliste"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948970",
      "brand_name": "PHARMALGEN WASP VENOM PROTEIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76251",
      "number_of_ais": "1",
      "ai_group_no": "0123307003"
    },
    "created_date": "2017-05-24T16:32:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948970",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:35:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN WASP VENOM PROTEIN",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Wasp Venom Protein",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "POLISTES SPP VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extrait protéique du venin de poliste",
    "drug_strength": "1.1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11179,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1850,
      "drug_code": 13950,
      "updated_date": "2025-12-03T01:06:25-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8292399,
          "ingredient": {
            "id": 994,
            "ingredient_code": 7639,
            "en_name": "POLISTES SPP VENOM PROTEIN EXTRACT",
            "fr_name": "Extrait protéique du venin de poliste"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948989",
      "brand_name": "PHARMALGEN WASP VENOM PROTEIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75433",
      "number_of_ais": "1",
      "ai_group_no": "0123307001"
    },
    "created_date": "2017-05-24T16:35:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948989",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:36:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN WASP VENOM PROTEIN",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Wasp Venom Protein",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "POLISTES SPP VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extrait protéique du venin de poliste",
    "drug_strength": "120MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11191,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2456,
      "drug_code": 15874,
      "updated_date": "2025-12-03T01:07:26-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8295909,
          "ingredient": {
            "id": 1174,
            "ingredient_code": 7638,
            "en_name": "DOLICHOVESPULA MACULATA VENOM PROTEIN EXTRACT",
            "fr_name": "Extrait de protéines de venin de dolichovespula maculata"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01949004",
      "brand_name": "PHARMALGEN WHITE FACED HORNET VENOM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "77637",
      "number_of_ais": "1",
      "ai_group_no": "0123308001"
    },
    "created_date": "2017-05-24T16:38:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01949004",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:37:39-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN WHITE FACED HORNET VENOM",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen White Faced Hornet Venom Protein",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "DOLICHOVESPULA MACULATA VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extrait de protéines de venin de dolichovespula maculata",
    "drug_strength": "120MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11194,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6892,
      "drug_code": 46471,
      "updated_date": "2025-12-03T01:13:17-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8313306,
          "ingredient": {
            "id": 1174,
            "ingredient_code": 7638,
            "en_name": "DOLICHOVESPULA MACULATA VENOM PROTEIN EXTRACT",
            "fr_name": "Extrait de protéines de venin de dolichovespula maculata"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948997",
      "brand_name": "PHARMALGEN WHITE FACED HORNET VENOM PROTEIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "X9455",
      "number_of_ais": "1",
      "ai_group_no": "0123308002"
    },
    "created_date": "2017-05-24T16:40:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948997",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:38:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN WHITE FACED HORNET VENOM PROTEIN",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen White Faced Hornet Venom Protein",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "DOLICHOVESPULA MACULATA VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extrait de protéines de venin de dolichovespula maculata",
    "drug_strength": "1.1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11197,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 6890,
      "drug_code": 46470,
      "updated_date": "2025-12-03T01:13:17-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8313305,
          "ingredient": {
            "id": 998,
            "ingredient_code": 7636,
            "en_name": "DOLICHOVESPULA ARENARIA VENOM PROTEIN EXTRACT",
            "fr_name": "Extraits de protéines de venin de dolichovespula arenaria"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948938",
      "brand_name": "PHARMALGEN YELLOW HORNET VENOM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "X9449",
      "number_of_ais": "1",
      "ai_group_no": "0123305002"
    },
    "created_date": "2017-05-24T16:42:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948938",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:39:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN YELLOW HORNET VENOM",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Yellow Hornet Venom Protein",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "DOLICHOVESPULA ARENARIA VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extraits de protéines de venin de dolichovespula arenaria",
    "drug_strength": "1.1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11204,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1854,
      "drug_code": 13952,
      "updated_date": "2025-12-03T01:06:25-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8292401,
          "ingredient": {
            "id": 998,
            "ingredient_code": 7636,
            "en_name": "DOLICHOVESPULA ARENARIA VENOM PROTEIN EXTRACT",
            "fr_name": "Extraits de protéines de venin de dolichovespula arenaria"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948946",
      "brand_name": "PHARMALGEN YELLOW HORNET VENOM PROTEIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75435",
      "number_of_ais": "1",
      "ai_group_no": "0123305001"
    },
    "created_date": "2017-05-24T16:45:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948946",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:39:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN YELLOW HORNET VENOM PROTEIN",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Yellow Hornet Venom Protein",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "DOLICHOVESPULA ARENARIA VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extraits de protéines de venin de dolichovespula arenaria",
    "drug_strength": "120MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11207,
    "drug": {
      "current_status": "MARKETED",
      "id": 23936,
      "drug_code": 86591,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 12246,
        "created_date": "2019-04-06T00:45:04-04:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 17559,
        "mfr_code": "",
        "name": "SUN PHARMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "126 EAST DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6T 1C1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258617,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380072",
      "brand_name": "TARO-VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294002"
    },
    "created_date": "2017-05-24T16:45:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380072",
    "company_name": "RANBAXY PHARMACEUTICALS CANADA INC.",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2018-11-28T00:00:00-05:00",
    "estimated_end_date": "2019-06-28T00:00:00-04:00",
    "actual_start_date": "2018-11-28T00:00:00-05:00",
    "actual_end_date": "2019-07-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2019-07-06T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RAN-VENLAFAXINE XR",
    "en_drug_common_name": "RAN-VENLAFAXINE XR",
    "fr_drug_brand_name": "RAN-VENLAFAXINE XR",
    "fr_drug_common_name": "RAN-VENLAFAXINE XR",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "VENLAFAXINE XR",
    "drug_strength": "37.5MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 11209,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 2194,
      "drug_code": 14598,
      "updated_date": "2025-12-03T01:06:42-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8293808,
          "ingredient": {
            "id": 996,
            "ingredient_code": 7637,
            "en_name": "VESPULA SPP VENOM PROTEIN EXTRACT",
            "fr_name": "Extrait de protéine de venin de guêpe (vespula spp)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948954",
      "brand_name": "PHARMALGEN YELLOW JACKET VENOM PROTEIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76252",
      "number_of_ais": "1",
      "ai_group_no": "0123306002"
    },
    "created_date": "2017-05-24T16:46:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948954",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:40:55-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN YELLOW JACKET VENOM PROTEIN",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Yellow Hornet Venom Protein",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "VESPULA SPP VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extrait de protéine de venin de guêpe (vespula spp)",
    "drug_strength": "1.1MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11213,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1852,
      "drug_code": 13951,
      "updated_date": "2025-12-03T01:06:25-05:00",
      "company": {
        "id": 322,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-12-03T00:30:16-05:00",
        "company_code": 13212,
        "mfr_code": "",
        "name": "ALK-ABELLÓ A/S",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "BOEGE ALLÉ 6-8",
        "province": "--",
        "country": "DENMARK",
        "city": "HORSHOLM",
        "postal_code": "2970",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8292400,
          "ingredient": {
            "id": 996,
            "ingredient_code": 7637,
            "en_name": "VESPULA SPP VENOM PROTEIN EXTRACT",
            "fr_name": "Extrait de protéine de venin de guêpe (vespula spp)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "120",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "01948962",
      "brand_name": "PHARMALGEN YELLOW JACKET VENOM PROTEIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75434",
      "number_of_ais": "1",
      "ai_group_no": "0123306001"
    },
    "created_date": "2017-05-24T16:47:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01948962",
    "company_name": "ALK ABELLO A/S",
    "atc_number": "V01AA",
    "atc_description": "ALLERGENS",
    "anticipated_start_date": "2016-11-01T00:00:00-04:00",
    "actual_start_date": "2016-12-01T00:00:00-05:00",
    "actual_end_date": "2023-04-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2025-05-15T12:41:30-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PHARMALGEN YELLOW JACKET VENOM PROTEIN",
    "en_drug_common_name": "Allergenic Extract",
    "fr_drug_brand_name": "Pharmalgen Yellow Jacket Venom Protein",
    "fr_drug_common_name": "Allergenic Extract",
    "en_ingredients": "VESPULA SPP VENOM PROTEIN EXTRACT",
    "fr_ingredients": "Extrait de protéine de venin de guêpe (vespula spp)",
    "drug_strength": "120MCG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRADERMAL\r\nSUBCUTANEOUS",
    "drug_route_fr": "Intradermique\r\nSous-cutanée",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": true,
    "late_marker_disabled": true,
    "tier_3": false
  },
  {
    "id": 11231,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 10948,
      "drug_code": 66912,
      "updated_date": "2025-05-15T04:02:43-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8333383,
          "ingredient": {
            "id": 138,
            "ingredient_code": 8551,
            "en_name": "CLINDAMYCIN",
            "fr_name": "Clindamycine (Chlorhydrate de clindamycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243050",
      "brand_name": "CLINDETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105830004"
    },
    "created_date": "2017-05-25T04:27:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243050",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "D10AF",
    "atc_description": "ANTI-ACNE PREPARATIONS FOR TOPICAL USE",
    "actual_start_date": "2017-06-02T00:00:00-04:00",
    "actual_end_date": "2017-09-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2020-02-27T16:55:27-05:00",
    "status": "resolved",
    "en_comments": "This product has been discontinued.",
    "fr_comments": "Ce produit a été abandonné.",
    "en_drug_brand_name": "CLINDETS",
    "en_drug_common_name": "Clindamycin phosphate solution in pledget",
    "fr_drug_brand_name": "CLINDETS",
    "fr_drug_common_name": "Tampons de solution de phosphate de clindamycine",
    "en_ingredients": "CLINDAMYCIN",
    "fr_ingredients": "CLINDAMYCINE",
    "drug_strength": "1%",
    "drug_dosage_form": "PAD",
    "drug_dosage_form_fr": "Compresse",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "60's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 11234,
    "drug": {
      "current_status": "MARKETED",
      "id": 6250,
      "drug_code": 43078,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253028,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02212188",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "P9370",
      "number_of_ais": "1",
      "ai_group_no": "0123238006"
    },
    "created_date": "2017-05-25T04:46:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212188",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-06-29T00:00:00-04:00",
    "actual_start_date": "2017-06-26T00:00:00-04:00",
    "actual_end_date": "2018-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-06-27T16:58:51-04:00",
    "status": "resolved",
    "en_comments": "Supply released July 2017 and August 2017 with limited quantity",
    "fr_comments": "Libération des stocks en juillet 2017 et août 2017 en quantités limitées",
    "en_drug_brand_name": "IMITREX INJECTION 12MG/ML",
    "en_drug_common_name": "Sumatriptan succinate injection",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Solution injectable de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "12MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "5x0.5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11237,
    "drug": {
      "current_status": "MARKETED",
      "id": 6250,
      "drug_code": 43078,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253028,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02212188",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "P9370",
      "number_of_ais": "1",
      "ai_group_no": "0123238006"
    },
    "created_date": "2017-05-25T04:50:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212188",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-03-23T00:00:00-04:00",
    "actual_start_date": "2017-06-12T00:00:00-04:00",
    "actual_end_date": "2018-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-03-16T14:05:11-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX INJECTION 12MG/ML",
    "en_drug_common_name": "Sumatriptan succinate injection",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Solution injectable de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "12MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2x0.5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11245,
    "drug": {
      "current_status": "DORMANT",
      "id": 6246,
      "drug_code": 43076,
      "updated_date": "2025-05-15T06:55:26-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8367202,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02212153",
      "brand_name": "IMITREX DF - TAB 50MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9368",
      "number_of_ais": "1",
      "ai_group_no": "0123238002"
    },
    "created_date": "2017-05-25T05:06:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212153",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-06-07T00:00:00-04:00",
    "actual_start_date": "2017-09-20T00:00:00-04:00",
    "actual_end_date": "2018-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-06-08T13:11:44-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX DF - TAB 50MG",
    "en_drug_common_name": "Sumatriptan succinate tablets",
    "fr_drug_brand_name": "IMITREX DF",
    "fr_drug_common_name": "Comprimés de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11250,
    "drug": {
      "current_status": "MARKETED",
      "id": 6248,
      "drug_code": 43077,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253027,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02212161",
      "brand_name": "IMITREX DF - TAB 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9369",
      "number_of_ais": "1",
      "ai_group_no": "0123238001"
    },
    "created_date": "2017-05-25T05:26:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212161",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-07-06T00:00:00-04:00",
    "actual_start_date": "2018-01-11T00:00:00-05:00",
    "actual_end_date": "2018-06-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-06-22T13:48:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX DF - TAB 100MG",
    "en_drug_common_name": "Sumatriptan succinate tablets",
    "fr_drug_brand_name": "IMITREX DF",
    "fr_drug_common_name": "Comprimés de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "6's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11253,
    "drug": {
      "current_status": "MARKETED",
      "id": 6250,
      "drug_code": 43078,
      "updated_date": "2025-05-15T02:31:02-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253028,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02212188",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "AUTO-INJECTOR",
      "pediatric_flag": false,
      "accession_number": "P9370",
      "number_of_ais": "1",
      "ai_group_no": "0123238006"
    },
    "created_date": "2017-05-25T05:38:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212188",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2018-02-28T00:00:00-05:00",
    "actual_start_date": "2017-06-29T00:00:00-04:00",
    "actual_end_date": "2018-02-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-02-08T16:02:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX INJECTION 12MG/ML",
    "en_drug_common_name": "Sumatriptan succinate injection",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Solution injectable de succinate de sumatriptan",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "SUMATRIPTAN",
    "drug_strength": "12MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2x0.5mL (Refill pack/L’emballage de recharge)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11280,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 8730,
      "drug_code": 6067,
      "updated_date": "2025-05-15T03:29:24-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8279690,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00632775",
      "brand_name": "RITALIN-SR TAB 20MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "62218",
      "number_of_ais": "1",
      "ai_group_no": "0107548002"
    },
    "created_date": "2017-05-25T14:40:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00632775",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2017-06-26T00:00:00-04:00",
    "actual_start_date": "2017-05-11T00:00:00-04:00",
    "actual_end_date": "2017-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-06-02T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "Lot pending inspection report from QA",
    "fr_comments": "Rapport d'inspection en attente de QA",
    "en_drug_brand_name": "RITALIN-SR TAB 20MG",
    "en_drug_common_name": "RITALIN 20MG SR TABS 100'S",
    "fr_drug_brand_name": "RITALIN SR 20MG",
    "fr_drug_common_name": "RITALIN 20MG SR TABS 100'S",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_b3": true,
    "tier_3": false
  },
  {
    "id": 11291,
    "drug": {
      "current_status": "MARKETED",
      "id": 3298,
      "drug_code": 18349,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252303,
          "ingredient": {
            "id": 82,
            "ingredient_code": 150,
            "en_name": "ACETYLSALICYLIC ACID",
            "fr_name": "Acide acétylsalicylique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02009013",
      "brand_name": "ASAPHEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80578",
      "number_of_ais": "1",
      "ai_group_no": "0101169013"
    },
    "created_date": "2017-05-25T19:43:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02009013",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N02BA",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "anticipated_start_date": "2017-09-02T00:00:00-04:00",
    "estimated_end_date": "2017-09-29T00:00:00-04:00",
    "actual_end_date": "2017-09-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-09-19T21:10:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ASAPHEN",
    "en_drug_common_name": "ASAPHEN",
    "fr_drug_brand_name": "ASAPHEN",
    "fr_drug_common_name": "ASAPHEN",
    "en_ingredients": "ACETYLSALICYLIC ACID",
    "fr_ingredients": "Acide acétylsalicylique",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 11294,
    "drug": {
      "current_status": "MARKETED",
      "id": 8812,
      "drug_code": 60939,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253530,
          "ingredient": {
            "id": 1358,
            "ingredient_code": 2041,
            "en_name": "ATENOLOL",
            "fr_name": "Aténolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02237600",
      "brand_name": "PMS-ATENOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113847002"
    },
    "created_date": "2017-05-25T19:44:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02237600",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-06-29T00:00:00-04:00",
    "estimated_end_date": "2018-05-15T00:00:00-04:00",
    "actual_start_date": "2017-06-29T00:00:00-04:00",
    "actual_end_date": "2018-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2018-04-19T13:06:36-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-ATENOLOL",
    "en_drug_common_name": "ATENOLOL",
    "fr_drug_brand_name": "PMS-ATENOLOL",
    "fr_drug_common_name": "ATENOLOL",
    "en_ingredients": "ATENOLOL",
    "fr_ingredients": "Aténolol",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11297,
    "drug": {
      "current_status": "MARKETED",
      "id": 29380,
      "drug_code": 91389,
      "updated_date": "2025-05-15T02:34:28-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260658,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02429446",
      "brand_name": "PMS-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2017-05-25T19:45:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02429446",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2017-06-14T00:00:00-04:00",
    "estimated_end_date": "2017-08-07T00:00:00-04:00",
    "actual_start_date": "2017-06-14T00:00:00-04:00",
    "actual_end_date": "2017-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-12-18T15:13:59-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "PMS-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "PMS-DULOXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11301,
    "drug": {
      "current_status": "DORMANT",
      "id": 5784,
      "drug_code": 38260,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367182,
          "ingredient": {
            "id": 674,
            "ingredient_code": 2395,
            "en_name": "LACTULOSE",
            "fr_name": "Lactulose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "667",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00703486",
      "brand_name": "PMS-LACTULOSE SYR 667MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "K0863",
      "number_of_ais": "1",
      "ai_group_no": "0113020001"
    },
    "created_date": "2017-05-25T19:47:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00703486",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AD",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "anticipated_start_date": "2017-09-25T00:00:00-04:00",
    "actual_start_date": "2017-09-25T00:00:00-04:00",
    "actual_end_date": "2018-05-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-05-05T05:00:13-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "en_drug_common_name": "LACTULOSE",
    "fr_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "fr_drug_common_name": "LACTULOSE",
    "en_ingredients": "LACTULOSE",
    "fr_ingredients": "Lactulose",
    "drug_strength": "667MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1L",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11304,
    "drug": {
      "current_status": "DORMANT",
      "id": 5784,
      "drug_code": 38260,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367182,
          "ingredient": {
            "id": 674,
            "ingredient_code": 2395,
            "en_name": "LACTULOSE",
            "fr_name": "Lactulose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "667",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00703486",
      "brand_name": "PMS-LACTULOSE SYR 667MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "K0863",
      "number_of_ais": "1",
      "ai_group_no": "0113020001"
    },
    "created_date": "2017-05-25T19:49:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00703486",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AD",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2017-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-16T14:24:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "en_drug_common_name": "LACTULOSE",
    "fr_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "fr_drug_common_name": "LACTULOSE",
    "en_ingredients": "LACTULOSE",
    "fr_ingredients": "Lactulose",
    "drug_strength": "667MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "15 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11315,
    "drug": {
      "current_status": "DORMANT",
      "id": 5784,
      "drug_code": 38260,
      "updated_date": "2025-12-03T02:32:16-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367182,
          "ingredient": {
            "id": 674,
            "ingredient_code": 2395,
            "en_name": "LACTULOSE",
            "fr_name": "Lactulose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "667",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00703486",
      "brand_name": "PMS-LACTULOSE SYR 667MG/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "K0863",
      "number_of_ais": "1",
      "ai_group_no": "0113020001"
    },
    "created_date": "2017-05-25T19:52:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00703486",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A06AD",
    "atc_description": "DRUGS FOR CONSTIPATION",
    "actual_start_date": "2017-05-22T00:00:00-04:00",
    "actual_end_date": "2017-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-16T15:40:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "en_drug_common_name": "LACTULOSE",
    "fr_drug_brand_name": "PMS-LACTULOSE SYR 667MG/ML",
    "fr_drug_common_name": "LACTULOSE",
    "en_ingredients": "LACTULOSE",
    "fr_ingredients": "Lactulose",
    "drug_strength": "667MG",
    "drug_dosage_form": "SYRUP",
    "drug_dosage_form_fr": "Sirop",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11318,
    "drug": {
      "current_status": "MARKETED",
      "id": 22084,
      "drug_code": 84460,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257911,
          "ingredient": {
            "id": 3228,
            "ingredient_code": 15568,
            "en_name": "PREGABALIN",
            "fr_name": "Prégabaline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359596",
      "brand_name": "PMS-PREGABALIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151121001"
    },
    "created_date": "2017-05-25T19:55:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359596",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2017-11-01T00:00:00-04:00",
    "actual_start_date": "2017-08-10T00:00:00-04:00",
    "actual_end_date": "2017-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-28T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-PREGABALIN",
    "en_drug_common_name": "PREGABALIN",
    "fr_drug_brand_name": "PMS-PREGABALIN",
    "fr_drug_common_name": "PREGABALIN",
    "en_ingredients": "PREGABALIN",
    "fr_ingredients": "Prégabaline",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11351,
    "drug": {
      "current_status": "DORMANT",
      "id": 16082,
      "drug_code": 76879,
      "updated_date": "2025-12-03T02:32:22-05:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367990,
          "ingredient": {
            "id": 2168,
            "ingredient_code": 932,
            "en_name": "RAMIPRIL",
            "fr_name": "Ramipril"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8367989,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02283174",
      "brand_name": "ALTACE HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0251649004"
    },
    "created_date": "2017-05-26T17:54:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02283174",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "C09BA",
    "atc_description": "ACE INHIBITORS, COMBINATIONS",
    "estimated_end_date": "2017-07-15T00:00:00-04:00",
    "actual_start_date": "2017-05-26T00:00:00-04:00",
    "actual_end_date": "2017-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-09-02T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ALTACE HCT",
    "en_drug_common_name": "ALTACE HCT",
    "fr_drug_brand_name": "ALTACE",
    "fr_drug_common_name": "ALTACE",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nRAMIPRIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nRamipril",
    "drug_strength": "25.0MG\r\n5.0MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "NA",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11354,
    "drug": {
      "current_status": "MARKETED",
      "id": 10444,
      "drug_code": 65700,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253941,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02242029",
      "brand_name": "QVAR",
      "brand_name_fr": "",
      "descriptor": "SOLUTION FOR ORAL INHALATION ONLY",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106320002"
    },
    "created_date": "2017-05-26T17:56:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242029",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "actual_start_date": "2017-05-26T00:00:00-04:00",
    "actual_end_date": "2017-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-06-23T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QVAR",
    "en_drug_common_name": "QVAR",
    "fr_drug_brand_name": "Qvar",
    "fr_drug_common_name": "Qvar",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "50MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "NA",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11357,
    "drug": {
      "current_status": "MARKETED",
      "id": 10446,
      "drug_code": 65701,
      "updated_date": "2025-05-15T02:31:09-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253942,
          "ingredient": {
            "id": 1492,
            "ingredient_code": 7567,
            "en_name": "BECLOMETHASONE DIPROPIONATE",
            "fr_name": "Dipropionate de béclométhasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02242030",
      "brand_name": "QVAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106320003"
    },
    "created_date": "2017-05-26T18:00:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242030",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "actual_start_date": "2017-05-25T00:00:00-04:00",
    "actual_end_date": "2017-06-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-06-23T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "QVAR",
    "en_drug_common_name": "QVAR",
    "fr_drug_brand_name": "Qvar",
    "fr_drug_common_name": "Qvar",
    "en_ingredients": "BECLOMETHASONE DIPROPIONATE",
    "fr_ingredients": "Dipropionate de béclométhasone",
    "drug_strength": "100MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "NA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11360,
    "drug": {
      "current_status": "MARKETED",
      "id": 4982,
      "drug_code": 2866,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250464,
          "ingredient": {
            "id": 1306,
            "ingredient_code": 8566,
            "en_name": "RIFAMPIN",
            "fr_name": "Rifampine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00393444",
      "brand_name": "ROFACT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51695",
      "number_of_ais": "1",
      "ai_group_no": "0105824002"
    },
    "created_date": "2017-05-26T18:02:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00393444",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "J04AB",
    "atc_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
    "estimated_end_date": "2017-06-15T00:00:00-04:00",
    "actual_start_date": "2017-05-25T00:00:00-04:00",
    "actual_end_date": "2017-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-06-16T14:39:33-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ROFACT 150MG",
    "en_drug_common_name": "ROFACT 150MG",
    "fr_drug_brand_name": "ROFACT",
    "fr_drug_common_name": "ROFACT",
    "en_ingredients": "RIFAMPIN",
    "fr_ingredients": "Rifampine",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "NA",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11363,
    "drug": {
      "current_status": "MARKETED",
      "id": 23332,
      "drug_code": 85917,
      "updated_date": "2025-05-15T02:33:03-04:00",
      "company": {
        "id": 12398,
        "created_date": "2019-06-06T21:30:04-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17575,
        "mfr_code": "",
        "name": "BAUSCH HEALTH, CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2150 BOUL. ST-ELZEAR OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 4A8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258412,
          "ingredient": {
            "id": 3742,
            "ingredient_code": 20982,
            "en_name": "COLESEVELAM HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de Colésévélam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "625",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02373955",
      "brand_name": "LODALIS",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153000001"
    },
    "created_date": "2017-05-26T18:03:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02373955",
    "company_name": "VALEANT CANADA LP/VALEANT CANADA S.E.C.",
    "atc_number": "C10AC",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2017-06-01T00:00:00-04:00",
    "actual_start_date": "2017-05-26T00:00:00-04:00",
    "actual_end_date": "2017-06-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-06-02T18:16:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LODALIS",
    "en_drug_common_name": "LODALIS",
    "fr_drug_brand_name": "LODALIS",
    "fr_drug_common_name": "LODALIS",
    "en_ingredients": "Colesevelam hydrochloride",
    "fr_ingredients": "Chlorhydrate de Colésévélam",
    "drug_strength": "625MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "NA",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11366,
    "drug": {
      "current_status": "MARKETED",
      "id": 22276,
      "drug_code": 84680,
      "updated_date": "2025-12-03T00:31:43-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8257970,
          "ingredient": {
            "id": 2544,
            "ingredient_code": 12633,
            "en_name": "FORMOTEROL FUMARATE DIHYDRATE",
            "fr_name": "Fumarate de formotérol dihydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8257969,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02361752",
      "brand_name": "ZENHALE",
      "brand_name_fr": "ZENHALE",
      "descriptor": "SUSPENSION",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252871005"
    },
    "created_date": "2017-05-26T18:59:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361752",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2017-06-05T00:00:00-04:00",
    "actual_start_date": "2017-05-23T00:00:00-04:00",
    "actual_end_date": "2017-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-06-07T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "There is an ongoing investigation.",
    "fr_comments": "IL y a une enquête en cours.",
    "en_drug_brand_name": "ZENHALE",
    "en_drug_common_name": "mometasone furoate & formoterol fumarate dihydrate inhalation aerosol",
    "fr_drug_brand_name": "ZENHALE",
    "fr_drug_common_name": "furoate de mométasone et fumarate de formotérol dihydraté en aérosol pour inhalation",
    "en_ingredients": "FORMOTEROL FUMARATE DIHYDRATE\r\nMOMETASONE FUROATE",
    "fr_ingredients": "Fumarate de formotérol dihydraté\r\nFuroate de mométasone",
    "drug_strength": "5MCG\r\n100MCG",
    "drug_dosage_form": "AEROSOL, METERED DOSE",
    "drug_dosage_form_fr": "Aérosol, dose mesurée",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "60 & 120 dose",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11369,
    "drug": {
      "current_status": "MARKETED",
      "id": 22278,
      "drug_code": 84681,
      "updated_date": "2025-12-03T00:31:43-05:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8257972,
          "ingredient": {
            "id": 348,
            "ingredient_code": 7504,
            "en_name": "MOMETASONE FUROATE",
            "fr_name": "Furoate de mométasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        },
        {
          "id": 8257971,
          "ingredient": {
            "id": 2544,
            "ingredient_code": 12633,
            "en_name": "FORMOTEROL FUMARATE DIHYDRATE",
            "fr_name": "Fumarate de formotérol dihydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02361760",
      "brand_name": "ZENHALE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252871004"
    },
    "created_date": "2017-05-26T19:08:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02361760",
    "company_name": "MERCK CANADA INC",
    "atc_number": "R03AK",
    "atc_description": "ADRENERGICS, INHALANTS",
    "estimated_end_date": "2017-06-05T00:00:00-04:00",
    "actual_start_date": "2017-05-23T00:00:00-04:00",
    "actual_end_date": "2017-06-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-06-07T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "There is an ongoing investigation.",
    "fr_comments": "IL y a une enquête en cours.",
    "en_drug_brand_name": "ZENHALE",
    "en_drug_common_name": "mometasone furoate & formoterol fumarate dihydrate inhalation aerosol",
    "fr_drug_brand_name": "ZENHALE",
    "fr_drug_common_name": "furoate de mométasone et fumarate de formotérol dihydraté en aérosol pour inhalation",
    "en_ingredients": "FORMOTEROL FUMARATE DIHYDRATE\r\nMOMETASONE FUROATE",
    "fr_ingredients": "Fumarate de formotérol dihydraté\r\nFuroate de mométasone",
    "drug_strength": "5MCG\r\n200MCG",
    "drug_dosage_form": "AEROSOL, METERED DOSE",
    "drug_dosage_form_fr": "Aérosol, dose mesurée",
    "drug_route": "INHALATION",
    "drug_route_fr": "Inhalation",
    "drug_package_quantity": "60 & 120 dose",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11376,
    "drug": {
      "current_status": "MARKETED",
      "id": 22708,
      "drug_code": 85245,
      "updated_date": "2025-05-15T02:32:56-04:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258185,
          "ingredient": {
            "id": 2540,
            "ingredient_code": 11733,
            "en_name": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
            "fr_name": "Dichlorhydrate de pramipexole monohydraté"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02367610",
      "brand_name": "PRAMIPEXOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152169002"
    },
    "created_date": "2017-05-26T19:42:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02367610",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "N04BC",
    "atc_description": "DOPAMINERGIC AGENTS",
    "anticipated_start_date": "2017-05-26T00:00:00-04:00",
    "estimated_end_date": "2017-06-16T00:00:00-04:00",
    "actual_start_date": "2017-05-26T00:00:00-04:00",
    "actual_end_date": "2017-06-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2017-06-08T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Delay in release of replenishment batch",
    "fr_comments": "Retard dans la libération du lot de réapprovisionnement",
    "en_drug_brand_name": "PRAMIPEXOLE",
    "en_drug_common_name": "PRAMIPEXOLE TABS",
    "fr_drug_brand_name": "PRAMIPEXOLE",
    "fr_drug_common_name": "PRAMIPEXOLE COMPRIMES",
    "en_ingredients": "PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE",
    "fr_ingredients": "Dichlorhydrate de pramipexole monohydraté",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11383,
    "drug": {
      "current_status": "MARKETED",
      "id": 7358,
      "drug_code": 49687,
      "updated_date": "2025-12-03T00:30:39-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253287,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "720",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253286,
          "ingredient": {
            "id": 486,
            "ingredient_code": 7746,
            "en_name": "HEPATITIS B SURFACE ANTIGEN",
            "fr_name": "Antigène de surface du virus de l'hépatite b (recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02230578",
      "brand_name": "TWINRIX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0265323001"
    },
    "created_date": "2017-05-26T19:56:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230578",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2017-07-11T00:00:00-04:00",
    "actual_start_date": "2017-05-24T00:00:00-04:00",
    "actual_end_date": "2017-07-10T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-07-19T13:54:34-04:00",
    "status": "resolved",
    "en_comments": "Supply disruptions may be seen in the private market. Product under allocation.",
    "fr_comments": "Des ruptures d’approvisionnement pourraient toucher le marché privé. Produit contingenté.",
    "en_drug_brand_name": "TWINRIX",
    "en_drug_common_name": "Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine",
    "fr_drug_brand_name": "TWINRIX",
    "fr_drug_common_name": "Vaccin bivalent contre l’hépatite A (inactivé) et l’hépatite B (recombinant)",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED\r\nHEPATITIS B SURFACE ANTIGEN",
    "fr_ingredients": "Vaccin contre l’hépatite A, inactivé\r\nAntigène de surface de l’hépatite B",
    "drug_strength": "720UNIT\r\n20MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1's",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11406,
    "drug": {
      "current_status": "MARKETED",
      "id": 26952,
      "drug_code": 89213,
      "updated_date": "2025-05-15T02:33:59-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259711,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02407442",
      "brand_name": "MYLAN-NITRO PATCH 0.2",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103615026"
    },
    "created_date": "2017-05-26T21:32:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02407442",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "estimated_end_date": "2017-10-27T00:00:00-04:00",
    "actual_start_date": "2017-10-12T00:00:00-04:00",
    "actual_end_date": "2017-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-10-19T14:06:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NITRO PATCH 0.2",
    "en_drug_common_name": "NITRO PATCH 0.2",
    "fr_drug_brand_name": "MYLAN-NITRO PATCH 0.2",
    "fr_drug_common_name": "NITRO PATCH 0.2",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "20.7MG",
    "drug_dosage_form": "PATCH (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Timbre (à libération prolongée)",
    "drug_route": "TRANSDERMAL",
    "drug_route_fr": "Transdermique",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11431,
    "drug": {
      "current_status": "MARKETED",
      "id": 10084,
      "drug_code": 64696,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 40,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 12250,
        "mfr_code": "",
        "name": "MERCK CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "16750 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-800-567-2594 \r\nmedinfocanada@merck.com"
      },
      "drug_ingredients": [
        {
          "id": 8253832,
          "ingredient": {
            "id": 2740,
            "ingredient_code": 11923,
            "en_name": "TEMOZOLOMIDE",
            "fr_name": "Témozolomide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02241093",
      "brand_name": "TEMODAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0138781001"
    },
    "created_date": "2017-05-29T17:26:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241093",
    "company_name": "MERCK CANADA INC",
    "atc_number": "L01AX",
    "atc_description": "ALKYLATINGAGENTS",
    "anticipated_start_date": "2017-05-29T00:00:00-04:00",
    "estimated_end_date": "2017-06-16T00:00:00-04:00",
    "actual_start_date": "2017-05-29T00:00:00-04:00",
    "actual_end_date": "2017-06-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2017-06-16T13:21:28-04:00",
    "status": "resolved",
    "en_comments": "limited quantity available.  also available in 20 cap sachet.",
    "fr_comments": "Quantités limitées disponibles.  sachet/Quantités disponibles en 20 cap sachet",
    "en_drug_brand_name": "TEMODAL",
    "en_drug_common_name": "temozolomide capsules",
    "fr_drug_brand_name": "TEMODAL",
    "fr_drug_common_name": "capsules de témozolomide",
    "en_ingredients": "TEMOZOLOMIDE",
    "fr_ingredients": "Témozolomide",
    "drug_strength": "5MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "5 cap sachet",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11438,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 4870,
      "drug_code": 2739,
      "updated_date": "2025-05-15T03:25:26-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8273776,
          "ingredient": {
            "id": 1350,
            "ingredient_code": 2167,
            "en_name": "METOPROLOL TARTRATE",
            "fr_name": "Tartrate de métoprolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00397431",
      "brand_name": "LOPRESOR 100MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51125",
      "number_of_ais": "1",
      "ai_group_no": "0111923003"
    },
    "created_date": "2017-05-29T20:25:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00397431",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "C07AB",
    "atc_description": "BETA BLOCKING AGENTS",
    "anticipated_start_date": "2017-05-31T00:00:00-04:00",
    "estimated_end_date": "2018-05-31T00:00:00-04:00",
    "actual_start_date": "2017-07-20T00:00:00-04:00",
    "actual_end_date": "2017-07-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2018-01-09T20:29:15-05:00",
    "status": "resolved",
    "en_comments": "Product discontinued - all stock depleted",
    "fr_comments": "Stock épuisé juillet 2017",
    "en_drug_brand_name": "LOPRESOR 100MG",
    "en_drug_common_name": "LOPRESOR 100MG TABS 100'S",
    "fr_drug_brand_name": "LOPRESOR",
    "fr_drug_common_name": "LOPRESOR 100MG TABS 100'S",
    "en_ingredients": "METOPROLOL TARTRATE",
    "fr_ingredients": "Tartrate de métoprolol",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "1 X 100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11479,
    "drug": {
      "current_status": "MARKETED",
      "id": 3708,
      "drug_code": 19197,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 386,
        "created_date": "2017-03-09T13:22:44-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4047,
        "mfr_code": "DKT08",
        "name": "DIOPTIC PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "136 SPARKS AVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 2S4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252458,
          "ingredient": {
            "id": 1266,
            "ingredient_code": 5532,
            "en_name": "FLUORESCEIN SODIUM",
            "fr_name": "Fluoroscéine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02160773",
      "brand_name": "DIOFLUOR STRIPS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81488",
      "number_of_ais": "1",
      "ai_group_no": "0107752003"
    },
    "created_date": "2017-05-30T13:28:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02160773",
    "company_name": "DIOPTIC PHARMACEUTICALS INC",
    "atc_number": "S01JA",
    "atc_description": "DIAGNOSTICAGENTS",
    "hc_updated_date": "2019-06-25T17:01:11-04:00",
    "anticipated_start_date": "2017-06-19T00:00:00-04:00",
    "actual_end_date": "2019-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2019-06-25T17:01:14-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DIOFLUOR STRIPS",
    "en_drug_common_name": "FLUORESCEIN SODIUM OPHTHALMIC STRIPS",
    "fr_drug_brand_name": "DIOFLUOR STRIPS",
    "fr_drug_common_name": "Fluorescéine Sodium Ophthalmic Strips",
    "en_ingredients": "FLUORESCEIN SODIUM",
    "fr_ingredients": "Fluoroscéine sodique",
    "drug_strength": "1MG",
    "drug_dosage_form": "STRIP",
    "drug_dosage_form_fr": "Bandelette",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "100 strips/box",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 11488,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 27910,
      "drug_code": 90112,
      "updated_date": "2025-05-15T04:21:52-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8354005,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02416522",
      "brand_name": "OLANZAPINE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2017-05-30T14:37:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416522",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2017-06-12T00:00:00-04:00",
    "estimated_end_date": "2017-08-18T00:00:00-04:00",
    "actual_end_date": "2017-08-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-10-18T21:42:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OLANZAPINE FOR INJECTION",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire",
    "drug_package_quantity": "1 VIAL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "marker_a2": false,
    "tier_3": false
  },
  {
    "id": 11491,
    "drug": {
      "current_status": "MARKETED",
      "id": 18048,
      "drug_code": 79242,
      "updated_date": "2025-05-15T02:32:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256348,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02306727",
      "brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2017-05-30T14:54:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02306727",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "anticipated_start_date": "2017-06-05T00:00:00-04:00",
    "estimated_end_date": "2017-07-28T00:00:00-04:00",
    "actual_end_date": "2017-07-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2017-07-18T19:28:49-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
    "en_drug_common_name": "PANTOPRAZOLE",
    "fr_drug_brand_name": "PANTOLOC",
    "fr_drug_common_name": "PANTOPRAZOLE",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "10 VIALS",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": true,
    "tier_3": false
  },
  {
    "id": 11522,
    "drug": {
      "current_status": "MARKETED",
      "id": 276,
      "drug_code": 10748,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251380,
          "ingredient": {
            "id": 210,
            "ingredient_code": 2375,
            "en_name": "CLOTRIMAZOLE",
            "fr_name": "Clotrimazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251379,
          "ingredient": {
            "id": 84,
            "ingredient_code": 7610,
            "en_name": "BETAMETHASONE",
            "fr_name": "Bétaméthasone (Valérate de bétaméthasone)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00611174",
      "brand_name": "LOTRIDERM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70771",
      "number_of_ais": "2",
      "ai_group_no": "0216399001"
    },
    "created_date": "2017-05-30T17:56:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00611174",
    "company_name": "MERCK CANADA INC",
    "atc_number": "D01AC",
    "atc_description": "ANTIFUNGALS FOR TOPICAL USE",
    "anticipated_start_date": "2017-06-06T00:00:00-04:00",
    "estimated_end_date": "2017-09-22T00:00:00-04:00",
    "actual_start_date": "2017-06-01T00:00:00-04:00",
    "actual_end_date": "2017-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2017-09-23T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "LOTRIDERM CREAM",
    "en_drug_common_name": "Clotrimazole and Betamethasone Dipropionate Cream",
    "fr_drug_brand_name": "LOTRIDERM CRÈME",
    "fr_drug_common_name": "Crème de Clotrimazole et de Dipropionate de Bétaméthasone",
    "en_ingredients": "BETAMETHASONE\r\nCLOTRIMAZOLE",
    "fr_ingredients": "Bétaméthasone\r\nClotrimazole",
    "drug_strength": "0.05%\r\n1%",
    "drug_dosage_form": "CREAM",
    "drug_dosage_form_fr": "Crème",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "15g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": true,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "tier_3": false
  },
  {
    "id": 11547,
    "drug": {
      "current_status": "MARKETED",
      "id": 3868,
      "drug_code": 19442,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252489,
          "ingredient": {
            "id": 158,
            "ingredient_code": 5319,
            "en_name": "POTASSIUM PHOSPHATE DIBASIC",
            "fr_name": "Phosphate de potassium dibasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "236",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252488,
          "ingredient": {
            "id": 160,
            "ingredient_code": 6337,
            "en_name": "POTASSIUM PHOSPHATE MONOBASIC",
            "fr_name": "Phosphate de potassium monobasique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "224",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139545",
      "brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81739",
      "number_of_ais": "2",
      "ai_group_no": "0207483001"
    },
    "created_date": "2017-05-30T18:32:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139545",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2024-08-31T00:00:00-04:00",
    "estimated_end_date": "2024-12-02T00:00:00-05:00",
    "actual_end_date": "2024-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-03T06:00:05-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Potassium Phosphates Injection, USP 3 mmol/mL Phosphorus SD Vial 15 mL effective August 31, 2024, until December 2, 2024.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous annoncer qu’en raison de retards de production, une interruption d’approvisionnement va toucher sa présentation de Phosphates de potassium injectables, USP3 mmol/mL, Phosphore, fiole DU, 15 mL du 31 aoȗt 2024 au 2 decembre 2024.",
    "en_drug_brand_name": "POTASSIUM PHOSPHATES INJECTION, USP",
    "en_drug_common_name": "POTASSIUM PHOSPHATES INJECTION, USP",
    "fr_drug_brand_name": "Phosphates de potassium injectables, USP",
    "fr_drug_common_name": "Phosphates de potassium injectables, USP",
    "en_ingredients": "POTASSIUM PHOSPHATE DIBASIC\r\nPOTASSIUM PHOSPHATE MONOBASIC",
    "fr_ingredients": "Phosphate de potassium dibasique\r\nPhosphate de potassium monobasique",
    "drug_strength": "236MG\r\n224MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "15",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_b3": false,
    "tier_3": false
  },
  {
    "id": 11567,
    "drug": {
      "current_status": "DORMANT",
      "id": 26434,
      "drug_code": 88766,
      "updated_date": "2025-12-03T02:32:34-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8368928,
          "ingredient": {
            "id": 2466,
            "ingredient_code": 11561,
            "en_name": "OLOPATADINE",
            "fr_name": "Olopatadine (Chlorhydrate d'olopatadine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02402823",
      "brand_name": "APO-OLOPATADINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132394002"
    },
    "created_date": "2017-05-30T19:09:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402823",
    "company_name": "APOTEX INC",
    "atc_number": "S01GX",
    "atc_description": "DECONGESTANTS AND ANTIALLERGICS",
    "estimated_end_date": "2017-06-30T00:00:00-04:00",
    "actual_start_date": "2017-05-29T00:00:00-04:00",
    "actual_end_date": "2017-06-29T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-30T05:00:01-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLOPATADINE",
    "en_drug_common_name": "OLOPATADINE",
    "fr_drug_brand_name": "APO-OLOPATADINE",
    "fr_drug_common_name": "OLOPATADINE",
    "en_ingredients": "OLOPATADINE",
    "fr_ingredients": "OLOPATADINE",
    "drug_strength": "0.2%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC",
    "drug_route_fr": "Ophtalmique",
    "drug_package_quantity": "2.5 ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "tier_3": false
  },
  {
    "id": 11570,
    "drug": {
      "current_status": "MARKETED",
      "id": 12052,
      "drug_code": 69999,
      "updated_date": "2025-05-15T02:31:19-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254469,
          "ingredient": {
            "id": 2978,
            "ingredient_code": 5863,
            "en_name": "METHAZOLAMIDE",
            "fr_name": "Méthazolamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245882",
      "brand_name": "METHAZOLAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107657001"
    },
    "created_date": "2017-05-30T19:47:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245882",
    "company_name": "AA PHARMA INC",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "actual_start_date": "2017-05-30T00:00:00-04:00",
    "actual_end_date": "2017-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2017-06-03T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "METHAZOLAMIDE",
    "en_drug_common_name": "Methazolamide",
    "fr_drug_brand_name": "Methazolamide",
    "fr_drug_common_name": "Methazolamide",
    "en_ingredients": "METHAZOLAMIDE",
    "fr_ingredients": "Méthazolamide",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "tier_3": false
  }
]